# PEPSICO INC (PEP) FY 2024 MD&A

Verbatim Item 7 Management's Discussion and Analysis from PEPSICO INC's 10-K for fiscal year 2024.

SEC filing source: https://www.sec.gov/Archives/edgar/data/77476/000007747625000007/pep-20241228.htm
Accession: 0000077476-25-000007
Filing date: 2025-02-04
Report date: 2024-12-28
Extracted from a substantive MD&A body after the formal Item 7 span was a TOC or reference stub.
Confidence: high

Company profile: /company/PEP/
All MD&A years: /company/PEP/mda/
Previous year: /company/PEP/mda/fy2023/ (FY 2023)
Next year: /company/PEP/mda/fy2025/ (FY 2025)

Executive Overview

PepsiCo is a leading global food and beverage company with a diverse and complementary portfolio of brands such as Lay’s, Doritos, Cheetos, Gatorade, Pepsi-Cola, Mountain Dew, Quaker and SodaStream. We operate through various channels, including authorized bottlers, contract manufacturers, and other third parties, to produce, market, distribute, and sell a wide array of beverages and convenient foods. Our reach extends to customers and consumers in more than 200 countries and territories around the world.

As a global company with strong local connections, we faced many of the same challenges in 2024 as our consumers, customers, and competitors worldwide. These included ongoing supply chain disruptions, persistent inflationary pressures, evolving consumer preferences and behaviors, an intensely competitive business environment, the continued expansion of e-commerce in a rapidly changing retail landscape, ongoing macroeconomic and political volatility, and an increasingly complex regulatory environment.

In response to these challenges, we have continued to adapt and innovate, reinforcing our resilience and continued focus on growth. We are focused on improving our productivity, optimizing our operations and harnessing our scale and capabilities across our markets, and further elevating the needs, occasions, and channels of consumers in our strategies to lead and shape the future of our categories. This is underpinned by our pep+ (PepsiCo Positive) transformation, now in its fourth year.

A Strategy for the Future: pep+ is our strategy to transform our company to create sustainable growth and value – today, tomorrow, and many years into the future. It is the way we are transforming our supply chain, evolving our portfolio, and making sure we have the right capabilities to support our people and our business throughout the world.

As a food and agricultural leader, we are working to help farmers adapt to climate change through investments in regenerative agriculture, training programs, and innovative technologies. We are operating net-zero water and energy facilities across many markets, electrifying our transport fleets, and accelerating the use of recycled plastics, so we can try to build a more sustainable business while reducing operational costs. Our leadership in regenerative agriculture not only supports farmers and the planet, but also strengthens our supply chain, helping us become more resilient while positioning us to deliver long-term value for shareholders. And thanks to the diversification across our portfolio, our categories, and the geographies in which we operate, we are better equipped to capitalize on opportunities across a wide range of consumer needs.

Our pep+ initiatives and ambitions are geared toward driving growth across every aspect of our operations, so that we can strengthen our business and deliver more value for our stakeholders.

Transforming Our Portfolio: Our consumer-centric portfolio transformation revolves around three key elements: our work to evolve our recipes to reduce sodium, saturated fat, and added sugar, while

34

Table of Contents

incorporating more diverse ingredients; our efforts to find innovative ways to deliver new occasions and engagements for consumers across our existing portfolio; and the strategic acquisition of brands that help us incorporate new and complementary foods and beverages into our portfolio.

Bringing Our Business Closer to the Consumer: We are continuously making investments that aim to help us provide consumers with more value, more personalization, and more choices. We will continue to innovate to create foods, beverages, and experiences that meet consumer needs without compromising the taste or quality they expect.

We are making changes to our organization to help us further increase productivity, sharpen our focus on growth and value, and create opportunities to better harness the expertise and scale of our food and beverage operations across markets. In the United States, we are reorganizing our U.S. Foods and Beverages businesses into one unified North America Region to harness scale, unlock synergies, and accelerate growth through category-leading brands and innovative products. Internationally, we are realigning our international beverages and foods businesses to ensure each category is distinctly managed and has the right resources and capabilities to meet the unique needs of consumers in every market.

North America Business: As part of the changes to our organizational structure, we’re working to enhance our connection with North American consumers, bringing sales and consumer insights closer together, so we can identify and act efficiently on shifts in demand. Combining supply chain operations allows us to harness scale, reduce duplication, and create a more cohesive system for managing inventory and logistics, thereby optimizing our go-to-market strategy and helping drive consistent best practices across the business.

At the same time, the company is focused on expanding our better-for-you offerings and product innovations in both foods and drinks to meet evolving consumer preferences. Through advanced technologies like artificial intelligence, we are optimizing our supply chain, reducing waste, and improving speed to market. These steps ensure the company operates with more precision while protecting margins in an inflationary environment. The immediate focus is on meeting consumer needs, operational excellence, competing for market share, and maintaining agility and resilience. These efforts are foundational to the North America business and driving near-term growth, while setting the stage for long-term success.

Productivity Fuels our Ability to Perform: In 2024, we delivered record productivity. Increases in automation in our plants and warehouses have empowered frontline decision-making, improved optimization across our transportation and fleet networks, and allowed greater focus on cost management and waste elimination. These efforts fuel our ability to reinvest in our brands and capabilities, so that we are well-positioned to support areas in which our business is performing well, while simultaneously allowing us to develop in new ways across our markets and our categories.

Focus on Growth: We remain focused on delivering growth and fueling innovation by driving positive action for people and the planet. By improving our productivity and aligning our operations and strategy to meet consumer needs, we aim to be well positioned to navigate the complexities of the global market and deliver sustainable, long-term value to our consumers and stakeholders.

Our Operations

See “Item 1. Business” for information on our divisions and a description of our distribution network, ingredients and other supplies, brands and intellectual property rights, seasonality, customers, competition, research and development, regulatory matters and human capital. In addition, see Note 1 to our consolidated financial statements for financial information about our divisions and geographic areas.

35

Table of Contents

Other Relationships

Certain members of our Board also serve on the boards of certain vendors and customers. These Board members do not participate in our vendor selection and negotiations nor in our customer negotiations. Our transactions with these vendors and customers are in the normal course of business and are consistent with terms negotiated with other vendors and customers. In addition, certain of our employees serve on the boards of Pepsi Bottling Ventures LLC and other affiliated companies of PepsiCo and do not receive incremental compensation for such services.

Our Business Risks

Risks Associated with Commodities and Our Supply Chain

During 2024, we continued to experience higher operating costs, including on transportation and labor costs, which may continue in 2025. Many of the commodities used in the production and transportation of our products are purchased in the open market. The prices we pay for such items are subject to fluctuation, and we manage this risk through the use of fixed-price contracts and purchase orders, pricing agreements and derivative instruments, including swaps and futures. A number of external factors, including volatile geopolitical conditions, the inflationary cost environment, adverse weather conditions, supply chain disruptions and labor shortages, have impacted and may continue to impact transportation and labor costs. When prices increase, we may or may not pass on such increases to our customers, which may result in reduced volume, revenue, margins and operating results.

See Note 9 to our consolidated financial statements for further information on how we manage our exposure to commodity prices.

Risks Associated with Climate Change

Certain jurisdictions in which our products are made, manufactured, distributed or sold have either imposed, or are considering imposing, new or increased legal and regulatory requirements to reduce or mitigate the potential effects of climate change, including regulation of greenhouse gas emissions and potential carbon pricing programs. These new or increased legal or regulatory requirements, along with initiatives to meet our sustainability goals, could result in significant increased costs and additional investments in facilities and equipment. However, we are unable to predict the scope, nature and timing of any new or increased environmental laws and regulations and therefore cannot predict the ultimate impact of such laws and regulations on our business or financial results. We continue to monitor existing and proposed laws and regulations in the jurisdictions in which our products are made, manufactured, distributed and sold and to consider actions we may take to potentially mitigate the unfavorable impact, if any, of such laws or regulations.

Risks Associated with International Operations

We are subject to risks in the normal course of business that are inherent to international operations. During the periods presented in this report, volatile economic, political, social and geopolitical conditions, civil unrest and wars and other military conflicts, acts of terrorism and natural disasters and other catastrophic events in certain markets in which our products are made, manufactured, distributed or sold, including in Argentina, Brazil, China, Mexico, the Middle East, Pakistan, Russia, Turkey and Ukraine, continue to result in challenging operating environments and have resulted in and could continue to result in changes in how we operate in certain of these markets. Debt and credit issues, currency controls or fluctuations in certain of these international markets (including restrictions on the transfer of funds to and from certain markets), as well as the threat or imposition of new, expanded or retaliatory tariffs (including recent U.S. tariffs imposed or threatened to be imposed on China, Canada and Mexico and other countries and any retaliatory actions taken by such countries), sanctions or export controls have also continued to impact our operations in certain of these international markets. We continue to closely monitor the

36

Table of Contents

economic, operating and political environment in the markets in which we operate, including risks of additional impairments or write-offs and currency devaluation, and to identify actions to potentially mitigate any unfavorable impacts on our future results.

Our operations in Russia accounted for 4% of our consolidated net revenue for each of the years ended December 28, 2024 and December 30, 2023. Russia accounted for 3% and 3% of our consolidated assets, 10% and 6% of our consolidated cash and cash equivalents, and 41% and 35% of our accumulated currency translation adjustment loss as of December 28, 2024 and December 30, 2023, respectively. Our operations in Ukraine accounted for less than 1% of our consolidated net revenue for each of the years ended December 28, 2024 and December 30, 2023 and of our consolidated assets as of December 28, 2024 and December 30, 2023.

See Notes 1 and 4 to our consolidated financial statements for a discussion of impairment and other charges recognized in the years ended December 28, 2024, December 30, 2023, and December 31, 2022.

Imposition of Taxes and Regulations on our Products

Certain jurisdictions in which our products are made, manufactured, distributed or sold have either imposed, or are considering imposing, new or increased taxes or regulations on the manufacture, distribution or sale of our products or their packaging, ingredients or substances contained in, or attributes of, our products or their packaging, commodities used in the production of our products or their packaging or the recyclability or recoverability of our packaging. These taxes and regulations vary in scope and form. For example, some taxes apply to all beverages, including non-caloric beverages, while others apply only to beverages with a caloric sweetener (e.g., sugar). Further, some regulations apply to all products using certain types of packaging (e.g., plastic), while others are designed to increase the sustainability of packaging, encourage waste reduction and increased recycling rates or facilitate the waste management process or restrict the sale of products in certain packaging. In addition, certain jurisdictions in which our snack products are sold have either imposed or are considering imposing, new or increased taxes on the manufacture, distribution or sale of certain of our snack products as a result of ingredients (such as sugar, sodium or saturated fat) contained in our products.

We sell a wide variety of beverages and convenient foods in more than 200 countries and territories and the profile of the products we sell, the amount of revenue attributable to such products and the type of packaging used vary by jurisdiction. Because of this, we cannot predict the scope or form potential taxes, regulations or other limitations on our products or their packaging may take, and therefore cannot predict the impact of such taxes, regulations or limitations on our financial results. In addition, taxes, regulations and limitations may impact us and our competitors differently. We expect continued scrutiny of certain ingredients and substances present in certain of our products and packaging. We continue to monitor existing and proposed taxes and regulations in the jurisdictions in which our products are made, manufactured, distributed and sold and to consider actions we may take to potentially mitigate the unfavorable impact, if any, of such taxes, regulations or limitations, including advocating alternative measures with respect to the imposition, form and scope of any such taxes, regulations or limitations.

OECD Global Minimum Tax

Numerous countries, including European Union member states, have enacted, or are expected to enact, legislation incorporating the OECD model rules for a global minimum tax rate of 15%. Widespread implementation is expected by the end of 2025, with certain countries that have not yet enacted potentially applying the legislation as of a retroactive date. As the legislation becomes effective in countries in which we do business, our taxes could increase and negatively impact our provision for income taxes. We will continue to monitor pending legislation and implementation by individual countries and evaluate the potential impact on our business in future periods.

37

Table of Contents

Retail Landscape

Our industry continues to be affected by disruption of the retail landscape, including the continued growth in sales through e-commerce websites and mobile commerce applications, including through subscription services, the integration of physical and digital operations among retailers and the international expansion of hard discounters. We have seen and expect to continue to see a further shift to e-commerce, online-to-offline and other online purchasing by consumers. We continue to monitor changes in the retail landscape and seek to identify actions we may take to build our global e-commerce and digital capabilities, such as expanding our direct-to-consumer business, and distribute our products effectively through all existing and emerging channels of trade and potentially mitigate any unfavorable impacts on our future results.

The retail industry also continues to be impacted by the actions and increasing power of retailers, including as a result consolidation of ownership resulting in large retailers or buying groups with increased purchasing power, particularly in North America, Europe and Latin America. We have seen and expect to continue to see retailers and buying groups impact our ability to compete in these jurisdictions. We continue to monitor our relationships with retailers and buying groups and seek to identify actions we may take to maintain mutually beneficial relationships and resolve any significant disputes and potentially mitigate any unfavorable impacts on our future results.

See also “Item 1A. Risk Factors,” “Executive Overview” above and “Market Risks” below for more information about these risks and the actions we have taken to address key challenges.

Risk Management Framework

The achievement of our strategic and operating objectives involves risks, many of which evolve over time. To identify, assess, prioritize, address, manage, monitor and communicate these risks across the Company’s operations and foster a corporate culture of integrity and risk awareness, we leverage an integrated risk management framework. This framework includes the following:

•PepsiCo’s Board has oversight responsibility for PepsiCo’s integrated risk management framework. One of the Board’s primary responsibilities is overseeing and interacting with senior management with respect to key aspects of the Company’s business, including risk assessment and risk mitigation of the Company’s top risks. Throughout the year, the Board and relevant Committees of the Board receive updates from management with respect to various enterprise risk management issues and dedicate a portion of their meetings to reviewing and discussing specific risk topics in greater detail, including risks related to cybersecurity, food safety, sustainability, human capital management and supply chain and commodity inflation. The Board receives and provides feedback on regular updates from management regarding the Company’s top risks, including updates from members of management responsible for overseeing impacted areas (for example, the Chief Strategy and Transformation Officer and Chief Information Security Officer), governance processes associated with managing these risks, the status of projects to strengthen the Company’s risk mitigation efforts and recent incidents impacting the industry and threat landscape. Given that cybersecurity risks can impact various areas of responsibility of the Committees of the Board, the Board believes it is useful and effective for the full Board to maintain direct oversight over cybersecurity matters. In evaluating top risks, the Board and management consider short-, medium- and long-term potential impacts on the Company’s business, financial condition and results of operations, including looking at the internal and external environment when evaluating risks, risk amplifiers and emerging trends, and considers the risk horizon as part of prioritizing the Company’s risk mitigation efforts. The Board receives updates through presentations, memos and other written materials, teleconferences and other appropriate means of communication, with numerous opportunities for discussion and feedback, and continuously evaluates its approach in addressing top risks as circumstances evolve. For

38

Table of Contents

example, as part of risk updates to the Board and relevant Committees during 2024, the Board or its relevant Committee were provided updates on the impact of disruptive events, including geopolitical events and tensions in certain international markets, such as the Russia-Ukraine conflict. The Board also receives periodic updates from external experts and advisers on global macroeconomic trends and conditions that may impact the Company’s strategy and financial performance, including geopolitical conflicts, economic instability, labor market trends, changing consumer behavior, retail disruption and digitalization.

The Board has tasked designated Committees of the Board with oversight of certain categories of risk management, and the Committees report to the Board regularly on these matters.

◦The Audit Committee of the Board reviews and assesses the guidelines and policies governing PepsiCo’s risk management and oversight processes, and assists the Board’s oversight of financial, compliance and employee safety risks facing PepsiCo. The Audit Committee also assists the Board’s oversight of the Company’s compliance with legal and regulatory requirements and the Chief Compliance & Ethics Officer, who reports to the General Counsel, meets regularly with the Audit Committee, including in executive session without management present;

◦The Compensation Committee of the Board reviews PepsiCo’s employee compensation policies and practices to assess whether such policies and practices could lead to unnecessary risk-taking behavior;

◦The Nominating and Corporate Governance Committee assists the Board in its oversight of the Company’s governance structure and other corporate governance matters, including succession planning; and

◦The Sustainability, Diversity and Public Policy Committee of the Board assists the Board in its oversight of PepsiCo’s policies, programs and related risks that concern key sustainability (including climate change), diversity, and public policy matters.

•The PepsiCo Risk Committee (PRC) meets regularly to identify, assess, prioritize and address top strategic, financial, operating, compliance, safety, reputational and other risks. The PRC is also responsible for reporting progress on our risk mitigation efforts to the Board and designated Committees. The PRC is comprised of a cross-functional, geographically diverse, senior management group, including PepsiCo’s Chairman of the Board of Directors and Chief Executive Officer, Chief Financial Officer, General Counsel, Sector Chief Executive Officers, and the heads of Enterprise Risk, Corporate Affairs, Human Resources, Research & Development, Information Technology, Sustainability, Strategy, Transformation, International Beverages, Commercial, Global Operations and Marketing;

•Division and key market risk committees, comprised of cross-functional senior management teams, meet regularly to identify, assess, prioritize and address division and country-specific business risks;

•PepsiCo’s Risk Management Office, which manages the overall risk management process, provides ongoing guidance, tools and analytical support to the PRC and the division and key country risk committees, identifies and assesses potential risks and facilitates ongoing communication between the parties, as well as with PepsiCo’s Board, the Audit Committee of the Board and other Committees of the Board;

•PepsiCo’s Internal Audit Department evaluates the ongoing effectiveness of our key internal controls through periodic audit and review procedures; and

39

Table of Contents

•PepsiCo’s Compliance & Ethics and Law Departments lead and coordinate our compliance policies and practices.

•PepsiCo’s Disclosure Committee, comprised of the General Counsel, Controller and heads of Internal Audit, Financial Planning & Analysis and Investor Relations, evaluates information from PepsiCo’s integrated risk management framework as part of the Disclosure Committee’s monitoring of the integrity and effectiveness of the Company’s disclosure controls and procedures. PepsiCo’s risk oversight processes and disclosure controls and procedures are designed to appropriately escalate key risks to the Board as well as to analyze potential risks for disclosure.

Market Risks

We are exposed to market risks arising from adverse changes in:

•commodity prices, affecting the cost of our raw materials and energy;

•foreign exchange rates and currency restrictions; and

•interest rates.

In the normal course of business, we manage commodity price, foreign exchange and interest rate risks through a variety of strategies, including productivity initiatives, global purchasing programs and hedging. Ongoing productivity initiatives involve the identification and effective implementation of meaningful cost-saving opportunities or efficiencies, including the use of derivatives. Our global purchasing programs include fixed-price contracts and purchase orders and pricing agreements. See “Item 1A. Risk Factors” for further discussion of our market risks.

The fair value of our derivatives fluctuates based on market rates and prices. The sensitivity of our derivatives to these market fluctuations is discussed below. See Note 9 to our consolidated financial statements for further discussion of these derivatives and our hedging policies. The fair value of our indefinite-lived intangible assets is impacted by changes in market conditions, including interest rates and inflationary, deflationary and recessionary conditions. See “Our Critical Accounting Policies and Estimates” for a discussion of the exposure of our goodwill and other intangible assets and pension and retiree medical plan assets and liabilities to risks related to market fluctuations.

Inflationary, deflationary and recessionary conditions impacting these market risks also impact the demand for and pricing of our products. See “Item 1A. Risk Factors” for further discussion.

Commodity Prices

Our commodity derivative contracts had a total notional value of $1.4 billion as of December 28, 2024 and $1.7 billion as of December 30, 2023. At the end of 2024, the potential change in fair value of commodity derivative contracts, assuming a 10% decrease in the underlying commodity price, would have increased our net unrealized losses in 2024 by $140 million, which would generally be offset by a reduction in the cost of the underlying commodity purchases.

Foreign Exchange

Our operations outside of the United States generated 44% of our consolidated net revenue in 2024, with Mexico, Russia, Canada, China, the United Kingdom, South Africa and Brazil, collectively, comprising approximately 25% of our consolidated net revenue in 2024. As a result, we are exposed to foreign exchange risks in the international markets in which our products are made, manufactured, distributed or sold. Additionally, we are exposed to foreign exchange risk from net investments in foreign subsidiaries, foreign currency purchases, foreign currency assets and liabilities created in the normal course of business. During 2024, unfavorable foreign exchange reduced net revenue performance by 1.5 percentage points,

40

Table of Contents

primarily due to declines in the Egyptian pound, Russian ruble, Mexican peso and Brazilian real. Currency declines against the U.S. dollar which are not offset could adversely impact our future financial results.

Our foreign exchange derivative contracts had a total notional value of $3.1 billion as of December 28, 2024 and $3.8 billion as of December 30, 2023. At the end of 2024, we estimate that an unfavorable 10% change in the underlying exchange rates would have decreased our net unrealized gains in 2024 by $319 million, which would be significantly offset by an inverse change in the fair value of the underlying exposure.

Our cross-currency swap contracts had a total notional value of $1.2 billion as of December 28, 2024 and $1.3 billion as of December 30, 2023. At the end of 2024, we estimate that an unfavorable 10% change in the underlying exchange rates would have increased our net unrealized losses in 2024 by $107 million, which would be significantly offset by an inverse change in the fair value of the underlying exposure.

The total notional amount of our debt instruments designated as net investment hedges was $2.9 billion as of December 28, 2024 and $3.0 billion as of December 30, 2023.

Interest Rates

Our interest rate swap contracts had a total notional value of $2.0 billion as of December 28, 2024. Assuming year-end 2024 investment levels and variable rate debt, a 1-percentage-point increase in interest rates would have decreased our net interest expense in 2024 by $32 million due to higher cash and cash equivalents and short-term investments levels, as compared with our variable rate debt.

OUR FINANCIAL RESULTS

Results of Operations — Consolidated Review

Volume

Physical or unit volume is one of the key metrics management uses internally to make operating and strategic decisions, including the preparation of our annual operating plan and the evaluation of our business performance. We believe volume provides additional information to facilitate the comparison of our historical operating performance and underlying trends, and provides additional transparency on how we evaluate our business because it measures demand for our products at the consumer level. Unit volume performance adjusts for the impacts of acquisitions and divestitures. Acquisitions and divestitures, when used in this report, reflect mergers and acquisitions activity, as well as divestitures and other structural changes, including changes in ownership or control in consolidated subsidiaries and nonconsolidated equity investees. Further, unit volume performance excludes the impact of a 53rd reporting week, where applicable. Our fiscal year ends on the last Saturday of each December, resulting in an additional reporting week every five or six years (53rd reporting week).

Beverage volume includes volume of concentrate sold to independent bottlers and volume of finished products bearing company-owned or licensed trademarks and allied brand products and joint venture trademarks sold by company-owned bottling operations. Beverage volume also includes volume of finished products bearing company-owned or licensed trademarks sold by our noncontrolled affiliates. Concentrate volume sold to independent bottlers is reported in concentrate shipments and equivalents (CSE), whereas finished beverage product volume is reported in bottler case sales (BCS). Both CSE and BCS convert all beverage volume to an 8-ounce-case metric. Typically, CSE and BCS are not equal in any given period due to seasonality, timing of product launches, product mix, bottler inventory practices and other factors. While our net revenue is not entirely based on BCS volume due to the independent bottlers in our supply chain, we believe that BCS is a better measure of the consumption of our beverage products. PBNA, LatAm, Europe, AMESA and APAC, either independently or in conjunction with third parties, make, market, distribute and sell ready-to-drink tea products through a joint venture with Unilever (under

41

Table of Contents

the Lipton brand name), and PBNA, either independently or in conjunction with third parties, makes, markets, distributes and sells ready-to-drink coffee products through a joint venture with Starbucks.

Convenient food volume includes volume sold by us and our noncontrolled affiliates of convenient food products bearing company-owned or licensed trademarks. Internationally, we measure convenient food product volume in kilograms, while in North America we measure convenient food product volume in pounds. FLNA makes, markets, distributes and sells Sabra refrigerated dips and spreads through a joint venture with Strauss Group. In December 2024, we acquired the Strauss Group’s 50% ownership in Sabra and Sabra became a wholly-owned subsidiary.

Consolidated Net Revenue and Operating Profit

[[GREPCENT_TABLE]]
[["","2024","","2023","","Change"],["Net revenue","$","91,854","","","$","91,471","","","\u2014","%"],["Operating profit","$","12,887","","","$","11,986","","","8","%"],["Operating margin","14.0","%","","13.1","%","","0.9"]]
[[/GREPCENT_TABLE]]

See “Results of Operations – Division Review” for a tabular presentation and discussion of key drivers of net revenue.

Operating profit increased 8% and operating margin improved 0.9 percentage points. Operating profit growth was primarily driven by effective net pricing, productivity savings and an 18-percentage-point impact of prior-year impairment charges related to the SodaStream business. These impacts were partially offset by certain operating cost increases, a decline in organic volume, an 8-percentage-point impact of higher impairment and other charges associated with our TBG investment and Juice Transaction-related receivables, a 5-percentage-point impact of higher restructuring charges and a 4-percentage-point unfavorable impact of an indirect tax reserve. Corporate unallocated expenses reflect a 3-percentage-point favorable impact driven primarily by a decrease in corporate expenses and prior-year contributions to The PepsiCo Foundation, Inc.

Other Consolidated Results 

[[GREPCENT_TABLE]]
[["","2024","","2023","","Change"],["Other pension and retiree medical benefits (expense)/income","$","(22)","","","$","250","","","$","(272)"],["Net interest expense and other","$","919","","","$","819","","","$","100"],["Annual tax rate","19.4","%","","19.8","%"],["Net income attributable to PepsiCo","$","9,578","","","$","9,074","","","5.5","%"],["Net income attributable to PepsiCo per common share \u2013 diluted","$","6.95","","","$","6.56","","","6","%"]]
[[/GREPCENT_TABLE]]

Other pension and retiree medical benefits expense increased $272 million, primarily reflecting higher settlement charges due to lump sum distributions to retired or terminated employees and the purchase of a group annuity contract whereby a third-party insurance company assumed the obligation to pay and administer future benefit payments for certain retirees.

Net interest expense and other increased $100 million, primarily due to higher interest rates on debt and higher average debt balances, partially offset by higher average cash balances and higher interest rates on average cash balances.

The reported tax rate decreased 0.4 percentage points, primarily reflecting a reduction in the state tax rate.

42

Table of Contents

Results of Operations — Division Review

See “Our Business Risks,” “Non-GAAP Measures” and “Items Affecting Comparability” for a discussion of items to consider when evaluating our results and related information regarding measures not in accordance with U.S. Generally Accepted Accounting Principles (GAAP).

In the discussions of net revenue and operating profit below, “effective net pricing” reflects the year-over-year impact of discrete pricing actions, sales incentive activities and mix resulting from selling varying products in different package sizes and in different countries.

Net Revenue and Organic Revenue Performance

Organic revenue performance is a non-GAAP financial measure. For further information on this measure, see “Non-GAAP Measures.”

[[GREPCENT_TABLE]]
[["","2024"],["","","","Impact of","","","","Impact of"],["","Reported % Change, GAAP Measure","","Foreign exchange translation","","Acquisitions and divestitures","","","","","","","","Organic % Change, Non-GAAP Measure(a)","","Organic volume(b)","","Effective net pricing"],["FLNA","(1)","%","","\u2014","","","\u2014","","","","","","","","","(0.5)","%","","(2.5)","","","2"],["QFNA (c)","(14)","%","","\u2014","","","\u2014","","","","","","","","","(14)","%","","(14)","","","0.5"],["PBNA","0.5","%","","\u2014","","","\u2014","","","","","","","","","1","%","","(3.5)","","","4"],["LatAm","0.5","%","","3","","","\u2014","","","","","","","","","4","%","","(2)","","","5"],["Europe","5","%","","2","","","\u2014","","","","","","","","","7","%","","2","","","6"],["AMESA","1","%","","9","","","\u2014","","","","","","","","","10","%","","1","","","9"],["APAC","1","%","","2","","","\u2014","","","","","","","","","3","%","","4","","","(1)"],["Total","\u2014","%","","1.5","","","\u2014","","","","","","","","","2","%","","(2)","","","4"]]
[[/GREPCENT_TABLE]]

(a)Amounts may not sum due to rounding.

(b)Excludes the impact of acquisitions and divestitures. In certain instances, the impact of organic volume on net revenue performance differs from the unit volume change disclosed in the following divisional discussions due to the impacts of product mix, nonconsolidated joint venture volume, and, for our franchise-owned beverage businesses, temporary timing differences between BCS and CSE. We report net revenue from our franchise-owned beverage businesses based on CSE. The volume sold by our nonconsolidated joint ventures has no direct impact on our net revenue.

(c)Net revenue decline was impacted by a previously announced voluntary recall of certain bars and cereals in our QFNA division (Quaker Recall).

43

Table of Contents

Operating Profit, Operating Profit Adjusted for Items Affecting Comparability and Operating Profit Performance Adjusted for Items Affecting Comparability on a Constant Currency Basis

Operating profit adjusted for items affecting comparability and operating profit performance adjusted for items affecting comparability on a constant currency basis are both non-GAAP financial measures. For further information on these measures, see “Non-GAAP Measures” and “Items Affecting Comparability.”

Operating Profit and Operating Profit Adjusted for Items Affecting Comparability

[[GREPCENT_TABLE]]
[["","2024"],["","","","Items Affecting Comparability(a)"],["","Reported, GAAP Measure","","Mark-to-market net impact","","Restructuring and impairment charges","","Acquisition and divestiture-related charges","","","","","","","","","","Impairment and other charges","","Product recall-related impact","","Indirect tax impact","","Core, Non-GAAP Measure"],["FLNA","$","6,316","","","$","\u2014","","","$","150","","","$","9","","","","","","","","","","","$","\u2014","","","$","\u2014","","","$","\u2014","","","$","6,475"],["QFNA","303","","","\u2014","","","11","","","\u2014","","","","","","","","","","","9","","","184","","","\u2014","","","507"],["PBNA","2,302","","","\u2014","","","238","","","8","","","","","","","","","","","556","","","\u2014","","","\u2014","","","3,104"],["LatAm","2,245","","","\u2014","","","51","","","\u2014","","","","","","","","","","","\u2014","","","\u2014","","","218","","","2,514"],["Europe","2,019","","","\u2014","","","123","","","\u2014","","","","","","","","","","","145","","","\u2014","","","\u2014","","","2,287"],["AMESA","798","","","\u2014","","","14","","","5","","","","","","","","","","","\u2014","","","\u2014","","","\u2014","","","817"],["APAC","811","","","\u2014","","","10","","","\u2014","","","","","","","","","","","4","","","\u2014","","","\u2014","","","825"],["Corporate unallocated expenses","(1,907)","","","(25)","","","101","","","\u2014","","","","","","","","","","","\u2014","","","\u2014","","","\u2014","","","(1,831)"],["Total","$","12,887","","","$","(25)","","","$","698","","","$","22","","","","","","","","","","","$","714","","","$","184","","","$","218","","","$","14,698"]]
[[/GREPCENT_TABLE]]

[[GREPCENT_TABLE]]
[["","2023"],["","","","Items Affecting Comparability(a)"],["","Reported, GAAP Measure","","Mark-to-market net impact","","Restructuring and impairment charges","","Acquisition and divestiture-related charges","","Impairment and other charges/credits","","Product recall-related impact","","Core, Non-GAAP Measure"],["FLNA","$","6,755","","","$","\u2014","","","$","42","","","$","\u2014","","","$","\u2014","","","$","\u2014","","","$","6,797"],["QFNA","492","","","\u2014","","","\u2014","","","\u2014","","","\u2014","","","136","","","628"],["PBNA","2,584","","","\u2014","","","41","","","16","","","321","","","\u2014","","","2,962"],["LatAm","2,252","","","\u2014","","","29","","","\u2014","","","2","","","\u2014","","","2,283"],["Europe","767","","","\u2014","","","223","","","(2)","","","855","","","\u2014","","","1,843"],["AMESA","807","","","\u2014","","","15","","","2","","","(7)","","","\u2014","","","817"],["APAC","713","","","\u2014","","","8","","","\u2014","","","59","","","\u2014","","","780"],["Corporate unallocated expenses","(2,384)","","","36","","","88","","","25","","","\u2014","","","\u2014","","","(2,235)"],["Total","$","11,986","","","$","36","","","$","446","","","$","41","","","$","1,230","","","$","136","","","$","13,875"]]
[[/GREPCENT_TABLE]]

(a)See “Items Affecting Comparability.”

44

Table of Contents

Operating Profit Performance and Operating Profit Performance Adjusted for Items Affecting Comparability on a Constant Currency Basis

[[GREPCENT_TABLE]]
[["","2024"],["","","","Impact of Items Affecting Comparability(a)","","","","","","Impact of"],["","Reported % Change, GAAP Measure","","Mark-to-market net impact","","Restructuring and impairment charges","","Acquisition and divestiture-related charges","","","","","","","","","","","Impairment and other charges/credits","","Product recall-related impact","","Indirect tax impact","","Core % Change, Non-GAAP Measure(b)","","Foreign exchange translation","","Core Constant Currency % Change, Non-GAAP Measure(b)"],["FLNA","(7)","%","","\u2014","","","2","","","\u2014","","","","","","","","","","","","\u2014","","","\u2014","","","\u2014","","","(5)","%","","\u2014","","","(5)","%"],["QFNA","(38)","%","","\u2014","","","3","","","\u2014","","","","","","","","","","","","3","","","14","","","\u2014","","","(19)","%","","\u2014","","","(19)","%"],["PBNA","(11)","%","","\u2014","","","7","","","\u2014","","","","","","","","","","","","9","","","\u2014","","","\u2014","","","5","%","","\u2014","","","5","%"],["LatAm","\u2014","%","","\u2014","","","1","","","\u2014","","","","","","","","","","","","\u2014","","","\u2014","","","10","","","10","%","","3","","","13","%"],["Europe","163","%","","\u2014","","","(17)","","","\u2014","","","","","","","","","","","","(122)","","","\u2014","","","\u2014","","","24","%","","3","","","27","%"],["AMESA","(1)","%","","\u2014","","","\u2014","","","0.5","","","","","","","","","","","","1","","","\u2014","","","\u2014","","","\u2014","%","","8","","","9","%"],["APAC","14","%","","\u2014","","","\u2014","","","\u2014","","","","","","","","","","","","(8)","","","\u2014","","","\u2014","","","6","%","","3","","","8","%"],["Corporate unallocated expenses","(20)","%","","2","","","\u2014","","","1","","","","","","","","","","","","\u2014","","","\u2014","","","\u2014","","","(18)","%","","\u2014","","","(18)","%"],["Total","8","%","","(1)","","","5","","","\u2014","","","","","","","","","","","","(10)","","","1","","","4","","","6","%","","2","","","8","%"]]
[[/GREPCENT_TABLE]]

(a)See “Items Affecting Comparability.”

(b)Amounts may not sum due to rounding.

FLNA

Net revenue decreased 1%, primarily driven by a decrease in organic volume, partially offset by effective net pricing.

Unit volume declined 2.5%, primarily driven by mid-single-digit declines in trademark Cheetos and trademark Tostitos and low-single-digit declines in trademark Lay’s and variety packs, partially offset by double-digit growth in trademark Chester’s and trademark Miss Vickie’s.

Operating profit decreased 7%, primarily reflecting certain operating cost increases, including strategic initiatives, and the decrease in organic volume. These impacts were partially offset by productivity savings and the effective net pricing.

QFNA

Net revenue decreased 14%, primarily driven by a decrease in organic volume, which was negatively impacted by the loss of sales from products included in the Quaker Recall.

Unit volume declined 14%, primarily driven by double-digit declines in bars, oatmeal, pancake syrup and mix and ready-to-eat cereals. The unit volume decline in bars and ready-to-eat cereals was negatively impacted by the loss of sales from products included in the Quaker Recall.

Operating profit decreased 38%, primarily reflecting the decrease in organic volume, certain operating cost increases and a 14-percentage-point impact of charges associated with the Quaker Recall, partially offset by productivity savings, a 12-percentage-point favorable impact of an insurance recovery related to the Quaker Recall, lower advertising and marketing expenses and effective net pricing.

PBNA

Net revenue increased 0.5%, primarily driven by effective net pricing, partially offset by an organic volume decline.

Unit volume declined 3%, driven by a 4% decline in non-carbonated beverage (NCB) volume and a 2% decline in CSD volume. The NCB volume decline primarily reflected a mid-single-digit decline in our overall water portfolio, a low-single-digit decline in Gatorade sports drinks and a high-single-digit decline in our Lipton ready-to-drink tea portfolio.

45

Table of Contents

Operating profit decreased 11%, primarily driven by certain operating cost increases, the decline in organic volume, a 9-percentage-point impact of higher impairment and other charges associated with our TBG investment and Juice Transaction-related receivables, a 7-percentage-point impact of higher restructuring charges and higher advertising and marketing expenses. These impacts were partially offset by the effective net pricing and productivity savings.

LatAm

Net revenue increased 0.5%, reflecting effective net pricing, partially offset by a 3-percentage-point impact of unfavorable foreign exchange translation and a net decline in organic volume.

Convenient foods unit volume declined 2%, primarily reflecting double-digit declines in Peru and Argentina, partially offset by low-single-digit growth in Brazil. Additionally, Mexico experienced a low-single-digit decline.

Beverage unit volume grew slightly, primarily reflecting mid-single-digit growth in Brazil and low-single-digit growth in Mexico, Guatemala and Chile, partially offset by a double-digit decline in Colombia and high-single-digit declines in Argentina and Peru.

Operating profit decreased slightly, primarily reflecting certain operating cost increases, a 10-percentage-point unfavorable impact of an indirect tax reserve, the net organic volume decline, higher advertising and marketing expenses and a 3-percentage-point impact of unfavorable foreign exchange translation, partially offset by the effective net pricing, productivity savings and a 5-percentage-point impact of lower commodity costs.

Europe

Net revenue increased 5%, primarily reflecting effective net pricing and organic volume growth, partially offset by a 2-percentage-point impact of unfavorable foreign exchange translation.

Convenient foods unit volume grew 2%, primarily reflecting mid-single-digit growth in Russia and low-single-digit growth in the United Kingdom, partially offset by a high-single-digit decline in France and a mid-single-digit decline in the Netherlands. Additionally, Turkey experienced low-single-digit growth.

Beverage unit volume grew 2%, primarily reflecting mid-single-digit growth in Russia and low-single-digit growth in Turkey, partially offset by a double-digit decline in France and a slight decline in Germany. Additionally, the United Kingdom experienced low-single-digit growth.

Operating profit increased 163%, primarily reflecting a 148-percentage-point favorable impact of the prior-year impairment charges related to the SodaStream business, the net revenue growth, productivity savings and a 17-percentage-point favorable impact of lower restructuring charges. These impacts were partially offset by certain operating cost increases, a 23-percentage-point impact of impairment and other charges associated with our TBG investment and Juice Transaction-related receivables, an 8-percentage-point impact of higher commodity costs and higher advertising and marketing costs.

AMESA

Net revenue increased 1%, primarily reflecting effective net pricing and organic volume growth, partially offset by a 9-percentage-point impact of unfavorable foreign exchange translation.

Convenient foods unit volume grew 2%, primarily reflecting mid-single-digit growth in South Africa and double-digit growth in India, partially offset by double-digit declines in the Middle East and Pakistan.

Beverage unit volume grew 1%, primarily reflecting double-digit growth in India, partially offset by a low-single-digit decline in the Middle East, a mid-single-digit decline in Pakistan and a high-single-digit decline in Nigeria.

46

Table of Contents

Operating profit decreased 1%, primarily reflecting certain operating cost increases, a 33-percentage-point impact of higher commodity costs, primarily packaging materials, potatoes and other ingredients, largely driven by transaction-related foreign exchange and an 8-percentage-point impact of unfavorable foreign exchange translation. These impacts were partially offset by the net revenue growth and productivity savings.

APAC

Net revenue increased 1%, primarily reflecting organic volume growth, partially offset by a 2-percentage-point impact of unfavorable foreign exchange translation and unfavorable net pricing.

Convenient foods unit volume grew 4%, primarily reflecting double-digit growth in Thailand and mid-single-digit growth in China. Additionally, Australia experienced mid-single-digit growth.

Beverage unit volume grew 1%, primarily reflecting high-single-digit growth in Vietnam, mid-single-digit growth in Thailand and low-single-digit growth in the Philippines, partially offset by a low-single-digit decline in China.

Operating profit increased 14%, primarily reflecting productivity savings, the organic volume growth, a 9-percentage-point favorable impact of impairment charges related to the Be & Cheery brand in the prior year and a 5-percentage-point impact of lower commodity costs. These impacts were partially offset by certain operating cost increases and the unfavorable net pricing.

Non-GAAP Measures

Certain financial measures contained in this Form 10-K adjust for the impact of specified items and are not in accordance with GAAP. We use non-GAAP financial measures internally to make operating and strategic decisions, including the preparation of our annual operating plan, evaluation of our overall business performance and as a factor in determining compensation for certain employees. We believe presenting non-GAAP financial measures in this Form 10-K provides additional information to facilitate comparison of our historical operating results and trends in our underlying operating results and provides additional transparency on how we evaluate our business. We also believe presenting these measures in this Form 10-K allows investors to view our performance using the same measures that we use in evaluating our financial and business performance and trends.

We consider quantitative and qualitative factors in assessing whether to adjust for the impact of items that may be significant or that could affect an understanding of our ongoing financial and business performance or trends. Examples of items for which we may make adjustments include: amounts related to mark-to-market gains or losses (non-cash); charges related to restructuring plans; charges associated with acquisitions and divestitures; gains associated with divestitures; asset impairment charges (non-cash); product recall-related impact; pension and retiree medical-related amounts, including all settlement and curtailment gains and losses; charges or adjustments related to the enactment of new laws, rules or regulations, such as tax law changes; amounts related to the resolution of tax positions; tax benefits related to reorganizations of our operations; debt redemptions, cash tender or exchange offers; and remeasurements of net monetary assets. See below and “Items Affecting Comparability” for a description of adjustments to our GAAP financial measures in this Form 10-K. 

Non-GAAP information should be considered as supplemental in nature and is not meant to be considered in isolation or as a substitute for the related financial information prepared in accordance with GAAP. In addition, our non-GAAP financial measures may not be the same as or comparable to similar non-GAAP measures presented by other companies.

47

Table of Contents

The following non-GAAP financial measures contained in this Form 10-K are discussed below:

Cost of sales, gross profit, selling, general and administrative expenses, impairment of intangible assets, other pension and retiree medical benefits expense/income, net interest expense and other, provision for income taxes, net income attributable to noncontrolling interests and net income attributable to PepsiCo, each adjusted for items affecting comparability, operating profit and net income attributable to PepsiCo per common share – diluted, each adjusted for items affecting comparability, and the corresponding constant currency growth rates

These measures exclude the net impact of mark-to-market gains and losses on centrally managed commodity derivatives that do not qualify for hedge accounting, restructuring and impairment charges related to our 2019 Multi-Year Productivity Plan (2019 Productivity Plan), charges associated with our acquisitions and divestitures, impairment and other charges/credits, product recall-related impact, indirect tax expense related to an international audit and the impact of settlement and curtailment gains and losses related to pension and retiree medical plans (see “Items Affecting Comparability” for a detailed description of each of these items). We also evaluate performance on operating profit and net income attributable to PepsiCo per common share – diluted, each adjusted for items affecting comparability, on a constant currency basis, which measure our financial results assuming constant foreign currency exchange rates used for translation based on the rates in effect for the comparable prior-year period. In order to compute our constant currency results, we multiply or divide, as appropriate, our current-year U.S. dollar results by the current-year average foreign exchange rates and then multiply or divide, as appropriate, those amounts by the prior-year average foreign exchange rates. We believe these measures provide useful information in evaluating the results of our business because they exclude items that we believe are not indicative of our ongoing performance or that we believe impact comparability with the prior year.

Organic revenue performance

We define organic revenue performance as a measure that adjusts for the impacts of foreign exchange translation, acquisitions and divestitures, and every five or six years, the impact of the 53rd reporting week. Adjusting for acquisitions and divestitures reflects mergers and acquisitions activity, as well as divestitures and other structural changes, including changes in ownership or control in consolidated subsidiaries and nonconsolidated equity investees. We believe organic revenue performance provides useful information in evaluating the results of our business because it excludes items that we believe are not indicative of ongoing performance or that we believe impact comparability with the prior year.

See “Net Revenue and Organic Revenue Performance” in “Results of Operations – Division Review” for further information.

Free cash flow

We define free cash flow as net cash from operating activities less capital spending, plus sales of property, plant and equipment. Since net capital spending is essential to our product innovation initiatives and maintaining our operational capabilities, we believe that it is a recurring and necessary use of cash. As such, we believe investors should also consider net capital spending when evaluating our cash from operating activities. Free cash flow is used by us primarily for acquisitions and financing activities, including debt repayments, dividends and share repurchases. Free cash flow is not a measure of cash available for discretionary expenditures since we have certain non-discretionary obligations such as debt service that are not deducted from the measure.

See “Free Cash Flow” in “Our Liquidity and Capital Resources” for further information.

48

Table of Contents

Return on invested capital (ROIC) and net ROIC, excluding items affecting comparability

We define ROIC as net income attributable to PepsiCo plus interest expense after-tax divided by the sum of quarterly average debt obligations and quarterly average common shareholders’ equity. Although ROIC is a common financial metric, numerous methods exist for calculating ROIC. Accordingly, the method used by management to calculate ROIC may differ from the methods other companies use to calculate their ROIC.

We believe this metric serves as a measure of how well we use our capital to generate returns. In addition, we use net ROIC, excluding items affecting comparability, to compare our performance over various reporting periods on a consistent basis because it removes from our operating results the impact of items that we believe are not indicative of our ongoing performance and reflects how management evaluates our operating results and trends. We define net ROIC, excluding items affecting comparability, as ROIC, adjusted for quarterly average cash, cash equivalents and short-term investments, after-tax interest income and items affecting comparability. We believe the calculation of ROIC and net ROIC, excluding items affecting comparability, provides useful information to investors and is an additional relevant comparison of our performance to consider when evaluating our capital allocation efficiency.

See “Return on Invested Capital” in “Our Liquidity and Capital Resources” for further information.

Items Affecting Comparability

Our reported financial results in this Form 10-K are impacted by the following items in each of the following years: 

[[GREPCENT_TABLE]]
[["","","","2024"],["","","","Cost of sales","","Gross profit","","Selling, general and administrative expenses","","","","Impairment of intangible assets","","","","Operating profit","","","","Other pension and retiree medical benefits (expense)/income","","","","Provision for income taxes(a)","","","","Net income attributable to PepsiCo"],["Reported, GAAP Measure","","","$","41,744","","","$","50,110","","","$","37,190","","","","","$","33","","","","","$","12,887","","","","","$","(22)","","","","","$","2,320","","","","","$","9,578"],["Items Affecting Comparability"],["Mark-to-market net impact","","","26","","","(26)","","","(1)","","","","","\u2014","","","","","(25)","","","","","\u2014","","","","","(6)","","","","","(19)"],["Restructuring and impairment charges","","","(133)","","","133","","","(551)","","","","","(14)","","","","","698","","","","","29","","","","","164","","","","","563"],["Acquisition and divestiture-related charges","","","\u2014","","","\u2014","","","(22)","","","","","\u2014","","","","","22","","","","","\u2014","","","","","4","","","","","18"],["Impairment and other charges","","","\u2014","","","\u2014","","","(695)","","","","","(19)","","","","","714","","","","","\u2014","","","","","184","","","","","530"],["Product recall-related impact","","","(176)","","","176","","","(8)","","","","","\u2014","","","","","184","","","","","3","","","","","44","","","","","143"],["Indirect tax impact","","","(218)","","","218","","","\u2014","","","","","\u2014","","","","","218","","","","","\u2014","","","","","\u2014","","","","","218"],["Pension and retiree medical-related impact","","","\u2014","","","\u2014","","","\u2014","","","","","\u2014","","","","","\u2014","","","","","276","","","","","61","","","","","215"],["Core, Non-GAAP Measure","","","$","41,243","","","$","50,611","","","$","35,913","","","","","$","\u2014","","","","","$","14,698","","","","","$","286","","","","","$","2,771","","","","","$","11,246"]]
[[/GREPCENT_TABLE]]

49

Table of Contents

[[GREPCENT_TABLE]]
[["","2023"],["","Cost of sales","","Gross profit","","Selling, general and administrative expenses","","","","Impairment of intangible assets","","Operating profit","","Other pension and retiree medical benefits income","","","","","","Provision for income taxes(a)","","Net income attributable to noncontrolling interests","","Net income attributable to PepsiCo"],["Reported, GAAP Measure","$","41,881","","","$","49,590","","","$","36,677","","","","","$","927","","","$","11,986","","","$","250","","","","","","","$","2,262","","","$","81","","","$","9,074"],["Items Affecting Comparability"],["Mark-to-market net impact","(3)","","","3","","","(33)","","","","","\u2014","","","36","","","\u2014","","","","","","","9","","","\u2014","","","27"],["Restructuring and impairment charges","(13)","","","13","","","(433)","","","","","\u2014","","","446","","","(1)","","","","","","","96","","","1","","","348"],["Acquisition and divestiture-related charges","\u2014","","","\u2014","","","(41)","","","","","\u2014","","","41","","","\u2014","","","","","","","18","","","\u2014","","","23"],["Impairment and other charges/credits","5","","","(5)","","","(308)","","","","","(927)","","","1,230","","","\u2014","","","","","","","284","","","\u2014","","","946"],["Product recall-related impact","(136)","","","136","","","\u2014","","","","","\u2014","","","136","","","\u2014","","","","","","","32","","","\u2014","","","104"],["Pension and retiree medical-related impact","\u2014","","","\u2014","","","\u2014","","","","","\u2014","","","\u2014","","","14","","","","","","","3","","","\u2014","","","11"],["Core, Non-GAAP Measure","$","41,734","","","$","49,737","","","$","35,862","","","","","$","\u2014","","","$","13,875","","","$","263","","","","","","","$","2,704","","","$","82","","","$","10,533"]]
[[/GREPCENT_TABLE]]

(a)Provision for income taxes is the expected tax charge/benefit on the underlying item based on the tax laws and income tax rates applicable to the underlying item in its corresponding tax jurisdiction.

[[GREPCENT_TABLE]]
[["","2024","","2023","","Change"],["Net income attributable to PepsiCo per common share \u2013 diluted, GAAP measure","$","6.95","","","$","6.56","","","6","%"],["Mark-to-market net impact","(0.01)","","","0.02"],["Restructuring and impairment charges","0.41","","","0.25"],["Acquisition and divestiture-related charges","0.01","","","0.02"],["Impairment and other charges/credits","0.38","","","0.68"],["Product recall-related impact","0.10","","","0.07"],["Indirect tax impact","0.16","","","\u2014"],["Pension and retiree medical-related impact","0.16","","","0.01"],["Core net income attributable to PepsiCo per common share \u2013 diluted, non-GAAP measure","$","8.16","","","$","7.62","","(a)","7","%"],["Impact of foreign exchange translation","","","","","2"],["Growth in core net income attributable to PepsiCo per common share \u2013 diluted, on a constant currency basis, non-GAAP measure","","","","","9","%"]]
[[/GREPCENT_TABLE]]

(a)Does not sum due to rounding.

Mark-to-Market Net Impact

We centrally manage commodity derivatives on behalf of our divisions. These commodity derivatives include agricultural products, metals, and energy. Commodity derivatives that do not qualify for hedge accounting treatment are marked to market each period with the resulting gains and losses recorded in corporate unallocated expenses as either cost of sales or selling, general and administrative expenses, depending on the underlying commodity. These gains and losses are subsequently reflected in division results when the divisions recognize the cost of the underlying commodity in operating profit. Therefore, the divisions realize the economic effects of the derivative without experiencing any resulting mark-to-market volatility, which remains in corporate unallocated expenses.

Restructuring and Impairment Charges

2019 Multi-Year Productivity Plan

The 2019 Productivity Plan leverages new technology and business models to further simplify, harmonize and automate processes; re-engineers our go-to-market and information systems, including deploying the right automation for each market; and simplifies our organization and optimizes our manufacturing and supply chain footprint. To build on the successful implementation of the 2019 Productivity Plan, in the fourth quarter of 2024, we further expanded and extended the plan through the end of 2030 to take advantage of additional opportunities within the initiatives described above. As a result, we expect to incur

50

Table of Contents

pre-tax charges of approximately $6.15 billion, including cash expenditures of approximately $5.1 billion, as compared to our previous estimate of pre-tax charges of approximately $3.65 billion, including cash expenditures of approximately $2.9 billion. Plan to date through December 28, 2024, we have incurred pre-tax charges of $2.6 billion, including cash expenditures of $1.9 billion. In our 2025 financial results, we expect to incur pre-tax charges of approximately $900 million, including cash expenditures of approximately $800 million. These charges will be funded primarily through cash from operations. We expect to incur the majority of the remaining pre-tax charges and cash expenditures through 2027, with the balance to be incurred through 2030. Charges include severance and other employee costs, asset impairments and other costs.

See Note 3 to our consolidated financial statements for further information related to our 2019 Productivity Plan. We regularly evaluate productivity initiatives beyond the productivity plan and other initiatives discussed above and in Note 3 to our consolidated financial statements.

Acquisition and Divestiture-Related Charges

Acquisition and divestiture-related charges primarily include transaction expenses, such as consulting, advisory and other professional fees, and merger and integration charges. Merger and integration charges include employee-related costs, contract termination costs, closing costs and other integration costs.

See Note 13 to our consolidated financial statements for further information.

Impairment and Other Charges/Credits

We recognized Russia-Ukraine conflict charges, brand portfolio impairment charges and other impairment charges as described below.

Russia-Ukraine Conflict Charges

In connection with the ongoing conflict in Ukraine, we recognized charges related to indefinite-lived intangible assets and property, plant and equipment impairment, allowance for expected credit losses, inventory write-downs and other costs in 2022. We also recognized adjustments to these charges in 2023.

See Notes 1 and 4 to our consolidated financial statements for further information.

Brand Portfolio Impairment Charges

We recognized intangible asset, investment and property, plant and equipment impairments and other charges as a result of management’s decision to reposition or discontinue the sale/distribution of certain brands and to sell an investment in 2022. We also recognized adjustments to these charges in 2023.

See Notes 1 and 4 to our consolidated financial statements for further information.

Other Impairment Charges

We recognized impairment charges taken as a result of our quantitative assessments of certain of our indefinite-lived intangible assets and related to our investment in TBG. In addition, we recorded allowance for expected credit losses related to outstanding receivables from TBG associated with the Juice Transaction.

See Notes 1, 4 and 9 to our consolidated financial statements for further information.

Product Recall-Related Impact

We recognized product returns, inventory write-offs and customer and consumer-related costs in our QFNA division associated with a voluntary recall of certain bars and cereals.

See Note 1 to our consolidated financial statements for further information.

51

Table of Contents

Indirect Tax Impact

We recognized additional expenses related to an indirect tax reserve in our LatAm division.

Pension and Retiree Medical-Related Impact

Pension and retiree medical-related impact includes settlement charges due to lump sum distributions to retired or terminated employees and the purchase of a group annuity contract whereby a third-party insurance company assumed the obligation to pay and administer future benefit payments for certain retirees. The settlement charge was triggered when the aggregate of the cumulative lump sum distributions and the annuity contract premium exceeded the total annual service and interest costs. Pension and retiree medical-related impact also includes curtailment losses due to restructuring actions as part of our 2019 Productivity Plan.

See Notes 7 and 13 to our consolidated financial statements for further information.

Our Liquidity and Capital Resources

We believe that our cash generating capability and financial condition, together with our revolving credit facilities, working capital lines and other available methods of debt financing, such as commercial paper borrowings and long-term debt financing, will be adequate to meet our operating, investing and financing needs, including with respect to our net capital spending plans. Our primary sources of liquidity include cash from operations, proceeds obtained from issuances of commercial paper and long-term debt, and cash and cash equivalents. These sources of cash are available to fund cash outflows that have both a short- and long-term component, including debt repayments and related interest payments; payments for acquisitions; operating leases; purchase, marketing, and other contractual commitments, including capital expenditures and the transition tax liability under the Tax Cuts and Jobs Act (TCJ Act). In addition, these sources of cash fund other cash outflows including anticipated dividend payments and share repurchases. We do not have guarantees or off-balance sheet financing arrangements, including variable interest entities, that we believe could have a material impact on our liquidity. See “Item 1A. Risk Factors,” “Our Business Risks” and Note 8 to our consolidated financial statements for further information.

As of December 28, 2024, cash, cash equivalents and short-term investments in our consolidated subsidiaries subject to currency controls or currency exchange restrictions were not material.

The TCJ Act imposed a one-time mandatory transition tax on undistributed international earnings. As of December 28, 2024, our mandatory transition tax liability was $1.7 billion, which must be paid through 2026 under the provisions of the TCJ Act; we currently expect to pay approximately $772 million of this liability in 2025. Any additional guidance issued by the Internal Revenue Service (IRS) may impact our recorded amounts for this transition tax liability. See Note 5 to our consolidated financial statements for further discussion of the TCJ Act.

Supply chain financing arrangements did not have a material impact on our liquidity or capital resources in the periods presented and we do not expect such arrangements to have a material impact on our liquidity or capital resources for the foreseeable future. See Note 14 to our consolidated financial statements for further discussion of supply chain financing arrangements.

Furthermore, our cash provided from operating activities is somewhat impacted by seasonality. Working capital needs are impacted by weekly sales, which are generally highest in the third quarter due to seasonal and holiday-related patterns and generally lowest in the first quarter. On a continuing basis, we consider various transactions to increase shareholder value and enhance our business results, including acquisitions, divestitures, joint ventures, dividends, share repurchases, productivity and other efficiency initiatives and other structural changes. These transactions may result in future cash proceeds or payments.

52

Table of Contents

The table below summarizes our cash activity: 

[[GREPCENT_TABLE]]
[["","2024","","2023"],["Net cash provided by operating activities","$","12,507","","","$","13,442"],["Net cash used for investing activities","$","(5,472)","","","$","(5,495)"],["Net cash used for financing activities","$","(7,556)","","","$","(3,009)"]]
[[/GREPCENT_TABLE]]

Operating Activities

In 2024, net cash provided by operating activities was $12.5 billion, compared to $13.4 billion in the prior year. The decrease in operating cash flow primarily reflects unfavorable working capital comparisons.

Investing Activities

In 2024, net cash used for investing activities was $5.5 billion, primarily reflecting net capital spending of $5.0 billion.

In 2023, net cash used for investing activities was $5.5 billion, primarily reflecting net capital spending of $5.3 billion.

See Note 1 to our consolidated financial statements for further discussion of capital spending by division and see Note 13 to our consolidated financial statements for further discussion of our acquisitions.

We regularly review our plans with respect to net capital spending and believe that we have sufficient liquidity to meet our net capital spending needs.

Financing Activities

In 2024, net cash used for financing activities was $7.6 billion, primarily reflecting the return of operating cash flow to our shareholders through dividend payments and share repurchases of $8.2 billion, as well as payments of long-term debt borrowings of $3.9 billion, partially offset by proceeds from the issuances of long-term debt of $4.0 billion.

In 2023, net cash used for financing activities was $3.0 billion, primarily reflecting the return of operating cash flow to our shareholders through dividend payments and share repurchases of $7.7 billion, as well as payments of long-term debt borrowings of $3.0 billion, partially offset by proceeds from issuances of long-term debt of $5.5 billion and net proceeds from short-term borrowings of $2.3 billion.

See Note 8 to our consolidated financial statements for further discussion of debt obligations.

We annually review our capital structure with our Board, including our dividend policy and share repurchase activity. On February 10, 2022, we announced a share repurchase program providing for the repurchase of up to $10.0 billion of PepsiCo common stock which commenced on February 11, 2022 and will expire on February 28, 2026. In addition, on February 4, 2025, we announced a 5% increase in our annualized dividend to $5.69 per share from $5.42 per share, effective with the dividend expected to be paid in June 2025. We expect to return a total of approximately $8.6 billion to shareholders in 2025, comprising dividends of approximately $7.6 billion and share repurchases of approximately $1.0 billion.

53

Table of Contents

Free Cash Flow

The table below reconciles net cash provided by operating activities, as reflected on our cash flow statement, to our free cash flow. Free cash flow is a non-GAAP financial measure. For further information on free cash flow, see “Non-GAAP Measures.”

[[GREPCENT_TABLE]]
[["","2024","","2023","","Change"],["Net cash provided by operating activities, GAAP measure","$","12,507","","","$","13,442","","","(7)","%"],["Capital spending","(5,318)","","","(5,518)"],["Sales of property, plant and equipment","342","","","198"],["Free cash flow, non-GAAP measure","$","7,531","","","$","8,122","","","(7)","%"]]
[[/GREPCENT_TABLE]]

We use free cash flow primarily for acquisitions and financing activities, including debt repayments, dividends and share repurchases. We expect to continue to return free cash flow to our shareholders primarily through dividends and share repurchases while maintaining Tier 1 commercial paper access, which we believe will facilitate appropriate financial flexibility and ready access to global capital and credit markets at favorable interest rates. However, see “Item 1A. Risk Factors” and “Our Business Risks” for certain factors that may impact our credit ratings or our operating cash flows.

Any downgrade of our credit ratings by a credit rating agency, especially any downgrade to below investment grade, whether or not as a result of our actions or factors which are beyond our control, could increase our future borrowing costs and impair our ability to access capital and credit markets on terms commercially acceptable to us, or at all. In addition, any downgrade of our current short-term credit ratings could impair our ability to access the commercial paper market with the same flexibility that we have experienced historically, and therefore require us to rely more heavily on more expensive types of debt financing. See “Item 1A. Risk Factors,” “Our Business Risks” and Note 8 to our consolidated financial statements for further information.

Changes in Line Items in Our Consolidated Financial Statements

Changes in line items in the income statement are discussed in “Results of Operations – Consolidated Review,” “Results of Operations – Division Review” and “Items Affecting Comparability.”

Changes in line items in the cash flow statement are discussed in “Our Liquidity and Capital Resources.”

Changes in line items in the balance sheet are discussed below:

Total Assets

As of December 28, 2024, total assets were $99.5 billion, compared to $100.5 billion as of December 30, 2023. The decrease in total assets is primarily driven by the following line item:

[[GREPCENT_TABLE]]
[["","Change(a)"],["Cash and cash equivalents (b)","$","(1.2)"]]
[[/GREPCENT_TABLE]]

(a)In billions.

(b)Refer to the cash flow statement for further information.

Total Liabilities

As of December 28, 2024, total liabilities were $81.3 billion, compared to $81.9 billion as of December 30, 2023. There were no material line item changes. See Notes 8 and 13 for further information regarding our liabilities.

Total Equity

See the equity statement and Notes 9 and 11 to our consolidated financial statements.

54

Table of Contents

Return on Invested Capital

ROIC is a non-GAAP financial measure. For further information on ROIC, see “Non-GAAP Measures.”

[[GREPCENT_TABLE]]
[["","2024"],["Net income attributable to PepsiCo","$","9,578"],["Interest expense","1,606"],["Tax on interest expense","(357)"],["","$","10,827"],["Average debt obligations (a)","$","44,844"],["Average common shareholders\u2019 equity (b)","18,898"],["Average invested capital","$","63,742"],["ROIC, non-GAAP measure","17.0","","%"]]
[[/GREPCENT_TABLE]]

(a)Includes a quarterly average of short-term and long-term debt obligations.

(b)Includes a quarterly average of common stock, capital in excess of par value, retained earnings, accumulated other comprehensive loss and repurchased common stock.

The table below reconciles ROIC as calculated above to net ROIC, excluding items affecting comparability.

[[GREPCENT_TABLE]]
[["","2024"],["ROIC, non-GAAP measure","17.0","","%"],["Impact of:"],["Average cash, cash equivalents and short-term investments","2.6"],["Interest income","(1.0)"],["Tax on interest income","0.2"],["Mark-to-market net impact (a)","\u2014"],["Restructuring and impairment charges (a)","0.6"],["Acquisition and divestiture-related charges (a)","\u2014"],["Impairment and other charges/credits (a)","0.5"],["Product recall-related impact (a)","0.1"],["Indirect tax impact (a)","0.2"],["Pension and retiree medical-related impact (a)","0.2"],["Core Net ROIC, non-GAAP measure","20.4","","%"]]
[[/GREPCENT_TABLE]]

(a)See “Items Affecting Comparability” for a detailed description.

OUR CRITICAL ACCOUNTING POLICIES AND ESTIMATES

An appreciation of our critical accounting policies and estimates is necessary to understand our financial results. These policies may require management to make difficult and subjective judgments regarding uncertainties, including the business and economic uncertainty resulting from volatile geopolitical conditions and the high interest rate and inflationary cost environment, and as a result, such estimates may significantly impact our financial results. The precision of these estimates and the likelihood of future changes depend on a number of underlying variables and a range of possible outcomes. We applied our critical accounting policies and estimation methods consistently in all material respects and for all periods presented. We have discussed our critical accounting policies and estimates with our Audit Committee.

55

Table of Contents

Our critical accounting policies and estimates are:

•revenue recognition;

•goodwill and other intangible assets;

•income tax expense and accruals; and

•pension and retiree medical plans.

Revenue Recognition

We recognize revenue when our performance obligation is satisfied. Our primary performance obligation (the distribution and sales of beverage and convenient food products) is satisfied upon the shipment or delivery of products to our customers, which is also when control is transferred. The transfer of control of products to our customers is typically based on written sales terms that generally do not allow for a right of return, except in the instance of a product recall or other limited circumstances that may allow for product returns. Our policy for DSD, including certain chilled products, is to remove and replace damaged and out-of-date products from store shelves to ensure that consumers receive the product quality and freshness they expect. Similarly, our policy for certain warehouse-distributed products is to replace damaged and out-of-date products. As a result, we record reserves, based on estimates, for product recall, anticipated damaged and out-of-date products.

Our products are sold for cash or on credit terms. Our credit terms, which are established in accordance with local and industry practices, typically require payment within 30 days of delivery in the United States, and generally within 30 to 90 days internationally, and may allow discounts for early payment.

We estimate and reserve for our expected credit loss exposure based on our experience with past due accounts and collectibility, write-off history, the aging of accounts receivable, our analysis of customer data, and forward-looking information (including the expected impact of a high interest rate and inflationary cost environment), leveraging estimates of creditworthiness and projections of default and recovery rates for certain of our customers.

Our policy is to provide customers with product when needed. In fact, our commitment to freshness and product dating serves to regulate the quantity of product shipped or delivered. In addition, DSD products are placed on the shelf by our employees with customer shelf space and storerooms limiting the quantity of product. For product delivered through other distribution networks, we monitor customer inventory levels.

As discussed in “Our Customers” in “Item 1. Business,” we offer sales incentives and discounts through various programs to customers and consumers. Total marketplace spending includes sales incentives, discounts, advertising and other marketing activities. Sales incentives and discounts are primarily accounted for as a reduction of revenue and include payments to customers for performing activities on our behalf, such as payments for in-store displays, payments to gain distribution of new products, payments for shelf space and discounts to promote lower retail prices. Sales incentives and discounts also include support provided to our independent bottlers through funding of advertising and other marketing activities.

A number of our sales incentives, such as bottler funding to independent bottlers and customer volume rebates, are based on annual targets, and accruals are established during the year, as products are delivered, for the expected payout, which may occur after year-end once reconciled and settled. These accruals are based on contract terms and our historical experience with similar programs and require management judgment with respect to estimating customer and consumer participation and performance levels. Differences between estimated expense and actual incentive costs are normally insignificant and

56

Table of Contents

are recognized in earnings in the period such differences are determined. In addition, certain advertising and marketing costs are also based on annual targets and recognized during the year as incurred.

See Note 2 to our consolidated financial statements for further information on our revenue recognition and related policies, including total marketplace spending.

Goodwill and Other Intangible Assets

We sell products under a number of brand names, many of which were developed by us. Brand development costs are expensed as incurred. We also purchase brands and other intangible assets in acquisitions. In a business combination, the consideration is first assigned to identifiable assets and liabilities, including brands and other intangible assets, based on estimated fair values, with any excess recorded as goodwill. Determining fair value requires significant estimates and assumptions, including those related to volatile geopolitical conditions and a high interest rate and inflationary cost environment, based on an evaluation of a number of factors, such as marketplace participants, product life cycles, market share, consumer awareness, brand history and future expansion expectations, amount and timing of future cash flows and the discount rate applied to the cash flows.

We believe that a brand has an indefinite life if it has a history of strong revenue and cash flow performance and we have the intent and ability to support the brand with marketplace spending for the foreseeable future. If these indefinite-lived brand criteria are not met, brands are amortized over their expected useful lives, which generally range from 20 to 40 years. Determining the expected life of a brand requires management judgment and is based on an evaluation of a number of factors, including market share, consumer awareness, brand history, future expansion expectations and regulatory restrictions, as well as the macroeconomic environment of the countries in which the brand is sold.

In connection with previous acquisitions, we reacquired certain franchise rights which provided the exclusive and perpetual rights to manufacture and/or distribute beverages for sale in specified territories. In determining the useful life of these franchise rights, many factors were considered, including the pre-existing perpetual bottling arrangements, the indefinite period expected for these franchise rights to contribute to our future cash flows, as well as the lack of any factors that would limit the useful life of these franchise rights to us, including legal, regulatory, contractual, competitive, economic or other factors. Therefore, certain of these franchise rights are considered as indefinite-lived. Franchise rights that are not considered indefinite-lived are amortized over the remaining contractual period of the contract in which the right was granted.

Indefinite-lived intangible assets and goodwill are not amortized and, as a result, are assessed for impairment at least annually, using either a qualitative or quantitative approach. We perform this annual assessment during our third quarter, or more frequently if circumstances indicate that the carrying value may not be recoverable. Where we use the qualitative assessment, first we determine if, based on qualitative factors, it is more likely than not that an impairment exists. Factors considered include macroeconomic conditions (including those related to volatile geopolitical conditions and a high interest rate and inflationary cost environment), industry and competitive conditions, legal and regulatory environment, historical financial performance and significant changes in the brand or reporting unit. If the qualitative assessment indicates that it is more likely than not that an impairment exists, then a quantitative assessment is performed.

In the quantitative assessment for indefinite-lived intangible assets and goodwill, an assessment is performed to determine the fair value of the indefinite-lived intangible asset and the reporting unit, respectively. Estimated fair value is determined using discounted cash flows and requires an analysis of several estimates including future cash flows or income consistent with management’s strategic business plans, annual sales growth rates, perpetuity growth assumptions and the selection of assumptions underlying a discount rate (weighted-average cost of capital) based on market data available at the time.

57

Table of Contents

Significant management judgment is necessary to estimate the impact of competitive operating, macroeconomic and other factors (including those related to volatile geopolitical conditions and a high interest rate and inflationary cost environment) to estimate future levels of sales, operating profit or cash flows. All assumptions used in our impairment evaluations for indefinite-lived intangible assets and goodwill, such as forecasted growth rates (including perpetuity growth assumptions) and weighted-average cost of capital, are based on the best available market information and are consistent with our internal forecasts and operating plans. A deterioration in these assumptions could adversely impact our results. Additionally, indefinite-lived intangible assets acquired in recent acquisitions are more susceptible to impairment because they are recorded at fair value at the time of acquisition. These assumptions could be adversely impacted by certain of the risks described in “Item 1A. Risk Factors” and “Our Business Risks.”

As of December 28, 2024, the estimated fair value of the SodaStream reporting unit narrowly exceeded its carrying value. Given the low coverage, there could be further impairment to the carrying value of the SodaStream reporting unit goodwill if future sales and operating profit results are not in line with the forecasted future cash flows of the business and/or if macroeconomic conditions worsen and drive an increase in the weighted-average cost of capital used to estimate its fair value. We continue to monitor the performance of the SodaStream reporting unit, as well as all of our indefinite-lived intangible assets.

Amortizable intangible assets are only evaluated for impairment upon a significant change in the operating or macroeconomic environment. If an evaluation of the undiscounted future cash flows indicates impairment, the asset is written down to its estimated fair value, which is based on its discounted future cash flows.

See Note 2 and Note 4 to our consolidated financial statements for further information.

Income Tax Expense and Accruals

Our annual tax rate is based on our income, statutory tax rates and tax structure and transactions, including transfer pricing arrangements, available to us in the various jurisdictions in which we operate. Significant judgment is required in determining our annual tax rate and in evaluating our tax positions. We establish reserves when, despite our belief that our tax return positions are fully supportable, we believe that certain positions are subject to challenge and that we likely will not succeed. We adjust these reserves, as well as the related interest, in light of changing facts and circumstances, such as the progress of a tax audit, new tax laws, relevant court cases or tax authority settlements. See “Item 1A. Risk Factors” for further discussion.

An estimated annual effective tax rate is applied to our quarterly operating results. In the event there is a significant or unusual item recognized in our quarterly operating results, the tax attributable to that item is separately calculated and recorded at the same time as that item. We consider the tax adjustments from the resolution of prior-year tax matters to be among such items.

Tax law requires items to be included in our tax returns at different times than the items are reflected in our consolidated financial statements. As a result, our annual tax rate reflected in our consolidated financial statements is different than that reported in our tax returns (our cash tax rate). Some of these differences are permanent, such as expenses that are not deductible in our tax return, and some differences reverse over time, such as depreciation expense. These temporary differences create deferred tax assets and liabilities. Deferred tax assets generally represent items that can be used as a tax deduction or credit in our tax returns in future years for which we have already recorded the tax benefit on our consolidated financial statements. We establish valuation allowances for our deferred tax assets if, based on the available evidence, it is not more likely than not that some portion or all of the deferred tax assets will be realized. Deferred tax liabilities generally represent tax expense recognized in our consolidated financial statements for which payment has been deferred, or expense for which we have already taken a deduction

58

Table of Contents

in our tax return but have not yet recognized as expense in our consolidated financial statements.

In 2024, our annual tax rate was 19.4% compared to 19.8% in 2023. See “Other Consolidated Results” for further information.

See Note 5 to our consolidated financial statements for further information.

Pension and Retiree Medical Plans

Our pension plans cover certain employees in the United States and certain international employees. Benefits are determined based on either years of service or a combination of years of service and earnings. Certain U.S. and Canada retirees are also eligible for medical and life insurance benefits (retiree medical) if they meet age and service requirements. Generally, our share of retiree medical costs is capped at specified dollar amounts, which vary based upon years of service, with retirees contributing the remainder of the cost. In addition, we have been phasing out certain subsidies of retiree medical benefits.

See “Items Affecting Comparability” and Note 7 to our consolidated financial statements for information about changes and settlements within our pension plans.

Our Assumptions

The determination of pension and retiree medical expenses and obligations requires the use of assumptions to estimate the amount of benefits that employees earn while working, as well as the present value of those benefits. Annual pension and retiree medical expense amounts are principally based on four components: (1) the value of benefits earned by employees for working during the year (service cost), (2) the increase in the projected benefit obligation due to the passage of time (interest cost), and (3) other gains and losses as discussed in Note 7 to our consolidated financial statements, reduced by (4) the expected return on assets for our funded plans.

Significant assumptions used to measure our annual pension and retiree medical expenses include:

•certain employee-related demographic factors, such as turnover, retirement age and mortality;

•the expected rate of return on assets in our funded plans; and

•the spot rates along the yield curve used to determine service and interest costs and the present value of liabilities.

Certain assumptions reflect our historical experience and management’s best judgment regarding future expectations. All actuarial assumptions are reviewed annually, except in the case of an interim remeasurement due to a significant event such as a curtailment or settlement. Due to the significant management judgment involved, these assumptions could have a material impact on the measurement of our pension and retiree medical expenses and obligations.

At each measurement date, the discount rates are based on interest rates for high-quality, long-term corporate debt securities with maturities comparable to those of our liabilities. Our U.S. obligation and pension and retiree medical expense is based on the discount rates determined using the Mercer Above Mean Curve. This curve includes bonds that closely match the timing and amount of our expected benefit payments and reflects the portfolio of investments we would consider to settle our liabilities.

See Note 7 to our consolidated financial statements for information about the expected rate of return on plan assets and our plans’ investment strategy. Although we review our expected long-term rates of return on an annual basis, our asset returns in a given year do not significantly influence our evaluation of long-term rates of return.

59

Table of Contents

Weighted-average assumptions for pension and retiree medical expense are as follows: 

[[GREPCENT_TABLE]]
[["","2025","","2024","","2023"],["Pension"],["Service cost discount rate","6.0","%","","5.4","%","","5.5","%"],["Interest cost discount rate","5.4","%","","5.1","%","","5.4","%"],["Expected rate of return on plan assets","7.1","%","","7.0","%","","7.0","%"],["Retiree medical"],["Service cost discount rate","5.6","%","","5.1","%","","5.4","%"],["Interest cost discount rate","5.2","%","","5.0","%","","5.3","%"],["Expected rate of return on plan assets","7.1","%","","7.1","%","","7.1","%"]]
[[/GREPCENT_TABLE]]

In 2024, the aggregate of lump sum distributions and the purchase of a group annuity contract exceeded the total of annual service and interest cost and triggered pre-tax settlement charges for certain U.S. defined pension plans. In addition, we expect the recognition of fixed income losses on plan assets, partially offset by higher discount rates, to increase our pension and retiree medical expense in 2025.

Sensitivity of Assumptions

A decrease in each of the collective discount rates or in the expected rate of return assumptions would increase expense for our benefit plans. A 100-basis-point decrease in each of the above discount rates and expected rate of return assumptions would individually increase 2025 pre-tax pension and retiree medical expense as follows:

[[GREPCENT_TABLE]]
[["Assumption","","Amount"],["Discount rates used in the calculation of expense","","$","74"],["Expected rate of return","","$","143"]]
[[/GREPCENT_TABLE]]

Funding

We make contributions to pension trusts that provide plan benefits for certain pension plans. These contributions are made in accordance with applicable tax regulations that provide for current tax deductions for our contributions and taxation to the employee only upon receipt of plan benefits. Generally, we do not fund our pension plans when our contributions would not be currently tax deductible. As our retiree medical plans are not subject to regulatory funding requirements, we generally fund these plans on a pay-as-you-go basis, although we periodically review available options to make additional contributions toward these benefits.

We made a discretionary contribution of $250 million to a U.S. qualified defined benefit plan in January 2025.

Our pension and retiree medical plan contributions are subject to change as a result of many factors, such as changes in interest rates, deviations between actual and expected asset returns and changes in tax or other benefit laws. We regularly evaluate different opportunities to reduce risk and volatility associated with our pension and retiree medical plans. See Note 7 to our consolidated financial statements for our past and expected contributions and estimated future benefit payments.

60

Table of Contents

Consolidated Statement of Income

PepsiCo, Inc. and Subsidiaries

Fiscal years ended December 28, 2024, December 30, 2023 and December 31, 2022

(in millions except per share amounts)

[[GREPCENT_TABLE]]
[["","2024","","2023","","2022"],["Net Revenue","$","91,854","","","$","91,471","","","$","86,392"],["Cost of sales","41,744","","","41,881","","","40,576"],["Gross profit","50,110","","","49,590","","","45,816"],["Selling, general and administrative expenses","37,190","","","36,677","","","34,459"],["Gain associated with the Juice Transaction (see Note 13)","\u2014","","","\u2014","","","(3,321)"],["Impairment of intangible assets (see Notes 1 and 4)","33","","","927","","","3,166"],["Operating Profit","12,887","","","11,986","","","11,512"],["Other pension and retiree medical benefits (expense)/income","(22)","","","250","","","132"],["Net interest expense and other","(919)","","","(819)","","","(939)"],["Income before income taxes","11,946","","","11,417","","","10,705"],["Provision for income taxes","2,320","","","2,262","","","1,727"],["Net income","9,626","","","9,155","","","8,978"],["Less: Net income attributable to noncontrolling interests","48","","","81","","","68"],["Net Income Attributable to PepsiCo","$","9,578","","","$","9,074","","","$","8,910"],["Net Income Attributable to PepsiCo per Common Share"],["Basic","$","6.97","","","$","6.59","","","$","6.45"],["Diluted","$","6.95","","","$","6.56","","","$","6.42"],["Weighted-average common shares outstanding"],["Basic","1,373","","","1,376","","","1,380"],["Diluted","1,378","","","1,383","","","1,387"]]
[[/GREPCENT_TABLE]]

See accompanying notes to the consolidated financial statements.

61

Table of Contents

Consolidated Statement of Comprehensive Income

PepsiCo, Inc. and Subsidiaries

Fiscal years ended December 28, 2024, December 30, 2023 and December 31, 2022

(in millions)

[[GREPCENT_TABLE]]
[["","2024","","2023","","2022"],["Net income","$","9,626","","","$","9,155","","","$","8,978"],["Other comprehensive loss, net of taxes:"],["Net currency translation adjustment","(1,962)","","","(307)","","","(643)"],["Net change on cash flow hedges","113","","","(32)","","","(158)"],["Net pension and retiree medical adjustments","5","","","(358)","","","389"],["Net change on available-for-sale debt securities and other","(234)","","","465","","","4"],["Total other comprehensive loss, net of taxes","(2,078)","","","(232)","","","(408)"],["Comprehensive income","7,548","","","8,923","","","8,570"],["Less: Comprehensive income attributable to noncontrolling interests","48","","","81","","","64"],["Comprehensive Income Attributable to PepsiCo","$","7,500","","","$","8,842","","","$","8,506"]]
[[/GREPCENT_TABLE]]

See accompanying notes to the consolidated financial statements.

62

Table of Contents

Consolidated Statement of Cash Flows

PepsiCo, Inc. and Subsidiaries

Fiscal years ended December 28, 2024, December 30, 2023 and December 31, 2022

(in millions)

[[GREPCENT_TABLE]]
[["","2024","","2023","","2022"],["Operating Activities"],["Net income","$","9,626","","","$","9,155","","","$","8,978"],["Depreciation and amortization","3,160","","","2,948","","","2,763"],["Gain associated with the Juice Transaction","\u2014","","","\u2014","","","(3,321)"],["Impairment and other charges","714","","","1,230","","","3,618"],["Indirect tax impact","218","","","\u2014","","","\u2014"],["Product recall-related impact","187","","","136","","","\u2014"],["Cash payments for product recall-related impact","(148)","","","\u2014","","","\u2014"],["Operating lease right-of-use asset amortization","655","","","570","","","517"],["Share-based compensation expense","362","","","380","","","343"],["Restructuring and impairment charges","727","","","445","","","411"],["Cash payments for restructuring charges","(436)","","","(434)","","","(224)"],["Pension and retiree medical plan expense","414","","","150","","","419"],["Pension and retiree medical plan contributions","(348)","","","(410)","","","(384)"],["Deferred income taxes and other tax charges and credits","(42)","","","(271)","","","(873)"],["Tax expense related to the TCJ Act","\u2014","","","\u2014","","","86"],["Tax payments related to the TCJ Act","(579)","","","(309)","","","(309)"],["Change in assets and liabilities:"],["Accounts and notes receivable","(138)","","","(793)","","","(1,763)"],["Inventories","(314)","","","(261)","","","(1,142)"],["Prepaid expenses and other current assets","40","","","(13)","","","118"],["Accounts payable and other current liabilities","(1,161)","","","420","","","1,842"],["Income taxes payable","(123)","","","310","","","57"],["Other, net","(307)","","","189","","","(325)"],["Net Cash Provided by Operating Activities","12,507","","","13,442","","","10,811"],["Investing Activities"],["Capital spending","(5,318)","","","(5,518)","","","(5,207)"],["Sales of property, plant and equipment","342","","","198","","","251"],["Acquisitions, net of cash acquired, investments in noncontrolled affiliates and purchases of intangible and other assets","(256)","","","(314)","","","(873)"],["Proceeds associated with the Juice Transaction","\u2014","","","\u2014","","","3,456"],["Other divestitures, sales of investments in noncontrolled affiliates and other assets","166","","","75","","","49"],["Short-term investments, by original maturity:"],["More than three months - purchases","(425)","","","(555)","","","(291)"],["More than three months - maturities","\u2014","","","556","","","150"],["More than three months - sales","\u2014","","","12","","","\u2014"],["Three months or less, net","5","","","3","","","24"],["Other investing, net","14","","","48","","","11"],["Net Cash Used for Investing Activities","(5,472)","","","(5,495)","","","(2,430)"]]
[[/GREPCENT_TABLE]]

(Continued on following page)

63

Table of Contents

Consolidated Statement of Cash Flows (continued)

PepsiCo, Inc. and Subsidiaries

Fiscal years ended December 28, 2024, December 30, 2023 and December 31, 2022

(in millions)

[[GREPCENT_TABLE]]
[["","2024","","2023","","2022"],["Financing Activities"],["Proceeds from issuances of long-term debt","$","4,042","","","$","5,482","","","$","3,377"],["Payments of long-term debt","(3,886)","","","(3,005)","","","(2,458)"],["Debt redemptions","\u2014","","","\u2014","","","(1,716)"],["Short-term borrowings, by original maturity:"],["More than three months - proceeds","5,786","","","5,428","","","1,969"],["More than three months - payments","(5,639)","","","(3,106)","","","(1,951)"],["Three months or less, net","392","","","(29)","","","(31)"],["Cash dividends paid","(7,229)","","","(6,682)","","","(6,172)"],["Share repurchases","(1,000)","","","(1,000)","","","(1,500)"],["Proceeds from exercises of stock options","166","","","116","","","138"],["Withholding tax payments on restricted stock units (RSUs) and performance stock units (PSUs) converted","(135)","","","(140)","","","(107)"],["Other financing","(53)","","","(73)","","","(72)"],["Net Cash Used for Financing Activities","(7,556)","","","(3,009)","","","(8,523)"],["Effect of exchange rate changes on cash and cash equivalents and restricted cash","(687)","","","(277)","","","(465)"],["Net (Decrease)/Increase in Cash and Cash Equivalents and Restricted Cash","(1,208)","","","4,661","","","(607)"],["Cash and Cash Equivalents and Restricted Cash, Beginning of Year","9,761","","","5,100","","","5,707"],["Cash and Cash Equivalents and Restricted Cash, End of Year","$","8,553","","","$","9,761","","","$","5,100"]]
[[/GREPCENT_TABLE]]

See accompanying notes to the consolidated financial statements.

64

Table of Contents

Consolidated Balance Sheet

PepsiCo, Inc. and Subsidiaries

December 28, 2024 and December 30, 2023

(in millions except per share amounts)

[[GREPCENT_TABLE]]
[["","2024","","2023"],["ASSETS"],["Current Assets"],["Cash and cash equivalents","$","8,505","","","$","9,711"],["Short-term investments","761","","","292"],["Accounts and notes receivable, net","10,333","","","10,815"],["Inventories"],["Raw materials and packaging","2,440","","","2,388"],["Work-in-process","104","","","104"],["Finished goods","2,762","","","2,842"],["","5,306","","","5,334"],["Prepaid expenses and other current assets","921","","","798"],["Total Current Assets","25,826","","","26,950"],["Property, Plant and Equipment, net","28,008","","","27,039"],["Amortizable Intangible Assets, net","1,102","","","1,199"],["Goodwill","17,534","","","17,728"],["Other Indefinite-Lived Intangible Assets","13,699","","","13,730"],["Investments in Noncontrolled Affiliates","1,985","","","2,714"],["Deferred Income Taxes","4,362","","","4,474"],["Other Assets","6,951","","","6,661"],["Total Assets","$","99,467","","","$","100,495"],["LIABILITIES AND EQUITY"],["Current Liabilities"],["Short-term debt obligations","$","7,082","","","$","6,510"],["Accounts payable and other current liabilities","24,454","","","25,137"],["Total Current Liabilities","31,536","","","31,647"],["Long-Term Debt Obligations","37,224","","","37,595"],["Deferred Income Taxes","3,484","","","3,895"],["Other Liabilities","9,052","","","8,721"],["Total Liabilities","81,296","","","81,858"],["Commitments and contingencies"],["PepsiCo Common Shareholders\u2019 Equity"],["Common stock, par value 12/3\u00a2 per share (authorized 3,600 shares; issued, net of repurchased common stock at par value: 1,372 and 1,374 shares, respectively)","23","","","23"],["Capital in excess of par value","4,385","","","4,261"],["Retained earnings","72,266","","","70,035"],["Accumulated other comprehensive loss","(17,612)","","","(15,534)"],["Repurchased common stock, in excess of par value 495 and 493 shares, respectively)","(41,021)","","","(40,282)"],["Total PepsiCo Common Shareholders\u2019 Equity","18,041","","","18,503"],["Noncontrolling interests","130","","","134"],["Total Equity","18,171","","","18,637"],["Total Liabilities and Equity","$","99,467","","","$","100,495"]]
[[/GREPCENT_TABLE]]

See accompanying notes to the consolidated financial statements.

65

Table of Contents

Consolidated Statement of Equity

PepsiCo, Inc. and Subsidiaries

Fiscal years ended December 28, 2024, December 30, 2023 and December 31, 2022

(in millions except per share amounts)

[[GREPCENT_TABLE]]
[["","2024","","2023","","2022"],["","Shares","","Amount","","Shares","","Amount","","Shares","","Amount"],["Common Stock"],["Balance, beginning of year","1,374","","","$","23","","","1,377","","","$","23","","","1,383","","","$","23"],["Change in repurchased common stock","(2)","","","\u2014","","","(3)","","","\u2014","","","(6)","","","\u2014"],["Balance, end of year","1,372","","","23","","","1,374","","","23","","","1,377","","","23"],["Capital in Excess of Par Value"],["Balance, beginning of year","","","4,261","","","","","4,134","","","","","4,001"],["Share-based compensation expense","","","357","","","","","379","","","","","346"],["Stock option exercises, RSUs and PSUs converted","","","(90)","","","","","(107)","","","","","(102)"],["Withholding tax on RSUs and PSUs converted","","","(135)","","","","","(140)","","","","","(107)"],["Other","","","(8)","","","","","(5)","","","","","(4)"],["Balance, end of year","","","4,385","","","","","4,261","","","","","4,134"],["Retained Earnings"],["Balance, beginning of year","","","70,035","","","","","67,800","","","","","65,165"],["Net income attributable to PepsiCo","","","9,578","","","","","9,074","","","","","8,910"],["Cash dividends declared (a)","","","(7,347)","","","","","(6,839)","","","","","(6,275)"],["Balance, end of year","","","72,266","","","","","70,035","","","","","67,800"],["Accumulated Other Comprehensive Loss"],["Balance, beginning of year","","","(15,534)","","","","","(15,302)","","","","","(14,898)"],["Other comprehensive loss attributable to PepsiCo","","","(2,078)","","","","","(232)","","","","","(404)"],["Balance, end of year","","","(17,612)","","","","","(15,534)","","","","","(15,302)"],["Repurchased Common Stock"],["Balance, beginning of year","(493)","","","(40,282)","","","(490)","","","(39,506)","","","(484)","","","(38,248)"],["Share repurchases","(6)","","","(1,000)","","","(6)","","","(1,000)","","","(9)","","","(1,500)"],["Stock option exercises, RSUs and PSUs converted","4","","","256","","","3","","","223","","","3","","","240"],["Other","\u2014","","","5","","","\u2014","","","1","","","\u2014","","","2"],["Balance, end of year","(495)","","","(41,021)","","","(493)","","","(40,282)","","","(490)","","","(39,506)"],["Total PepsiCo Common Shareholders\u2019 Equity","","","18,041","","","","","18,503","","","","","17,149"],["Noncontrolling Interests"],["Balance, beginning of year","","","134","","","","","124","","","","","108"],["Net income attributable to noncontrolling interests","","","48","","","","","81","","","","","68"],["Distributions to noncontrolling interests","","","(49)","","","","","(68)","","","","","(69)"],["Acquisitions","","","\u2014","","","","","\u2014","","","","","21"],["Other, net","","","(3)","","","","","(3)","","","","","(4)"],["Balance, end of year","","","130","","","","","134","","","","","124"],["Total Equity","","","$","18,171","","","","","$","18,637","","","","","$","17,273"]]
[[/GREPCENT_TABLE]]

(a) Cash dividends declared per common share were $5.3300, $4.9450 and $4.5250 for 2024, 2023 and 2022, respectively.

See accompanying notes to the consolidated financial statements.

66

Table of Contents

Notes to the Consolidated Financial Statements

Note 1 — Basis of Presentation and Our Divisions

Basis of Presentation

The accompanying consolidated financial statements have been prepared in accordance with GAAP and include the consolidated accounts of PepsiCo, Inc. and the affiliates that we control. In addition, we include our share of the results of certain other affiliates using the equity method based on our economic ownership interest, our ability to exercise significant influence over the operating or financial decisions of these affiliates or our ability to direct their economic resources. We do not control these other affiliates, as our ownership in these other affiliates is generally 50% or less. Intercompany balances and transactions are eliminated. As a result of exchange restrictions and other operating restrictions, we do not have control over our Venezuelan subsidiaries. As such, our Venezuelan subsidiaries are not included within our consolidated financial results for any period presented.

Raw materials, direct labor and plant overhead, as well as purchasing and receiving costs, costs directly related to production planning, inspection costs and raw materials handling facilities, are included in cost of sales. The costs of moving, storing and delivering finished product, including merchandising activities, are included in selling, general and administrative expenses.

The preparation of our consolidated financial statements requires us to make estimates and assumptions that affect reported amounts of assets, liabilities, revenues, expenses and disclosure of contingent assets and liabilities. Estimates are used in determining, among other items, sales incentives accruals, tax reserves, share-based compensation, pension and retiree medical accruals, amounts and useful lives for intangible assets and future cash flows associated with impairment testing for indefinite-lived intangible assets, goodwill and other long-lived assets. We evaluate our estimates on an ongoing basis using our historical experience, as well as other factors we believe appropriate under the circumstances, such as current economic conditions, and adjust or revise our estimates as circumstances change. Additionally, the business and economic uncertainty resulting from volatile geopolitical conditions and changes in the interest rate and inflationary cost environment have made such estimates and assumptions more difficult to calculate. As future events and their effect cannot be determined with precision, actual results could differ significantly from those estimates.

Our fiscal year ends on the last Saturday of each December, resulting in a 53rd reporting week every five or six years, including in our 2022 financial results. While our North America financial results are reported on a weekly calendar basis, our international operations are reported on a monthly calendar basis. The following chart details our quarterly reporting schedule:

[[GREPCENT_TABLE]]
[["Quarter","","United States and Canada","","International"],["First Quarter","","12 weeks","","January and February"],["Second Quarter","","12 weeks","","March, April and May"],["Third Quarter","","12 weeks","","June, July and August"],["Fourth Quarter","","16 weeks (17 weeks for 2022)","","September, October, November and December"]]
[[/GREPCENT_TABLE]]

Unless otherwise noted, tabular dollars are in millions, except per share amounts. All per share amounts reflect common per share amounts, assume dilution unless otherwise noted, and are based on unrounded amounts. Certain reclassifications were made to the prior year’s consolidated financial statements to conform to the current year presentation.

67

Table of Contents

Our Divisions

We are organized into seven reportable segments (also referred to as divisions), as follows:

1)Frito-Lay North America (FLNA), which includes our branded convenient food businesses in the United States and Canada;

2)Quaker Foods North America (QFNA), which includes our branded convenient food businesses, such as cereal, rice, pasta and other branded food, in the United States and Canada;

3)PepsiCo Beverages North America (PBNA), which includes our beverage businesses in the United States and Canada;

4)Latin America (LatAm), which includes all of our beverage and convenient food businesses in Latin America;

5)Europe, which includes all of our beverage and convenient food businesses in Europe;

6)Africa, Middle East and South Asia (AMESA), which includes all of our beverage and convenient food businesses in Africa, the Middle East and South Asia; and

7)Asia Pacific, Australia and New Zealand and China region (APAC), which includes all of our beverage and convenient food businesses in Asia Pacific, Australia and New Zealand, and China region.

Changes to Organizational Structure

The division amounts and discussions included in this Form 10-K reflect the reportable segments that existed through the end of 2024. Effective beginning with our first quarter of 2025, we realigned certain of our reportable segments to be consistent with certain changes to our organizational structure and how the Chief Executive Officer will monitor the performance of these segments.

In North America, the food businesses, FLNA and QFNA, will be reported together as PepsiCo Foods North America. These changes do not impact our PBNA segment.

Internationally, the foods businesses in LatAm, Europe, AMESA and APAC will be reorganized into three reportable segments: Latin America Foods, Europe, Middle East and Africa (EMEA), and Other International Foods. Other International Foods will include the foods businesses in APAC and India, currently part of AMESA.

Our international franchise beverage businesses that were part of our LatAm, Europe, AMESA and APAC segments will be reported as International Beverages Franchise.

The company-owned bottling businesses operating internationally are all located within EMEA and will be reported in the newly created EMEA segment.

Our historical segment reporting will be recast beginning first quarter 2025 to reflect the new organizational structure.

Through our operations, authorized bottlers, contract manufacturers and other third parties, we make, market, distribute and sell a wide variety of beverages and convenient foods, serving customers and consumers in more than 200 countries and territories with our largest operations in the United States, Mexico, Russia, Canada, China, the United Kingdom, South Africa and Brazil.

The accounting policies for the divisions are the same as those described in Note 2, except for the following allocation methodologies:

•share-based compensation expense;

•pension and retiree medical expense; and

•derivatives.

68

Table of Contents

Share-Based Compensation Expense

Our divisions are held accountable for share-based compensation expense and, therefore, this expense is allocated to our divisions as an incremental employee compensation cost. The expense allocated to our divisions excludes any impact of changes in our assumptions during the year which reflect market conditions over which division management has no control. Therefore, any variances between allocated expense and our actual expense are recognized in corporate unallocated expenses.

Pension and Retiree Medical Expense

Pension and retiree medical service costs measured at fixed discount rates are reflected in division results. The variance between the fixed discount rate used to determine the service cost reflected in division results and the discount rate as disclosed in Note 7 is reflected in corporate unallocated expenses.

Derivatives

We centrally manage commodity derivatives on behalf of our divisions. These commodity derivatives include agricultural products, metals, and energy. Commodity derivatives that do not qualify for hedge accounting treatment are marked to market each period with the resulting gains and losses recorded in corporate unallocated expenses as either cost of sales or selling, general and administrative expenses, depending on the underlying commodity. These gains and losses are subsequently reflected in division results when the divisions recognize the cost of the underlying commodity in operating profit. Therefore, the divisions realize the economic effects of the derivative without experiencing any resulting mark-to-market volatility, which remains in corporate unallocated expenses. These derivatives hedge underlying commodity price risk and were not entered into for trading or speculative purposes.

Net Revenue, Significant Expenses and Operating Profit/(Loss) by Division

Our chief operating decision maker (CODM) is our Chairman and Chief Executive Officer. Our CODM uses division operating profit/(loss) as the profit measure to evaluate division performance and allocate resources across divisions. Corporate unallocated expenses, other pension and retiree medical benefits (expense)/income and net interest expense and other are centrally managed costs and are therefore excluded from this profit measure to provide better transparency of our division operating results. Our CODM considers variances of actual performance to our annual operating plan and periodic forecasts when making decisions.

Significant expenses are expenses which are regularly provided to the CODM and are included in division operating profit/(loss). These consist of segment cost of sales, segment selling, general and administrative expenses, and various items affecting comparability. Segment cost of sales includes raw materials, direct labor and plant overhead, as well as purchasing and receiving costs, costs directly related to production planning, inspection costs and raw materials handling facilities, excluding the impact of items affecting comparability. Segment selling, general and administrative expenses include the costs to execute sales to customers, distribution costs, including the costs of shipping and handling activities, which include certain merchandising activities, costs related to brand and product marketing to consumers, other ongoing operating costs that are not directly related to manufacturing, distribution, selling, advertising or marketing activities as well as other income or expense items, excluding the impact of items affecting comparability. Items affecting comparability include restructuring and impairment charges, acquisition and divestiture-related charges, impairment and other charges/credits, product recall-related impact, indirect tax impact and gain associated with the Juice Transaction.

Asset and other balance sheet information for divisions is not provided to the CODM.

69

Table of Contents

Net revenue, significant expenses and operating profit/(loss) of each division are as follows:

[[GREPCENT_TABLE]]
[["","2024"],["","FLNA","","QFNA","","PBNA","","LatAm","","Europe","","AMESA","","APAC","","Total"],["Net revenue","$","24,755","","","$","2,676","","","$","27,769","","","$","11,718","","","$","13,874","","","$","6,217","","","$","4,845","","","$","91,854"],["Segment cost of sales (a)","8,786","","","1,459","","","12,701","","","4,762","","","7,219","","","3,885","","","2,431"],["Segment selling, general and administrative expenses (a)(b)","9,494","","","710","","","11,964","","","4,442","","","4,368","","","1,515","","","1,589"],["Restructuring and impairment charges (c)","150","","","11","","","238","","","51","","","123","","","14","","","10"],["Acquisition and divestiture-related charges (d)","9","","","\u2014","","","8","","","\u2014","","","\u2014","","","5","","","\u2014"],["Impairment and other charges (e)","\u2014","","","9","","","556","","","\u2014","","","145","","","\u2014","","","4"],["Product recall-related impact (f)","\u2014","","","184","","","\u2014","","","\u2014","","","\u2014","","","\u2014","","","\u2014"],["Indirect tax impact (g)","\u2014","","","\u2014","","","\u2014","","","218","","","\u2014","","","\u2014","","","\u2014"],["Division operating profit","$","6,316","","","$","303","","","$","2,302","","","$","2,245","","","$","2,019","","","$","798","","","$","811","","","$","14,794"],["Corporate unallocated expenses","","","","","","","","","","","","","","","(1,907)"],["Operating profit","","","","","","","","","","","","","","","12,887"],["Other pension and retiree medical benefits expense","","","","","","","","","","","","","","","(22)"],["Net interest expense and other","","","","","","","","","","","","","","","(919)"],["Income before income taxes","","","","","","","","","","","","","","","$","11,946"]]
[[/GREPCENT_TABLE]]

[[GREPCENT_TABLE]]
[["","2023"],["","FLNA","","QFNA","","PBNA","","LatAm","","Europe","","AMESA","","APAC","","Total"],["Net revenue","$","24,914","","","$","3,101","","","$","27,626","","","$","11,654","","","$","13,234","","","$","6,139","","","$","4,803","","","$","91,471"],["Segment cost of sales (a)","8,829","","","1,603","","","12,856","","","4,958","","","7,178","","","3,888","","","2,422"],["Segment selling, general and administrative expenses (a)","9,288","","","870","","","11,808","","","4,413","","","4,213","","","1,434","","","1,601"],["Restructuring and impairment charges (c)","42","","","\u2014","","","41","","","29","","","223","","","15","","","8"],["Acquisition and divestiture-related charges (d)","\u2014","","","\u2014","","","16","","","\u2014","","","(2)","","","2","","","\u2014"],["Impairment and other charges/credits (e)","\u2014","","","\u2014","","","321","","","2","","","855","","","(7)","","","59"],["Product recall-related impact (f)","\u2014","","","136","","","\u2014","","","\u2014","","","\u2014","","","\u2014","","","\u2014"],["Division operating profit","$","6,755","","","$","492","","","$","2,584","","","$","2,252","","","$","767","","","$","807","","","$","713","","","$","14,370"],["Corporate unallocated expenses","","","","","","","","","","","","","","","(2,384)"],["Operating profit","","","","","","","","","","","","","","","11,986"],["Other pension and retiree medical benefits income","","","","","","","","","","","","","","","250"],["Net interest expense and other","","","","","","","","","","","","","","","(819)"],["Income before income taxes","","","","","","","","","","","","","","","$","11,417"]]
[[/GREPCENT_TABLE]]

70

Table of Contents

[[GREPCENT_TABLE]]
[["","2022"],["","FLNA","","QFNA","","PBNA","","LatAm","","Europe","","AMESA","","APAC","","Total"],["Net revenue","$","23,291","","","$","3,160","","","$","26,213","","","$","9,779","","","$","12,724","","","$","6,438","","","$","4,787","","","$","86,392"],["Segment cost of sales (a)","8,183","","","1,673","","","12,154","","","4,490","","","7,173","","","4,108","","","2,509"],["Segment selling, general and administrative expenses (a)","8,839","","","876","","","11,383","","","3,559","","","4,168","","","1,459","","","1,548"],["Restructuring and impairment charges (c)","46","","","7","","","68","","","32","","","109","","","12","","","16"],["Acquisition and divestiture-related charges (d)","\u2014","","","\u2014","","","51","","","\u2014","","","14","","","3","","","\u2014"],["Gain associated with the Juice Transaction (h)","\u2014","","","\u2014","","","(3,029)","","","\u2014","","","(292)","","","\u2014","","","\u2014"],["Impairment and other charges (e)","88","","","\u2014","","","160","","","71","","","2,932","","","190","","","177"],["Division operating profit/(loss)","$","6,135","","","$","604","","","$","5,426","","","$","1,627","","","$","(1,380)","","","$","666","","","$","537","","","$","13,615"],["Corporate unallocated expenses","","","","","","","","","","","","","","","(2,103)"],["Operating profit","","","","","","","","","","","","","","","11,512"],["Other pension and retiree medical benefits income","","","","","","","","","","","","","","","132"],["Net interest expense and other","","","","","","","","","","","","","","","(939)"],["Income before income taxes","","","","","","","","","","","","","","","$","10,705"]]
[[/GREPCENT_TABLE]]

(a)Does not include items recorded in the cost of sales or selling, general and administrative expenses lines on our income statement that are presented in the restructuring and impairment charges, acquisition and divestiture-related charges, impairment and other charges/credits, product recall-related impact and indirect tax impact lines of these tables.

(b)We recognized a pre-tax gain of $122 million ($92 million after-tax or $0.07 per share) in our FLNA division, recorded in selling, general and administrative expenses, related to the remeasurement of our previously held 50% equity ownership in Sabra at fair value. See Note 13 for further information.

(c)See Note 3 for further information related to restructuring and impairment charges.

(d)See Note 13 for further information related to acquisitions and divestiture-related charges.

(e)See below and Note 4 for impairment and other charges taken related to the Russia-Ukraine conflict, brand portfolio impairment and other impairment.

(f)In 2024, we recorded a pre-tax charge of $187 million ($143 million after-tax or $0.10 per share) associated with the Quaker Recall with $176 million recorded in cost of sales related to property, plant and equipment write-offs, employee severance costs and other costs, $8 million recorded in selling, general and administrative expenses and $3 million recorded in other pension and retiree medical benefits (expense)/income, which is not included in operating profit. In 2023, we recorded a pre-tax charge of $136 million ($104 million after-tax or $0.07 per share) in cost of sales for product returns, inventory write-offs and customer and consumer-related costs associated with the Quaker Recall.

(g)We recorded a pre-tax charge of $218 million ($218 million after-tax or $0.16 per share) in cost of sales related to an indirect tax reserve in our LatAm division.

(h)We recorded a gain of $3,029 million and $292 million in our PBNA and Europe divisions, respectively, associated with the Juice Transaction. The total after-tax amount was $2,888 million or $2.08 per share. See Note 13 for further information.

Disaggregation of Net Revenue

Our primary performance obligation is the distribution and sales of beverage and convenient food products to our customers. The following table reflects the percentage of net revenue generated between our beverage business and our convenient food business for each of our international divisions, as well as our consolidated net revenue:

[[GREPCENT_TABLE]]
[["","2024","","2023","","2022"],["","Beverages(a)","","Convenient Foods","","Beverages(a)","","Convenient Foods","","Beverages(a)","","Convenient Foods"],["LatAm","10","%","","90","%","","9","%","","91","%","","9","%","","91","%"],["Europe","48","%","","52","%","","48","%","","52","%","","50","%","","50","%"],["AMESA","30","%","","70","%","","29","%","","71","%","","30","%","","70","%"],["APAC","23","%","","77","%","","23","%","","77","%","","23","%","","77","%"],["PepsiCo","42","%","","58","%","","41","%","","59","%","","42","%","","58","%"]]
[[/GREPCENT_TABLE]]

(a)Beverage revenue from company-owned bottlers, which primarily includes our consolidated bottling operations in our PBNA and Europe divisions, is 35% of our consolidated net revenue in both 2024 and 2023, and 37% of our consolidated net revenue in 2022. Generally, our finished goods beverage operations produce higher net revenue, but lower operating margins as compared to concentrate sold to authorized bottling partners for the manufacture of finished goods beverages.

71

Table of Contents

Impairment and Other Charges

We recognized Russia-Ukraine conflict charges, brand portfolio impairment charges and other impairment charges as described below.

A summary of pre-tax charges taken in 2022 in our Europe division as a result of the Russia-Ukraine conflict is as follows:

[[GREPCENT_TABLE]]
[["","","","","","","","","","Cost of sales","","Selling, general and administrative expenses","","Impairment of intangible assets(a)","","Total"],["Impairment charges related to intangible assets","","","","","","","","","$","\u2014","","","$","\u2014","","","$","1,198","","","$","1,198"],["Impairment charges related to property, plant and equipment","","","","","","","","","103","","","22","","","\u2014","","","125"],["Allowance for expected credit losses","","","","","","","","","\u2014","","","12","","","\u2014","","","12"],["Allowance for inventory write downs","","","","","","","","","28","","","1","","","\u2014","","","29"],["Other","","","","","","","","","9","","","42","","","\u2014","","","51"],["Total","","","","","","","","","$","140","","","$","77","","","$","1,198","","","$","1,415"],["After-tax amount","","","","","","","","","","","","","","","$","1,124"],["Impact on net income attributable to PepsiCo per common share","","","","","","","","","","","","","","","$","(0.81)"]]
[[/GREPCENT_TABLE]]

(a)See Note 4 for further information. For information on our policies for indefinite-lived intangible assets, see Note 2.

In 2023, a pre-tax credit of $7 million ($7 million after-tax or $0.01 per share) was recorded in our Europe division, primarily in selling, general and administrative expenses, representing adjustments for changes in estimates of previously recorded amounts.

A summary of pre-tax charges taken in 2022 as a result of our decision to reposition or discontinue the sale/distribution of certain brands and to sell an investment is as follows:

[[GREPCENT_TABLE]]
[["","","","","","","","","","Cost of sales","","Selling, general and administrative expenses","","Impairment of intangible assets","","Total"],["PBNA","","","","","","","","","$","26","","","$","8","","","$","126","","","$","160","","Impairment and other charges associated with distribution rights and inventory due to the termination of Bang energy drinks distribution agreement"],["LatAm","","","","","","","","","\u2014","","","35","","","36","","","71","","Loss on sale and impairment of intangible assets related to the sale of certain non-strategic brands"],["Europe","","","","","","","","","1","","","10","","","242","","","253","","Primarily impairment of intangible assets related to the discontinuation or repositioning of certain juice and dairy brands in Russia (a)"],["AMESA","","","","","","","","","29","","","121","","","9","","","159","","Primarily impairment of investment, property, plant and equipment and intangible assets related to the sale or discontinuation of non-strategic investment and brands"],["APAC","","","","","","","","","5","","","\u2014","","","\u2014","","","5","","Impairment of property, plant and equipment related to the discontinuation of a non-strategic brand in China"],["Total","","","","","","","","","$","61","","","$","174","","","$","413","","","$","648"],["After-tax amount","","","","","","","","","","","","","","","$","522"],["Impact on net income attributable to PepsiCo per common share","","","","","","","","","","","","","","","$","(0.38)"]]
[[/GREPCENT_TABLE]]

(a)See Note 4 for further information. For information on our policies for indefinite-lived intangible assets, see Note 2.

72

Table of Contents

In 2023, a pre-tax credit of $13 million ($13 million after-tax or $0.01 per share) was recorded in our AMESA division, with $9 million in selling, general and administrative expenses and $4 million in cost of sales. In addition, a pre-tax charge of $2 million ($1 million after-tax with a nominal amount per share) was recorded in our LatAm division in selling, general and administrative expenses. Both of these amounts represent adjustments for changes in estimates of previously recorded amounts.

A summary of pre-tax other impairment charges taken as a result of our quantitative assessments is as follows:

[[GREPCENT_TABLE]]
[["","","","","2024","","2023","","","","","","2022"],["FLNA","","","","$","\u2014","","","$","\u2014","","","","","","","$","88","","","Related to a baked fruit convenient food brand (recorded in impairment of intangible assets)"],["QFNA","","","","9","","","\u2014","","","","","","","\u2014","","","Related to a nutrition bar brand (recorded in impairment of intangible assets)"],["PBNA","","","","556","","","321","","","","","","","\u2014","","","2024 includes other-than-temporary impairment of our remaining investment in TBG and allowance for expected credit losses related to receivables associated with the Juice Transaction (recorded in selling, general and administrative expenses). 2023 includes our proportionate share of TBG\u2019s indefinite-lived intangible assets impairment and other-than-temporary impairment of our investment in TBG (recorded in selling, general and administrative expenses) (a)"],["Europe","","","","145","","","862","","","","","","","1,264","","","2024 primarily includes other-than-temporary impairment of our investment in TBG and allowance for expected credit losses related to certain receivables from TBG (recorded in selling, general and administrative expenses). 2023 and 2022 are related to the SodaStream brand and goodwill (recorded in impairment of intangible assets) (a)(b)"],["AMESA","","","","\u2014","","","6","","","","","","","31","","Related to brands from the Pioneer Food Group Ltd. acquisition (recorded in impairment of intangible assets)"],["APAC","","","","4","","","59","","","","","","","172","","Primarily related to the Be & Cheery brand (recorded in impairment of intangible assets)"],["Total","","","","$","714","","","$","1,248","","","","","","","$","1,555"],["After-tax amount","","","","$","584","","","$","1,033","","","","","","","$","1,301"],["Impact on net income attributable to PepsiCo per common share","","","","$","(0.42)","","","$","(0.75)","","","","","","","$","(0.94)"]]
[[/GREPCENT_TABLE]]

(a)See Note 9 for further information regarding our proportionate share of TBG’s indefinite-lived intangible assets impairment and other-than temporary impairment of our investment in TBG. In 2024, we recorded an allowance for expected credit losses of $193 million, primarily related to outstanding receivables associated with the Juice Transaction.

(b)See Note 4 for further information regarding impairment of intangible assets. For information on our policies for indefinite-lived intangible assets, see Note 2.

73

Table of Contents

Other Division Information

Capital spending, amortization of intangible assets, and depreciation and other amortization of each division are as follows:

[[GREPCENT_TABLE]]
[["","Capital Spending","","Amortization of Intangible Assets","","Depreciation and Other Amortization"],["","2024","","2023","","2022","","2024","","2023","","2022","","2024","","2023","","2022"],["FLNA","$","1,182","","","$","1,341","","","$","1,464","","","$","10","","","$","11","","","$","11","","","$","806","","","$","736","","","$","653"],["QFNA","124","","","103","","","93","","","\u2014","","","\u2014","","","\u2014","","","46","","","51","","","47"],["PBNA","1,541","","","1,723","","","1,714","","","22","","","22","","","22","","","1,047","","","1,003","","","930"],["LatAm","837","","","841","","","581","","","2","","","2","","","3","","","394","","","372","","","306"],["Europe","568","","","551","","","668","","","29","","","29","","","30","","","377","","","347","","","357"],["AMESA","450","","","391","","","307","","","3","","","3","","","4","","","172","","","167","","","179"],["APAC","294","","","284","","","241","","","8","","","8","","","8","","","116","","","99","","","92"],["Total division","4,996","","","5,234","","","5,068","","","74","","","75","","","78","","","2,958","","","2,775","","","2,564"],["Corporate","322","","","284","","","139","","","\u2014","","","\u2014","","","\u2014","","","128","","","98","","","121"],["Total","$","5,318","","","$","5,518","","","$","5,207","","","$","74","","","$","75","","","$","78","","","$","3,086","","","$","2,873","","","$","2,685"]]
[[/GREPCENT_TABLE]]

Net revenue and long-lived assets by country are as follows:

[[GREPCENT_TABLE]]
[["","Net Revenue","","Long-Lived Assets(a)"],["","2024","","2023","","2022","","2024","","2023"],["United States","$","51,668","","","$","52,165","","","$","49,390","","","$","41,547","","","$","41,234"],["Mexico","7,123","","","7,011","","","5,472","","","2,392","","","2,509"],["Russia","3,880","","","3,566","","","4,118","","","1,667","","","1,986"],["Canada","3,764","","","3,722","","","3,536","","","2,681","","","2,815"],["China","2,709","","","2,703","","","2,752","","","1,538","","","1,510"],["United Kingdom","2,063","","","1,946","","","1,844","","","871","","","868"],["South Africa","1,859","","","1,707","","","1,837","","","1,302","","","1,305"],["Brazil","1,765","","","1,779","","","1,617","","","497","","","573"],["All other countries","17,023","","","16,872","","","15,826","","","11,179","","","11,226"],["Total","$","91,854","","","$","91,471","","","$","86,392","","","$","63,674","","","$","64,026"]]
[[/GREPCENT_TABLE]]

(a)Long-lived assets represent property, plant and equipment, indefinite-lived intangible assets, amortizable intangible assets, investments in noncontrolled affiliates and other investments included in other assets. These assets are reported in the country where they are primarily used. See Notes 2 and 15 for further information on property, plant and equipment. See Notes 2 and 4 for further information on goodwill and other intangible assets. See Notes 9 and 15 for further information on other assets.

Corporate Unallocated Expenses

Corporate unallocated expenses include costs of our corporate headquarters, centrally managed initiatives such as commodity derivative gains and losses, foreign exchange transaction gains and losses, our ongoing business transformation initiatives, unallocated research and development costs, unallocated insurance and benefit programs, certain gains and losses on equity investments, as well as certain other items.

Note 2 — Our Significant Accounting Policies

Revenue Recognition

We recognize revenue when our performance obligation is satisfied. Our primary performance obligation (the distribution and sales of beverage and convenient food products) is satisfied upon the shipment or delivery of products to our customers, which is also when control is transferred. Merchandising activities are performed after a customer obtains control of the product, are accounted for as fulfillment of our performance obligation to ship or deliver product to our customers and are recorded in selling, general and

74

Table of Contents

administrative expenses. Merchandising activities are immaterial in the context of our contracts. In addition, we exclude from net revenue all sales, use, value-added and certain excise taxes assessed by government authorities on revenue producing transactions.

The transfer of control of products to our customers is typically based on written sales terms that generally do not allow for a right of return, except in the instance of a product recall or other limited circumstances that may allow for product returns. Our policy for DSD, including certain chilled products, is to remove and replace damaged and out-of-date products from store shelves to ensure that consumers receive the product quality and freshness they expect. Similarly, our policy for certain warehouse-distributed products is to replace damaged and out-of-date products. As a result, we record reserves, based on estimates, for product recall, anticipated damaged and out-of-date products.

Our products are sold for cash or on credit terms. Our credit terms, which are established in accordance with local and industry practices, typically require payment within 30 days of delivery in the United States, and generally within 30 to 90 days internationally, and may allow discounts for early payment.

We estimate and reserve for our expected credit loss exposure based on our experience with past due accounts and collectibility, write-off history, the aging of accounts receivable, our analysis of customer data, and forward-looking information (including the expected impact of a high interest rate and inflationary cost environment), leveraging estimates of creditworthiness and projections of default and recovery rates for certain of our customers.

We are exposed to concentration of credit risk from our major customers, including Walmart. We have not experienced credit issues with these customers. In 2024, sales to Walmart and its affiliates (including Sam’s) represented approximately 14% of our consolidated net revenue, including concentrate sales to our independent bottlers, which were used in finished goods sold by them to Walmart.

Total Marketplace Spending

We offer sales incentives and discounts through various programs to customers and consumers. Total marketplace spending includes sales incentives, discounts, advertising and other marketing activities. Sales incentives and discounts are primarily accounted for as a reduction of revenue and include payments to customers for performing activities on our behalf, such as payments for in-store displays, payments to gain distribution of new products, payments for shelf space and discounts to promote lower retail prices. Sales incentives and discounts also include support provided to our independent bottlers through funding of advertising and other marketing activities.

A number of our sales incentives, such as bottler funding to independent bottlers and customer volume rebates, are based on annual targets, and accruals are established during the year, as products are delivered, for the expected payout, which may occur after year-end once reconciled and settled. These accruals are based on contract terms and our historical experience with similar programs and require management judgment with respect to estimating customer and consumer participation and performance levels. Differences between estimated expense and actual incentive costs are normally insignificant and are recognized in earnings in the period such differences are determined. In addition, certain advertising and marketing costs are also based on annual targets and recognized during the year as incurred.

The terms of most of our incentive arrangements do not exceed one year and, therefore, do not require highly uncertain long-term estimates. Certain arrangements, such as fountain pouring rights, may extend beyond one year. Upfront payments to customers under these arrangements are recognized over the shorter of the economic or contractual life, primarily as a reduction of revenue, and the remaining balances of $237 million as of December 28, 2024 and $228 million as of December 30, 2023 are included in prepaid expenses and other current assets and other assets on our balance sheet.

75

Table of Contents

For interim reporting, our policy is to allocate our forecasted full-year sales incentives for most of our programs to each of our interim reporting periods in the same year that benefits from the programs. The allocation methodology is based on our forecasted sales incentives for the full year and the proportion of each interim period’s actual gross revenue or volume, as applicable, to our forecasted annual gross revenue or volume, as applicable. Based on our review of the forecasts at each interim period, any changes in estimates and the related allocation of sales incentives are recognized beginning in the interim period that they are identified. In addition, we apply a similar allocation methodology for interim reporting purposes for certain advertising and other marketing activities. Our annual consolidated financial statements are not impacted by this interim allocation methodology.

Advertising and other marketing activities, reported as selling, general and administrative expenses, totaled $5.9 billion in 2024, $5.7 billion in 2023 and $5.2 billion in 2022, including advertising expenses of $3.9 billion in 2024, $3.8 billion in 2023 and $3.5 billion in 2022. Deferred advertising costs are not expensed until the year first used and consist of:

•media and personal service prepayments;

•promotional materials in inventory; and

•production costs of future media advertising.

Deferred advertising costs of $58 million and $67 million as of December 28, 2024 and December 30, 2023, respectively, are classified as prepaid expenses and other current assets on our balance sheet.

Distribution Costs

Distribution costs, including the costs of shipping and handling activities, which include certain merchandising activities, are reported as selling, general and administrative expenses. Shipping and handling expenses were $16.0 billion in 2024, $15.4 billion in 2023 and $15.0 billion in 2022.

Software Costs

We capitalize certain computer software and software development costs incurred in connection with developing or obtaining computer software for internal use when both the preliminary project stage is completed and it is probable that the software will be used as intended. Capitalized software costs include (1) external direct costs of materials and services utilized in developing or obtaining computer software, (2) compensation and related benefits for employees who are directly associated with the software projects and (3) interest costs incurred while developing internal-use computer software. Capitalized software costs are included in property, plant and equipment on our balance sheet and amortized on a straight-line basis when placed into service over the estimated useful lives of the software, which approximate five to 10 years. Software amortization totaled $199 million in 2024, $159 million in 2023 and $123 million in 2022. Net capitalized software and development costs were $1.5 billion and $1.4 billion as of December 28, 2024 and December 30, 2023, respectively.

Commitments and Contingencies

We are subject to various claims and contingencies related to lawsuits, certain taxes and environmental matters, as well as commitments under contractual and other commercial obligations. We recognize liabilities for contingencies and commitments when a loss is probable and estimable.

Research and Development

We engage in a variety of research and development activities and continue to invest to accelerate growth and to drive innovation globally. Consumer research is excluded from research and development costs and included in other marketing costs. Research and development costs were $813 million, $804 million and

76

Table of Contents

$771 million in 2024, 2023 and 2022, respectively, and are reported within selling, general and administrative expenses.

Goodwill and Other Intangible Assets

Indefinite-lived intangible assets and goodwill are not amortized and, as a result, are assessed for impairment at least annually, using either a qualitative or quantitative approach. We perform this annual assessment during our third quarter, or more frequently if circumstances indicate that the carrying value may not be recoverable. Where we use the qualitative assessment, first we determine if, based on qualitative factors, it is more likely than not that an impairment exists. Factors considered include macroeconomic conditions (including those related to volatile geopolitical conditions and a high interest rate and inflationary cost environment), industry and competitive conditions, legal and regulatory environment, historical financial performance and significant changes in the brand or reporting unit. If the qualitative assessment indicates that it is more likely than not that an impairment exists, then a quantitative assessment is performed.

In the quantitative assessment for indefinite-lived intangible assets and goodwill, an assessment is performed to determine the fair value of the indefinite-lived intangible asset and the reporting unit, respectively. Estimated fair value is determined using discounted cash flows and requires an analysis of several estimates including future cash flows or income consistent with management’s strategic business plans, annual sales growth rates, perpetuity growth assumptions and the selection of assumptions underlying a discount rate (weighted-average cost of capital) based on market data available at the time. Significant management judgment is necessary to estimate the impact of competitive operating, macroeconomic and other factors (including those related to volatile geopolitical conditions and a high interest rate and inflationary cost environment) to estimate future levels of sales, operating profit or cash flows. All assumptions used in our impairment evaluations for indefinite-lived intangible assets and goodwill, such as forecasted growth rates (including perpetuity growth assumptions) and weighted-average cost of capital, are based on the best available market information and are consistent with our internal forecasts and operating plans. A deterioration in these assumptions could adversely impact our results.

Amortizable intangible assets are only evaluated for impairment upon a significant change in the operating or macroeconomic environment. If an evaluation of the undiscounted future cash flows indicates impairment, the asset is written down to its estimated fair value, which is based on its discounted future cash flows.

See Note 4 for further information.

Other Significant Accounting Policies

Our other significant accounting policies are disclosed as follows:

•Basis of Presentation – Note 1 includes a description of our policies regarding use of estimates, basis of presentation and consolidation.

•Income Taxes – Note 5.

•Share-Based Compensation – Note 6.

•Pension, Retiree Medical and Savings Plans – Note 7.

•Financial Instruments – Note 9.

•Leases – Note 12.

•Supply Chain Financing Arrangements – Note 14.

•Cash Equivalents – Cash equivalents are highly liquid investments with original maturities of three months or less.

77

Table of Contents

•Inventories – Inventories are valued at the lower of cost or net realizable value. Cost is determined using the average; first-in, first-out (FIFO); or, in limited instances, last-in, first-out (LIFO) methods. For inventories valued under the LIFO method, the differences between the LIFO and FIFO methods of valuing inventories are not material.

•Property, Plant and Equipment – Note 15. Property, plant and equipment is recorded at historical cost. Depreciation is recognized on a straight-line basis over an asset’s estimated useful life. Construction in progress is not depreciated until ready for service.

•Translation of Financial Statements of Foreign Subsidiaries – Financial statements of foreign subsidiaries are translated into U.S. dollars using period-end exchange rates for assets and liabilities and average exchange rates for revenues and expenses. Adjustments resulting from translating net assets are reported as a separate component of accumulated other comprehensive loss within common shareholders’ equity as currency translation adjustment.

Recently Issued Accounting Pronouncements

Adopted

In November 2023, the Financial Accounting Standards Board (FASB) issued guidance to enhance disclosure of expenses of a public entity’s reportable segments. The new guidance requires a public entity to disclose on an annual and interim basis: (1) significant segment expenses that are regularly provided to the CODM and included within each reported measure of segment profit or loss, (2) an amount for other segment items (the difference between segment revenue less the significant expenses disclosed under the significant expense principle and each reported measure of segment profit or loss), including a description of its composition, and (3) information about a reportable segment’s: (a) profit or loss, and (b) assets, if provided to CODM, and on an annual basis, the title and position of the CODM and an explanation of how the CODM uses the reported measure(s) of segment profit or loss in assessing segment performance and how to allocate resources. The new guidance also clarifies that if the CODM uses more than one measure of a segment’s profit or loss, one or more of those measures may be reported and requires that a public entity that has a single reportable segment provide all the disclosures required by the amendments in the guidance and all existing segment disclosures. We adopted the guidance in our 2024 annual reporting, on a retrospective basis. See Note 1 for further information.

In September 2022, the FASB issued guidance to enhance the transparency of supplier finance programs to allow financial statement users to understand the effect on working capital, liquidity and cash flows. The new guidance requires disclosure of key terms of the program, including a description of the payment terms, payment timing and assets pledged as security or other forms of guarantees provided to the finance provider or intermediary. Other requirements include the disclosure of the amount that remains unpaid as of the end of the reporting period, a description of where these obligations are presented in the balance sheet and a rollforward of the obligation during the annual period. We adopted the guidance in the first quarter of 2023, except for the rollforward, which we adopted in our 2024 annual reporting, on a prospective basis. See Note 14 for further information.

Not Yet Adopted

In November 2024, the FASB issued guidance to improve the disclosure of expenses in commonly presented expense captions. The new guidance requires a public entity to provide tabular disclosure, on an annual and interim basis, of amounts for the following expense categories: (1) purchases of inventory, (2) employee compensation, (3) depreciation and (4) intangible asset amortization, as included in each relevant expense caption. A relevant expense caption is an expense caption presented on the face of the income statement that contains any of the expense categories noted. Additionally, on an annual and interim basis, a qualitative description is required for amounts remaining in relevant expense captions that are not separately disaggregated quantitatively. The guidance also requires certain amounts that are

78

Table of Contents

currently required to be disclosed to be included in the same tabular disclosure as these disaggregation requirements. Furthermore, on an annual and interim basis, a public entity is required to separately disclose selling expenses and annually, disclose a description of the selling expenses. The guidance is effective for 2027 annual reporting, and in the first quarter of 2028 for interim reporting, with early adoption permitted, to be applied on a prospective basis, with retrospective application permitted. We will adopt the guidance when it becomes effective, in our 2027 annual reporting and each quarter thereafter, on a prospective basis.

In December 2023, the FASB issued guidance to enhance transparency of income tax disclosures. On an annual basis, the new guidance requires a public entity to disclose: (1) specific categories in the rate reconciliation, (2) additional information for reconciling items that are equal to or greater than 5% of the amount computed by multiplying income (or loss) from continuing operations before income tax expense (or benefit) by the applicable statutory income tax rate, (3) income taxes paid (net of refunds received) disaggregated by federal (national), state, and foreign taxes, with foreign taxes disaggregated by individual jurisdictions in which income taxes paid is equal to or greater than 5% of total income taxes paid, (4) income (or loss) from continuing operations before income tax expense (or benefit) disaggregated between domestic and foreign, and (5) income tax expense (or benefit) from continuing operations disaggregated between federal (national), state and foreign. The guidance is effective for fiscal year 2025 annual reporting, with early adoption permitted, to be applied on a prospective basis, with retrospective application permitted. We will adopt the guidance when it becomes effective, in our 2025 annual reporting, on a prospective basis.

Note 3 — Restructuring and Impairment Charges

2019 Multi-Year Productivity Plan

The 2019 Productivity Plan leverages new technology and business models to further simplify, harmonize and automate processes; re-engineers our go-to-market and information systems, including deploying the right automation for each market; and simplifies our organization and optimizes our manufacturing and supply chain footprint. To build on the successful implementation of the 2019 Productivity Plan, in the fourth quarter of 2024, we further expanded and extended the plan through the end of 2030 to take advantage of additional opportunities within the initiatives described above. As a result, we expect to incur pre-tax charges of approximately $6.15 billion, including cash expenditures of approximately $5.1 billion, as compared to our previous estimate of pre-tax charges of approximately $3.65 billion, including cash expenditures of approximately $2.9 billion. These pre-tax charges are expected to consist of approximately 55% of severance and other employee-related costs, 10% for asset impairments (all non-cash) resulting from plant closures and related actions and 35% for other costs associated with the implementation of our initiatives.

The total plan pre-tax charges are expected to be incurred by division approximately as follows:

[[GREPCENT_TABLE]]
[["","FLNA","","QFNA","","PBNA","","LatAm","","Europe","","AMESA","","APAC","","Corporate"],["Expected pre-tax charges","15","%","","1","%","","25","%","","10","%","","25","%","","5","%","","4","%","","15","%"]]
[[/GREPCENT_TABLE]]

79

Table of Contents

A summary of our 2019 Productivity Plan charges is as follows:

[[GREPCENT_TABLE]]
[["","2024","","2023","","2022"],["Cost of sales","$","133","","","$","13","","","$","33"],["Selling, general and administrative expenses","551","","","433","","","347"],["Impairment of intangible assets","14","","","\u2014","","","\u2014"],["Other pension and retiree medical benefits expense/(income) (a)","29","","","(1)","","","31"],["Total restructuring and impairment charges","$","727","","","$","445","","","$","411"],["After-tax amount","$","563","","","$","349","","","$","334"],["Impact on net income attributable to PepsiCo per common share","$","(0.41)","","","$","(0.25)","","","$","(0.24)"]]
[[/GREPCENT_TABLE]]

[[GREPCENT_TABLE]]
[["","2024","","2023","","2022","","Plan to Datethrough 12/28/2024"],["FLNA","$","150","","","$","42","","","$","46","","","$","402"],["QFNA","11","","","\u2014","","","7","","","30"],["PBNA","238","","","41","","","68","","","505"],["LatAm","51","","","29","","","32","","","251"],["Europe","123","","","223","","","109","","","689"],["AMESA","14","","","15","","","12","","","111"],["APAC","10","","","8","","","16","","","95"],["Corporate","101","","","88","","","90","","","418"],["","698","","","446","","","380","","","2,501"],["Other pension and retiree medical benefits expense/(income) (a)","29","","","(1)","","","31","","","126"],["Total","$","727","","","$","445","","","$","411","","","$","2,627"]]
[[/GREPCENT_TABLE]]

(a)Income amount represents adjustments for changes in estimates of previously recorded amounts.

[[GREPCENT_TABLE]]
[["","","","","","Plan to Datethrough 12/28/2024"],["Severance and other employee costs","","","","","$","1,434"],["Asset impairments","","","","","306"],["Other costs","","","","","887"],["Total","","","","","$","2,627"]]
[[/GREPCENT_TABLE]]

Severance and other employee costs primarily include severance and other termination benefits, as well as voluntary separation arrangements. Other costs primarily include costs associated with the implementation of our initiatives, including consulting and other professional fees, as well as contract termination costs.

80

Table of Contents

A summary of our 2019 Productivity Plan is as follows:

[[GREPCENT_TABLE]]
[["","Severance and Other Employee Costs","","Asset Impairments","","Other Costs","","Total"],["Liability as of December 25, 2021","$","64","","","$","\u2014","","","$","7","","","$","71"],["2022 restructuring charges","243","","","33","","","135","","","411"],["Cash payments (a)","(90)","","","\u2014","","","(134)","","","(224)"],["Non-cash charges and translation","(29)","","","(33)","","","\u2014","","","(62)"],["Liability as of December 31, 2022","188","","","\u2014","","","8","","","196"],["2023 restructuring charges","243","","","2","","","200","","","445"],["Cash payments (a)","(242)","","","\u2014","","","(192)","","","(434)"],["Non-cash charges and translation","(1)","","","(2)","","","(7)","","","(10)"],["Liability as of December 30, 2023","188","","","\u2014","","","9","","","197"],["2024 restructuring charges","384","","","114","","","229","","","727"],["Cash payments (a)","(204)","","","\u2014","","","(232)","","","(436)"],["Non-cash charges and translation","(30)","","","(114)","","","20","","","(124)"],["Liability as of December 28, 2024","$","338","","","$","\u2014","","","$","26","","","$","364"]]
[[/GREPCENT_TABLE]]

(a)Excludes cash expenditures of $7 million in 2024, and $1 million each in 2023 and 2022, reported in the cash flow statement in pension and retiree medical plan contributions.

The majority of the restructuring accrual at December 28, 2024 is expected to be paid by the end of 2025.

Other Productivity Initiatives

There were no material charges related to other productivity and efficiency initiatives outside the scope of the 2019 Productivity Plan.

We regularly evaluate different productivity initiatives beyond the productivity plan and other initiatives described above.

For information on additional impairment charges, see Notes 1, 4 and 9 for impairment and other charges taken related to the Russia-Ukraine conflict, brand portfolio impairment charges and other impairment charges.

Note 4 — Intangible Assets

A summary of our amortizable intangible assets is as follows:

[[GREPCENT_TABLE]]
[["","","","2024","","2023","","2022"],["","Average Useful Life (Years)","","Gross","","Accumulated Amortization","","Net","","Gross","","Accumulated Amortization","","Net"],["Acquired franchise rights","56 \u2013 60","","$","821","","","$","(223)","","","$","598","","","$","840","","","$","(214)","","","$","626"],["Customer relationships","15 \u2013 24","","565","","","(279)","","","286","","","560","","","(265)","","","295"],["Brands","20 \u2013 40","","1,051","","","(977)","","","74","","","1,093","","","(989)","","","104"],["Other identifiable intangibles","10 \u2013 24","","420","","","(276)","","","144","","","449","","","(275)","","","174"],["Total","","","$","2,857","","","$","(1,755)","","","$","1,102","","","$","2,942","","","$","(1,743)","","","$","1,199"],["Amortization expense","","","","","","","$","74","","","","","","","$","75","","","$","78"]]
[[/GREPCENT_TABLE]]

81

Table of Contents

Amortization is recognized on a straight-line basis over an intangible asset’s estimated useful life. Amortization of intangible assets for each of the next five years, based on existing intangible assets as of December 28, 2024 and using average 2024 foreign exchange rates, is expected to be as follows:

[[GREPCENT_TABLE]]
[["","2025","","2026","","2027","","2028","","2029"],["Five-year projected amortization","$","73","","","$","64","","","$","60","","","$","59","","","$","58"]]
[[/GREPCENT_TABLE]]

Depreciable and amortizable assets are evaluated for impairment upon a significant change in the operating or macroeconomic environment. In these circumstances, if an evaluation of the undiscounted cash flows indicates impairment, the asset is written down to its estimated fair value, which is based on discounted future cash flows. Useful lives are periodically evaluated to determine whether events or circumstances have occurred which indicate the need for revision.

Indefinite-Lived Intangible Assets

As discussed in Note 2, we perform our annual impairment assessment on indefinite-lived intangible assets during our third quarter. The annual impairment assessment on indefinite-lived intangible assets performed in the third quarter of 2024, based on best available market information and our internal forecasts and operating plans at the time, did not result in any material impairment charges.

As of December 28, 2024, the estimated fair value of the SodaStream reporting unit narrowly exceeded its carrying value. Given the low coverage, there could be further impairment to the carrying value of the SodaStream reporting unit goodwill if future sales and operating profit results are not in line with the forecasted future cash flows of the business and/or if macroeconomic conditions worsen and drive an increase in the weighted-average cost of capital used to estimate its fair value. We continue to monitor the performance of the SodaStream reporting unit, as well as all of our indefinite-lived intangible assets.

We did not recognize any impairment charges for goodwill in the year ended December 28, 2024.

In the fourth quarter of 2023, macroeconomic conditions, including higher interest rates, inflationary costs, and the ongoing conflict in the Middle East, and recent business performance indicated a deterioration of the significant inputs used to determine the fair value of our indefinite-lived intangible assets in various markets, primarily assumptions underlying the weighted-average cost of capital and the impact of economic uncertainty on current and future financial performance, and required us to perform a quantitative assessment on certain assets. The fair value of our indefinite-lived intangible assets was estimated using discounted cash flows under the income approach, which we consider to be a Level 3 measurement. We determined that the carrying value exceeded the fair value for certain of our intangible assets, which reflects the increase in the weighted-average cost of capital as well as our most current estimates of future sales and their contributions to operating profit and expected future cash flows (including perpetuity growth assumptions). As a result of the quantitative assessment, we recorded pre-tax impairment charges of $0.6 billion ($0.5 billion after-tax or $0.35 per share) for brands and $0.3 billion ($0.3 billion after-tax or $0.22 per share) for goodwill, both in impairment of intangible assets, primarily related to the SodaStream brand and reporting unit in our Europe division, in the year ended December 30, 2023. See Note 1 for further information.

In the first quarter of 2022, we discontinued or repositioned certain juice and dairy brands in Russia in our Europe division. As a result, we recognized pre-tax impairment charges of $241 million ($193 million after-tax or $0.14 per share) in impairment of intangible assets, primarily related to indefinite-lived intangible assets in the year ended December 31, 2022. See Note 1 for further information.

In the second quarter of 2022, macroeconomic factors, sanctions and other regulations as a result of the Russia-Ukraine conflict indicated a material deterioration of the significant inputs used to determine the fair value of our indefinite-lived intangible assets in Russia, primarily assumptions underlying the

82

Table of Contents

weighted-average cost of capital. These factors required us to perform a quantitative assessment, despite the absence of a material adverse impact on these assets’ financial performance (e.g., sales, operating profit, cash flows). The fair value of our indefinite-lived intangible assets in Russia was estimated using discounted cash flows under the income approach, which we consider to be a Level 3 measurement. We determined that the carrying value exceeded the fair value, with the decrease in the fair value primarily attributable to a significant increase in the weighted-average cost of capital, which reflected the macroeconomic uncertainty in Russia. As a result of the quantitative assessment, we recorded pre-tax impairment charges of $1.2 billion ($958 million after-tax or $0.69 per share) in impairment of intangible assets, related to our juice and dairy brands in Russia in our Europe division, in the year ended December 31, 2022. See Note 1 for further information.

In the fourth quarter of 2022, macroeconomic conditions including a high interest rate and inflationary cost environment, coupled with recent business performance, indicated a deterioration of the significant inputs used to determine the fair value of our indefinite-lived intangible assets in various markets, primarily assumptions underlying the weighted-average cost of capital and the impact of economic uncertainty on current and future financial performance, and required us to perform a quantitative assessment on certain assets. The fair value of our indefinite-lived intangible assets was estimated using discounted cash flows under the income approach, which we consider to be a Level 3 measurement. We determined that the carrying value exceeded the fair value, which reflected the increase in the weighted-average cost of capital as well as our most current estimates of future sales and their contributions to operating profit and expected future cash flows (including perpetuity growth assumptions). As a result of the quantitative assessment, we recognized pre-tax impairment charges of $1.6 billion ($1.3 billion after-tax or $0.94 per share) in impairment of intangible assets, primarily related to the SodaStream brand in our Europe division, in the year ended December 31, 2022. See Note 1 for further information.

We did not recognize any impairment charges for goodwill in the year ended December 31, 2022.

For further information on our policies for indefinite-lived intangible assets, see Note 2.

The components of indefinite-lived intangible assets are as follows:

[[GREPCENT_TABLE]]
[["","2024","","2023"],["Goodwill","$","17,534","","","$","17,728"],["Other indefinite-lived intangible assets"],["Reacquired franchise rights","7,437","","","7,533"],["Acquired franchise rights","1,858","","","1,891"],["Brands (a)","4,404","","","4,306"],["Total indefinite-lived intangible assets","$","31,233","","","$","31,458"]]
[[/GREPCENT_TABLE]]

(a) Increase is related to the acquisition of remaining ownership in Sabra. See Note 13 for further information.

83

Table of Contents

The change in the book value of goodwill is as follows:

[[GREPCENT_TABLE]]
[["","FLNA","","QFNA","","PBNA","","LatAm","","Europe (a)","","AMESA","","APAC","","Total"],["Balance as of December 31, 2022","$","451","","","$","189","","","$","11,947","","","$","436","","","$","3,646","","","$","1,015","","","$","518","","","$","18,202"],["Acquisitions","\u2014","","","\u2014","","","4","","","\u2014","","","\u2014","","","34","","","\u2014","","","38"],["Impairment","\u2014","","","\u2014","","","\u2014","","","\u2014","","","(290)","","","\u2014","","","\u2014","","","(290)"],["Translation and other","2","","","\u2014","","","10","","","24","","","(190)","","","(58)","","","(10)","","","(222)"],["Balance as of December 30, 2023","453","","","189","","","11,961","","","460","","","3,166","","","991","","","508","","","17,728"],["Acquisitions (b)","159","","","\u2014","","","\u2014","","","\u2014","","","\u2014","","","\u2014","","","3","","","162"],["Translation and other","(10)","","","\u2014","","","(36)","","","(47)","","","(220)","","","(21)","","","(22)","","","(356)"],["Balance as of December 28, 2024","$","602","","","$","189","","","$","11,925","","","$","413","","","$","2,946","","","$","970","","","$","489","","","$","17,534"]]
[[/GREPCENT_TABLE]]

(a)Impairment in 2023 is related to SodaStream. Translation and other in 2023 primarily reflects the depreciation of the Russian ruble, partially offset by appreciation of the euro and British pound. Translation and other in 2024 primarily reflects the depreciation of the Russian ruble and euro.

(b)Primarily related to the acquisition of remaining ownership in Sabra. See Note 13 for further information.

Note 5 — Income Taxes

The components of income before income taxes are as follows:

[[GREPCENT_TABLE]]
[["","","2024","","2023","","2022"],["United States","","$","2,590","","","$","4,120","","","$","7,305"],["Foreign","","9,356","","","7,297","","","3,400"],["","","$","11,946","","","$","11,417","","","$","10,705"]]
[[/GREPCENT_TABLE]]

The provision for income taxes consisted of the following:

[[GREPCENT_TABLE]]
[["","2024","","2023","","2022"],["Current:"],["U.S. Federal","$","1,033","","","$","1,133","","","$","1,137"],["Foreign","1,406","","","1,201","","","1,027"],["State","255","","","309","","","246"],["","2,694","","","2,643","","","2,410"],["Deferred:"],["U.S. Federal","(306)","","","(109)","","","22"],["Foreign","(10)","","","(212)","","","(709)"],["State","(58)","","","(60)","","","4"],["","(374)","","","(381)","","","(683)"],["","$","2,320","","","$","2,262","","","$","1,727"]]
[[/GREPCENT_TABLE]]

84

Table of Contents

A reconciliation of the U.S. Federal statutory tax rate to our annual tax rate is as follows:

[[GREPCENT_TABLE]]
[["","2024","","2023","","2022"],["U.S. Federal statutory tax rate","21.0","%","","21.0","%","","21.0","%"],["State income tax, net of U.S. Federal tax benefit","1.3","","","1.8","","","1.8"],["Lower taxes on foreign results","(2.5)","","","(2.5)","","","(1.5)"],["One-time mandatory transition tax - TCJ Act","\u2014","","","\u2014","","","0.8"],["Juice Transaction","\u2014","","","(0.1)","","","(2.4)"],["Tax settlements","\u2014","","","\u2014","","","(3.0)"],["Other, net","(0.4)","","","(0.4)","","","(0.6)"],["Annual tax rate","19.4","%","","19.8","%","","16.1","%"]]
[[/GREPCENT_TABLE]]

Tax Cuts and Jobs Act

In 2022, we recorded $86 million ($0.06 per share) of net tax expense related to the TCJ Act as a result of correlating adjustments related to a partial audit settlement with the IRS for tax years 2014 through 2019.

As of December 28, 2024, our mandatory transition tax liability was $1.7 billion, which must be paid through 2026 under the provisions of the TCJ Act. We reduced our liability through cash payments and application of tax overpayments by $579 million in 2024, and $309 million in each of 2023 and 2022. We currently expect to pay approximately $772 million of this liability in 2025.

The TCJ Act also created a requirement that certain income earned by foreign subsidiaries, known as global intangible low-tax income (GILTI), must be included in the gross income of their U.S. shareholder. The FASB allows an accounting policy election of either recognizing deferred taxes for temporary differences expected to reverse as GILTI in future years or recognizing such taxes as a current-period expense when incurred. We elected to treat the tax effect of GILTI as a current-period expense when incurred.

Other Tax Matters

On October 29, 2021, we filed a formal written protest of a final assessment from the IRS audit for the tax years 2014 through 2016 and requested an appeals conference. In 2022, we came to an agreement with the IRS to settle one of the issues assessed in the 2014 through 2016 tax audit. The agreement covers tax years 2014 through 2019. As a result, we reduced our reserves for uncertain tax positions, including any correlating adjustments impacting the mandatory transition tax liability under the TCJ Act, resulting in a net non-cash tax benefit of $233 million ($0.17 per share) in 2022. Tax years 2014 through 2019 remain under audit for other issues.

In 2024 and 2023, tax benefits of $54 million ($0.04 per share) and $68 million ($0.05 per share), respectively, were recorded related to the impairment of certain consolidated investments.

85

Table of Contents

Deferred tax liabilities and assets are comprised of the following:

[[GREPCENT_TABLE]]
[["","2024","","2023"],["Deferred tax liabilities"],["Debt guarantee of wholly-owned subsidiary","$","578","","","$","578"],["Property, plant and equipment","1,868","","","1,978"],["Recapture of net operating losses","488","","","492"],["Pension liabilities","112","","","167"],["Right-of-use assets","772","","","660"],["Investment in TBG","\u2014","","","93"],["Other","301","","","350"],["Gross deferred tax liabilities","4,119","","","4,318"],["Deferred tax assets"],["Net carryforwards","6,737","","","6,877"],["Intangible assets other than nondeductible goodwill","1,599","","","1,758"],["Share-based compensation","148","","","137"],["Retiree medical benefits","104","","","114"],["Other employee-related benefits","415","","","412"],["Deductible state tax and interest benefits","202","","","176"],["Lease liabilities","773","","","660"],["Capitalized research and development","256","","","210"],["Other","948","","","1,031"],["Gross deferred tax assets","11,182","","","11,375"],["Valuation allowances","(6,185)","","","(6,478)"],["Deferred tax assets, net","4,997","","","4,897"],["Net deferred tax (assets)/liabilities","$","(878)","","","$","(579)"]]
[[/GREPCENT_TABLE]]

A summary of our valuation allowance activity is as follows:

[[GREPCENT_TABLE]]
[["","2024","","2023","","2022"],["Balance, beginning of year","$","6,478","","","$","5,013","","","$","4,628"],["(Benefit)/provision","(198)","","","1,419","","","492"],["Other (deductions)/additions","(95)","","","46","","","(107)"],["Balance, end of year","$","6,185","","","$","6,478","","","$","5,013"]]
[[/GREPCENT_TABLE]]

86

Table of Contents

Reserves

A number of years may elapse before a particular matter, for which we have established a reserve, is audited and finally resolved. The number of years with open tax audits varies depending on the tax jurisdiction. Our major taxing jurisdictions and the related open tax audits are as follows:

[[GREPCENT_TABLE]]
[["Jurisdiction","","Years Open to Audit","","Years Currently Under Audit"],["United States","","2014-2023","","2014-2019"],["Mexico","","2014-2023","","2014-2019"],["United Kingdom","","2021-2023","","None"],["Canada (Domestic)","","2018-2023","","2019"],["Canada (International)","","2012-2023","","2012-2019"],["Russia","","2021-2023","","None"]]
[[/GREPCENT_TABLE]]

Our annual tax rate is based on our income, statutory tax rates and tax planning strategies and transactions, including transfer pricing arrangements, available to us in the various jurisdictions in which we operate. Significant judgment is required in determining our annual tax rate and in evaluating our tax positions. We establish reserves when, despite our belief that our tax return positions are fully supportable, we believe that certain positions are subject to challenge and that we likely will not succeed. We adjust these reserves, as well as the related interest, in light of changing facts and circumstances, such as the progress of a tax audit, new tax laws, relevant court cases or tax authority settlements. Settlement of any particular issue would usually require the use of cash. Favorable resolution would be recognized as a reduction to our annual tax rate in the year of resolution.

As of December 28, 2024, the total gross amount of reserves for income taxes, reported in other liabilities, was $2.3 billion. We accrue interest related to reserves for income taxes in our provision for income taxes and any associated penalties are recorded in selling, general and administrative expenses. The gross amount of interest accrued, reported in other liabilities, was $469 million as of December 28, 2024, of which $103 million of tax expense was recognized in 2024. The gross amount of interest accrued, reported in other liabilities, was $390 million as of December 30, 2023, of which $102 million of tax expense was recognized in 2023.

A reconciliation of unrecognized tax benefits is as follows:

[[GREPCENT_TABLE]]
[["","2024","","2023"],["Balance, beginning of year","$","2,093","","","$","1,867"],["Additions for tax positions related to the current year","210","","","225"],["Additions for tax positions from prior years","108","","","123"],["Reductions for tax positions from prior years","(46)","","","(51)"],["Settlement payments","(24)","","","(16)"],["Statutes of limitations expiration","(31)","","","(33)"],["Translation and other","(26)","","","(22)"],["Balance, end of year","$","2,284","","","$","2,093"]]
[[/GREPCENT_TABLE]]

Carryforwards and Allowances

Operating loss carryforwards and income tax credits totaling $34.0 billion as of December 28, 2024 are being carried forward in a number of foreign and state jurisdictions where we are permitted to use tax operating losses and income tax credits from prior periods to reduce future taxable income or income tax liabilities. These operating losses and income tax credits will expire as follows: $0.4 billion in 2025, $29.1

87

Table of Contents

billion between 2026 and 2041 and $4.5 billion may be carried forward indefinitely. We establish valuation allowances for our deferred tax assets if, based on the available evidence, it is not more likely than not that some portion or all of the deferred tax assets will be realized.

Undistributed International Earnings

As of December 28, 2024, we had approximately $11 billion of undistributed international earnings. We intend to continue to reinvest $11 billion of earnings outside the United States for the foreseeable future and while future distribution of these earnings would not be subject to U.S. federal tax expense, no deferred tax liabilities with respect to items such as certain foreign exchange gains or losses, foreign withholding taxes or state taxes have been recognized. It is not practicable for us to determine the amount of unrecognized tax expense on these reinvested international earnings.

Note 6 — Share-Based Compensation

Our share-based compensation program is designed to attract and retain employees while also aligning employees’ interests with the interests of our shareholders. PepsiCo has granted stock options, RSUs, PSUs and long-term cash awards to employees under the shareholder-approved PepsiCo, Inc. Long-Term Incentive Plan (LTIP). Executives who are awarded long-term incentives based on their performance may generally elect to receive their grant in the form of stock options or RSUs, or a combination thereof. Executives who elect stock options receive four stock options for every one RSU that would have otherwise been granted. Certain executive officers and other senior executives do not have a choice and are granted 66% PSUs and 34% long-term cash, each of which are subject to pre-established performance targets.

The Company may use authorized and unissued shares to meet share requirements resulting from the exercise of stock options and the vesting of RSUs and PSUs.

As of December 28, 2024, 95 million shares were available for future share-based compensation grants under the LTIP.

The following table summarizes our total share-based compensation expense, which is primarily recorded in selling, general and administrative expenses, and excess tax benefits recognized:

[[GREPCENT_TABLE]]
[["","2024","","2023","","2022"],["Share-based compensation expense - equity awards","$","362","","","$","380","","","$","343"],["Share-based compensation expense - liability awards","7","","","19","","","30"],["Acquisition and divestiture-related charges","\u2014","","","\u2014","","","3"],["Restructuring charges","(5)","","","(1)","","","\u2014"],["Total","$","364","","","$","398","","","$","376"],["Income tax benefits recognized in earnings related to share-based compensation","$","68","","","$","73","","","$","62"],["Excess tax benefits related to share-based compensation","$","33","","","$","36","","","$","44"]]
[[/GREPCENT_TABLE]]

As of December 28, 2024, there was $398 million of total unrecognized compensation cost related to nonvested share-based compensation grants. This unrecognized compensation cost is expected to be recognized over a weighted-average period of two years.

Method of Accounting and Our Assumptions

The fair value of share-based award grants is amortized to expense over the vesting period, primarily three years. Awards to employees eligible for retirement prior to the award becoming fully vested are amortized to expense over the period through the date that the employee first becomes eligible to retire and is no

88

Table of Contents

longer required to provide service to earn the award. In addition, we use historical data to estimate forfeiture rates and record share-based compensation expense only for those awards that are expected to vest.

We do not backdate, reprice or grant share-based compensation awards retroactively. Repricing of awards would require shareholder approval under the LTIP.

Stock Options

A stock option permits the holder to purchase shares of PepsiCo common stock at a specified price. We account for our employee stock options under the fair value method of accounting using a Black-Scholes valuation model to measure stock option expense at the date of grant. All stock option grants have an exercise price equal to the fair market value of our common stock on the date of grant and generally have a 10-year term.

Our weighted-average Black-Scholes fair value assumptions are as follows:

[[GREPCENT_TABLE]]
[["","2024","","2023","","2022"],["Expected life","7 years","","7 years","","7 years"],["Risk-free interest rate","4.2","%","","4.2","%","","1.9","%"],["Expected volatility","16","%","","16","%","","16","%"],["Expected dividend yield","2.9","%","","2.7","%","","2.5","%"]]
[[/GREPCENT_TABLE]]

The expected life is the period over which our employee groups are expected to hold their options. It is based on our historical experience with similar grants. The risk-free interest rate is based on the expected U.S. Treasury rate over the expected life. Volatility reflects movements in our stock price over the most recent historical period equivalent to the expected life. Dividend yield is estimated over the expected life based on our stated dividend policy and forecasts of net income, share repurchases and stock price.

A summary of our stock option activity for the year ended December 28, 2024 is as follows:

[[GREPCENT_TABLE]]
[["","Options(a)","","Weighted-Average Exercise Price Per Unit","","Weighted-Average Contractual Life Remaining (years)","","Aggregate IntrinsicValue(a)"],["Outstanding at December 30, 2023","11,167","","","$","136.10"],["Granted","2,034","","","$","164.48"],["Exercised","(1,555)","","","$","107.36"],["Forfeited/expired","(591)","","","$","165.37"],["Outstanding at December 28, 2024","11,055","","","$","143.88","","","6.16","","$","177,780"],["Exercisable at December 28, 2024","5,369","","","$","119.78","","","3.98","","$","177,780"],["Expected to vest as of December 28, 2024","5,403","","","$","166.64","","","8.19","","$","\u2014"]]
[[/GREPCENT_TABLE]]

(a)In thousands.

Restricted Stock Units and Performance Stock Units

Each RSU represents our obligation to deliver to the holder one share of PepsiCo common stock when the award vests at the end of the service period. PSUs are awards pursuant to which a number of shares are delivered to the holder upon vesting at the end of the service period based on PepsiCo’s performance against specified financial performance metrics. The number of shares may be increased to the maximum or reduced to the minimum threshold based on the results of these performance metrics in accordance with

89

Table of Contents

the terms established at the time of the award. During the vesting period, RSUs and PSUs accrue dividend equivalents that pay out in cash (without interest) if and when the applicable RSU or PSU vests and becomes payable.

The fair value of RSUs and PSUs are measured at the market price of the Company’s stock on the date of grant.

A summary of our RSU and PSU activity for the year ended December 28, 2024 is as follows:

[[GREPCENT_TABLE]]
[["","RSUs/PSUs(a)","","Weighted-Average Grant-Date Fair Value Per Unit","","Weighted-Average Contractual Life Remaining (years)","","AggregateIntrinsicValue(a)"],["Outstanding at December 30, 2023","5,598","","","$","156.43"],["Granted","2,348","","","$","164.25"],["Converted","(2,055)","","","$","134.42"],["Forfeited","(525)","","","$","165.96"],["Outstanding at December 28, 2024 (b)","5,366","","","$","166.09","","","1.28","","$","820,429"],["Expected to vest as of December 28, 2024 (c)","5,306","","","$","166.14","","","1.20","","$","811,310"]]
[[/GREPCENT_TABLE]]

(a)In thousands. Outstanding awards are disclosed at target.

(b)The outstanding PSUs for which the vesting period has not ended as of December 28, 2024, at the threshold, target and maximum award levels were zero, 0.7 million and 1.3 million, respectively.

(c)Represents the number of outstanding awards expected to vest, including estimated performance adjustments on all outstanding PSUs as of December 28, 2024.

Long-Term Cash

Certain executive officers and other senior executives were granted long-term cash awards for which final payout is based on PepsiCo’s total shareholder return relative to a specific set of peer companies and achievement of a specified performance target over a three-year performance period.

Long-term cash awards that qualify as liability awards under share-based compensation guidance are valued through the end of the performance period on a mark-to-market basis using the Monte Carlo simulation model.

A summary of our long-term cash activity for the year ended December 28, 2024 is as follows:

[[GREPCENT_TABLE]]
[["","Long-Term Cash Award(a)","","Balance Sheet Date Fair Value(b)","","Contractual Life Remaining (years)"],["Outstanding at December 30, 2023","$","51,851"],["Granted","19,499"],["Vested","(15,241)"],["Forfeited","(2,139)"],["Outstanding at December 28, 2024 (c)","$","53,970","","","$","36,199","","","1.24"],["Expected to vest as of December 28, 2024","$","49,546","","","$","32,681","","","1.24"]]
[[/GREPCENT_TABLE]]

(a)In thousands, disclosed at target.

(b)In thousands, based on the most recent valuation as of December 28, 2024.

(c)The outstanding awards for which the vesting period has not ended as of December 28, 2024, at the threshold, target and maximum award levels based on the achievement of its market conditions were zero, $54 million and $108 million, respectively.

90

Table of Contents

Other Share-Based Compensation Data

The following is a summary of other share-based compensation data:

[[GREPCENT_TABLE]]
[["","2024","","2023","","2022"],["Stock Options"],["Total number of options granted (a)","2,034","","","2,162","","","2,422"],["Weighted-average grant-date fair value per unit of options granted","$","27.29","","","$","29.81","","","$","19.72"],["Total intrinsic value of options exercised (a)","$","99,388","","","$","100,209","","","$","134,580"],["Total grant-date fair value of options vested (a)","$","14,759","","","$","11,830","","","$","9,661"],["RSUs/PSUs"],["Total number of RSUs/PSUs granted (a)","2,348","","","2,151","","","2,263"],["Weighted-average grant-date fair value per unit of RSUs/PSUs granted","$","164.25","","","$","171.11","","","$","163.02"],["Total intrinsic value of RSUs/PSUs converted (a)","$","372,612","","","$","396,123","","","$","329,705"],["Total grant-date fair value of RSUs/PSUs vested (a)","$","280,673","","","$","286,605","","","$","196,649"]]
[[/GREPCENT_TABLE]]

(a)In thousands.

As of December 28, 2024 and December 30, 2023, there were approximately 311,000 and 330,000 outstanding awards, respectively, consisting primarily of phantom stock units that were granted under the PepsiCo Director Deferral Program and will be settled in shares of PepsiCo common stock pursuant to the LTIP at the end of the applicable deferral period, not included in the tables above.

91

Table of Contents

Note 7 — Pension, Retiree Medical and Savings Plans

In 2024, we recognized a pre-tax settlement charge of $213 million ($165 million after-tax or $0.12 per share) in a U.S. qualified defined benefit pension plan due to lump sum distributions to retired or terminated employees and the purchase of a group annuity contract whereby a third-party insurance company assumed the obligation to pay and administer future benefit payments for certain retirees. The settlement charge was triggered when the aggregate of the cumulative lump sum distributions and the annuity contract premium exceeded the total annual service and interest cost.

Effective December 31, 2022, we merged two U.S. qualified defined benefit pension plans, PepsiCo Employees Retirement Plan I (Plan I), mostly inactive participants, and PepsiCo Employees Retirement Plan A, mostly active participants, with Plan I remaining. The accrued benefits offered to the plans’ participants were unchanged. The merger was made to provide additional flexibility in evaluating opportunities to reduce risk and volatility. Actuarial gains and losses of the merged plan will be amortized over the average remaining life expectancy of participants. There was no material impact to pre-tax pension benefits expense from this merger.

In 2022, we transferred pension and retiree medical obligations of $145 million and related assets to TBG in connection with the Juice Transaction. See Note 13 for further information.

In 2020, we adopted an amendment to the U.S. qualified defined benefit plans to freeze benefit accruals for salaried participants, effective December 31, 2025.

Gains and losses resulting from actual experience differing from our assumptions, including the difference between the actual and expected return on plan assets, as well as changes in our assumptions, are determined at each measurement date. These differences are recognized as a component of net gain or loss in accumulated other comprehensive loss within common shareholders’ equity. If this net accumulated gain or loss exceeds 10% of the greater of the market-related value of plan assets or plan obligations, a portion of the net gain or loss is included in other pension and retiree medical benefits (expense)/income for the following year based upon the average remaining service life for participants in PepsiCo Employees Retirement Hourly Plan (Plan H) (approximately 11 years) and retiree medical (approximately 11 years), and the remaining life expectancy for participants in Plan I (approximately 26 years).

The cost or benefit of plan changes that increase or decrease benefits for prior employee service (prior service cost/(credit)) is included in other pension and retiree medical benefits (expense)/income on a straight-line basis over the average remaining service life for participants in Plan H, and the remaining life expectancy for participants in Plan I, except that prior service cost/(credit) for salaried participants subject to the benefit accruals freeze effective December 31, 2025 is amortized on a straight-line basis over the period up to the effective date of the freeze.

92

Table of Contents

Selected financial information for our pension and retiree medical plans is as follows: 

[[GREPCENT_TABLE]]
[["","Pension","","Retiree Medical"],["","U.S.","","International"],["","2024","","2023","","2024","","2023","","2024","","2023"],["Change in projected benefit obligation"],["Obligation at beginning of year","$","12,035","","","$","11,543","","","$","2,986","","","$","2,603","","","$","677","","","$","714"],["Service cost","347","","","327","","","46","","","43","","","31","","","29"],["Interest cost","585","","","593","","","144","","","141","","","32","","","36"],["Plan amendments","12","","","13","","","1","","","\u2014","","","\u2014","","","\u2014"],["Participant contributions","\u2014","","","\u2014","","","2","","","2","","","\u2014","","","\u2014"],["Experience (gain)/loss","(563)","","","603","","","(55)","","","194","","","(44)","","","(22)"],["Benefit payments","(617)","","","(1,006)","","","(108)","","","(116)","","","(78)","","","(80)"],["Settlement/curtailment","(506)","","","(36)","","","(62)","","","(26)","","","\u2014","","","\u2014"],["Special termination benefits","31","","","(1)","","","\u2014","","","\u2014","","","1","","","\u2014"],["Other, including foreign currency adjustment","\u2014","","","(1)","","","(168)","","","145","","","(3)","","","\u2014"],["Obligation at end of year","$","11,324","","","$","12,035","","","$","2,786","","","$","2,986","","","$","616","","","$","677"],["Change in fair value of plan assets"],["Fair value at beginning of year","$","11,541","","","$","11,148","","","$","3,528","","","$","3,195","","","$","183","","","$","196"],["Actual return on plan assets","(10)","","","1,121","","","142","","","267","","","5","","","21"],["Employer contributions/funding","236","","","314","","","59","","","50","","","53","","","46"],["Participant contributions","\u2014","","","\u2014","","","2","","","2","","","\u2014","","","\u2014"],["Benefit payments","(617)","","","(1,006)","","","(108)","","","(116)","","","(78)","","","(80)"],["Settlement","(539)","","","(36)","","","(62)","","","(26)","","","\u2014","","","\u2014"],["Other, including foreign currency adjustment","(2)","","","\u2014","","","(164)","","","156","","","\u2014","","","\u2014"],["Fair value at end of year","$","10,609","","","$","11,541","","","$","3,397","","","$","3,528","","","$","163","","","$","183"],["Funded status","$","(715)","","","$","(494)","","","$","611","","","$","542","","","$","(453)","","","$","(494)"]]
[[/GREPCENT_TABLE]]

[[GREPCENT_TABLE]]
[["Amounts recognized"],["Other assets","$","388","","","$","313","","","$","792","","","$","727","","","$","\u2014","","","$","\u2014"],["Other current liabilities","(85)","","","(75)","","","(10)","","","(11)","","","(52)","","","(52)"],["Other liabilities","(1,018)","","","(732)","","","(171)","","","(174)","","","(401)","","","(442)"],["Net amount recognized","$","(715)","","","$","(494)","","","$","611","","","$","542","","","$","(453)","","","$","(494)"],["Amounts included in accumulated other comprehensive loss (pre-tax)"],["Net loss/(gain)","$","3,618","","","$","3,596","","","$","633","","","$","707","","","$","(333)","","","$","(323)"],["Prior service cost/(credit)","54","","","18","","","(5)","","","(8)","","","(14)","","","(19)"],["Total","$","3,672","","","$","3,614","","","$","628","","","$","699","","","$","(347)","","","$","(342)"],["Changes recognized in net loss/(gain) included in other comprehensive loss"],["Net loss/(gain) arising in current year","$","320","","","$","333","","","$","8","","","$","119","","","$","(36)","","","$","(30)"],["Amortization and settlement recognition","(298)","","","(74)","","","(43)","","","(23)","","","25","","","27"],["Foreign currency translation (gain)/loss","\u2014","","","\u2014","","","(39)","","","40","","","1","","","\u2014"],["Total","$","22","","","$","259","","","$","(74)","","","$","136","","","$","(10)","","","$","(3)"],["Accumulated benefit obligation at end of year","$","11,069","","","$","11,653","","","$","2,638","","","$","2,835"]]
[[/GREPCENT_TABLE]]

The net loss arising in the current year is primarily attributable to lower actual asset return as compared to expected return on plan assets and actual experience differing from demographic assumptions, partially offset by experience gain primarily due to higher discount rates.

93

Table of Contents

The amount we report in operating profit as pension and retiree medical cost is service cost, which is the value of benefits earned by employees for working during the year.

The amounts we report below operating profit as pension and retiree medical cost consist of the following components:

•Interest cost is the accrued interest on the projected benefit obligation due to the passage of time.

•Expected return on plan assets is the long-term return we expect to earn on plan investments for our funded plans that will be used to settle future benefit obligations.

•Amortization of prior service cost/(credit) represents the recognition in the income statement of benefit changes resulting from plan amendments.

•Amortization of net loss/(gain) represents the recognition in the income statement of changes in the amount of plan assets and the projected benefit obligation based on changes in assumptions and actual experience.

•Settlement/curtailment loss/(gain) represents the result of actions that effectively eliminate all or a portion of related projected benefit obligations. Settlements are triggered when payouts to settle the projected benefit obligation of a plan due to lump sums or other events exceed the total of annual service and interest cost. Settlements are recognized when actions are irrevocable and we are relieved of the primary responsibility and risk for projected benefit obligations. Lump sum payouts are generally higher when interest rates are lower. Curtailments are recognized when events such as plant closures, the sale of a business, or plan changes result in a significant reduction of future service or benefits. Curtailment losses are recognized when an event is probable and estimable, while curtailment gains are recognized when an event has occurred (when the related employees terminate or an amendment is adopted).

•Special termination benefits are the additional benefits offered to employees upon departure due to actions such as restructuring.

The components of total pension and retiree medical benefit costs are as follows:

[[GREPCENT_TABLE]]
[["","Pension","","Retiree Medical"],["","U.S.","","International"],["","2024","","2023","","2022","","2024","","2023","","2022","","2024","","2023","","2022"],["Service cost","$","347","","","$","327","","","$","487","","","$","46","","","$","43","","","$","64","","","$","31","","","$","29","","","$","37"],["Other pension and retiree medical benefits expense/(income):"],["Interest cost","$","585","","","$","593","","","$","434","","","$","144","","","$","141","","","$","90","","","$","32","","","$","36","","","$","19"],["Expected return on plan assets","(871)","","","(851)","","","(912)","","","(205)","","","(192)","","","(218)","","","(13)","","","(13)","","","(16)"],["Amortization of prior service credits","(24)","","","(26)","","","(28)","","","(2)","","","(1)","","","(1)","","","(5)","","","(6)","","","(8)"],["Amortization of net losses/(gains)","77","","","70","","","149","","","21","","","13","","","29","","","(25)","","","(27)","","","(14)"],["Settlement/curtailment losses/(gains) (a)","254","","","4","","","322","","","22","","","10","","","1","","","\u2014","","","\u2014","","","(16)"],["Special termination benefits","31","","","(1)","","","37","","","\u2014","","","\u2014","","","\u2014","","","1","","","\u2014","","","\u2014"],["Total other pension and retiree medical benefits expense/(income)","$","52","","","$","(211)","","","$","2","","","$","(20)","","","$","(29)","","","$","(99)","","","$","(10)","","","$","(10)","","","$","(35)"],["Total","$","399","","","$","116","","","$","489","","","$","26","","","$","14","","","$","(35)","","","$","21","","","$","19","","","$","2"]]
[[/GREPCENT_TABLE]]

(a)In 2024, U.S. includes a settlement charge of $213 million ($165 million after-tax or $0.12 per share) related to the aggregate of lump sum distributions and the purchase of a group annuity contract exceeding the total of annual service and interest cost. In 2022, U.S. includes a settlement charge of $318 million ($246 million after-tax or $0.18 per share) related to lump sum distributions exceeding the total of annual service and interest cost.

94

Table of Contents

The following table provides the weighted-average assumptions used to determine net periodic benefit cost and projected benefit obligation for our pension and retiree medical plans:

[[GREPCENT_TABLE]]
[["","Pension","","Retiree Medical"],["","U.S.","","International"],["","2024","","2023","","2022","","2024","","2023","","2022","","2024","","2023","","2022"],["Net Periodic Benefit Cost"],["Service cost discount rate (a)","5.1","%","","5.4","%","","3.1","%","","6.9","%","","7.0","%","","4.2","%","","5.1","%","","5.4","%","","2.8","%"],["Interest cost discount rate (a)","5.1","%","","5.4","%","","3.1","%","","5.0","%","","5.4","%","","2.3","%","","5.0","%","","5.3","%","","2.1","%"],["Expected return on plan assets (a)","7.4","%","","7.4","%","","6.7","%","","5.8","%","","5.7","%","","5.3","%","","7.1","%","","7.1","%","","5.7","%"],["Rate of salary increases","3.9","%","","3.2","%","","3.0","%","","4.3","%","","4.2","%","","3.3","%"],["Projected Benefit Obligation"],["Discount rate","5.7","%","","5.1","%","","5.4","%","","5.5","%","","5.1","%","","5.3","%","","5.5","%","","5.1","%","","5.4","%"],["Rate of salary increases","3.9","%","","3.9","%","","3.2","%","","4.0","%","","4.3","%","","4.2","%"]]
[[/GREPCENT_TABLE]]

(a)2022 U.S. rates reflect remeasurement of a U.S. qualified defined benefit pension plan in the second quarter of 2022.

The following table provides selected information about plans with accumulated benefit obligation and total projected benefit obligation in excess of plan assets:

[[GREPCENT_TABLE]]
[["","Pension","","Retiree Medical"],["","U.S.","","International"],["","2024","","2023","","2024","","2023","","2024","","2023"],["Selected information for plans with accumulated benefit obligation in excess of plan assets"],["Obligation for service to date","$","(7,315)","","","$","(631)","","","$","(194)","","","$","(255)"],["Fair value of plan assets","$","6,399","","","$","\u2014","","","$","135","","","$","190"],["Selected information for plans with projected benefit obligation in excess of plan assets"],["Benefit obligation","$","(7,502)","","","$","(8,223)","","","$","(346)","","","$","(375)","","","$","(616)","","","$","(677)"],["Fair value of plan assets","$","6,399","","","$","7,416","","","$","165","","","$","190","","","$","163","","","$","183"]]
[[/GREPCENT_TABLE]]

Of the total projected pension benefit obligation as of December 28, 2024, approximately $664 million relates to plans that we do not fund because the funding of such plans does not receive favorable tax treatment.

Future Benefit Payments    

Our estimated future benefit payments are as follows:

[[GREPCENT_TABLE]]
[["","2025","","2026","","2027","","2028","","2029","","2030 - 2034"],["Pension","$","1,053","","","$","1,145","","","$","953","","","$","982","","","$","1,008","","","$","5,327"],["Retiree medical (a)","$","77","","","$","75","","","$","72","","","$","69","","","$","67","","","$","295"]]
[[/GREPCENT_TABLE]]

(a)Expected future benefit payments for our retiree medical plans do not reflect any estimated subsidies expected to be received under the 2003 Medicare Act. Subsidies are expected to be less than $1 million for each of the years from 2025 through 2029 and approximately $2 million in total for 2030 through 2034.

These future benefit payments to beneficiaries include payments from both funded and unfunded plans.

95

Table of Contents

Funding

Contributions to our pension and retiree medical plans were as follows:

[[GREPCENT_TABLE]]
[["","Pension","","Retiree Medical"],["","2024","","2023","","2022","","2024","","2023","","2022"],["Discretionary (a)","$","161","","","$","267","","","$","160","","","$","\u2014","","","$","\u2014","","","$","\u2014"],["Non-discretionary","134","","","97","","","176","","","53","","","46","","","48"],["Total","$","295","","","$","364","","","$","336","","","$","53","","","$","46","","","$","48"]]
[[/GREPCENT_TABLE]]

(a)Includes $150 million contribution in 2024, $250 million contribution in 2023 and $150 million contribution in 2022 to fund our U.S. qualified defined benefit plans.

We made a discretionary contribution of $250 million to a U.S. qualified defined benefit plan in January 2025. In addition, in 2025, we expect to make non-discretionary contributions of approximately $102 million to our U.S. and international pension benefit plans and contributions of approximately $52 million for retiree medical benefits.

We also regularly evaluate opportunities to reduce risk and volatility associated with our pension and retiree medical plans.

Plan Assets

Our pension plan investment strategy includes the use of actively managed accounts and is reviewed periodically in conjunction with plan obligations, an evaluation of market conditions, tolerance for risk and cash requirements for benefit payments. This strategy is also applicable to funds held for the retiree medical plans. Our investment objective includes ensuring that funds are available to meet the plans’ benefit obligations when they become due. Assets contributed to our pension plans are no longer controlled by us, but become the property of our individual pension plans. However, we are indirectly impacted by changes in these plan assets as compared to changes in our projected obligations. Our overall investment policy is to prudently invest plan assets in a well-diversified portfolio of equity and high-quality debt securities and real estate to achieve our long-term return expectations. Our investment policy also permits the use of derivative instruments, such as futures and forward contracts, to reduce interest rate and foreign currency risks. Futures contracts represent commitments to purchase or sell securities at a future date and at a specified price. Forward contracts consist of currency forwards. We also participate in securities lending programs to generate additional income by loaning plan assets to borrowers on a fully collateralized basis, including both cash and non-cash collaterals.

For 2025 and 2024, our expected long-term rate of return on U.S. plan assets is 7.5% and 7.4%, respectively. Our target investment allocations for U.S. plan assets are as follows:

[[GREPCENT_TABLE]]
[["","2025","","2024"],["Fixed income","56","%","","55","%"],["U.S. equity","22","%","","22","%"],["International equity","18","%","","19","%"],["Real estate","4","%","","4","%"]]
[[/GREPCENT_TABLE]]

Actual investment allocations may vary from our target investment allocations due to prevailing market conditions. We regularly review our actual investment allocations and periodically rebalance our investments.

The expected return on plan assets is based on our investment strategy and our expectations for long-term rates of return by asset class, taking into account volatility and correlation among asset classes and our historical experience. We also review current levels of interest rates and inflation to assess the reasonableness of the long-term rates. We evaluate our expected return assumptions annually to ensure

96

Table of Contents

that they are reasonable. To calculate the expected return on plan assets, our market-related value of assets for fixed income is the actual fair value. For all other asset categories, such as equity securities, we use a method that recognizes investment gains or losses (the difference between the expected and actual return based on the market-related value of assets) over a five-year period. This has the effect of reducing year-to-year volatility.

Plan assets measured at fair value as of year-end 2024 and 2023 are categorized consistently by Level 1 (quoted prices in active markets for identical assets), Level 2 (significant other observable inputs) and Level 3 (significant unobservable inputs) in both years and are as follows:

[[GREPCENT_TABLE]]
[["","Fair Value Hierarchy Level","","2024","","2023"],["U.S. plan assets (a)(b)"],["Equity securities, including preferred stock (c)","1","","$","4,270","","","$","4,698"],["Government securities (d)","2","","1,538","","","1,812"],["Corporate bonds (d)","2","","3,903","","","4,233"],["Mortgage-backed securities (d)","2","","125","","","133"],["Contracts with insurance companies (e)","3","","1","","","1"],["Cash and cash equivalents (f) (g)","1, 2","","732","","","349"],["Sub-total U.S. plan assets","","","10,569","","","11,226"],["Real estate and other commingled funds measured at net asset value (h)","","","561","","","411"],["Securities lending payables, net of dividends and interest receivable (g)","","","(358)","","","87"],["Total U.S. plan assets","","","$","10,772","","","$","11,724"],["International plan assets"],["Equity securities (c)","1","","$","1,172","","","$","1,175"],["Government securities (d)","2","","932","","","1,207"],["Corporate bonds (d)","2","","469","","","267"],["Fixed income commingled funds (i)","1","","557","","","526"],["Contracts with insurance companies (e)","3","","29","","","30"],["Cash and cash equivalents","1","","128","","","143"],["Sub-total international plan assets","","","3,287","","","3,348"],["Real estate commingled funds measured at net asset value (h)","","","79","","","162"],["Dividends and interest receivable","","","31","","","18"],["Total international plan assets","","","$","3,397","","","$","3,528"]]
[[/GREPCENT_TABLE]]

(a)Includes $163 million and $183 million in 2024 and 2023, respectively, of retiree medical plan assets that are restricted for purposes of providing health benefits for U.S. retirees and their beneficiaries.

(b)Includes securities loaned to borrowers under the securities lending program with fair value of $630 million in 2024.

(c)Invested in U.S. and international common stock and commingled funds, and the preferred stock portfolio was invested in domestic and international corporate preferred stock investments. The common and preferred stock investments are based on quoted prices in active markets. The commingled funds are based on the published price of the fund and include one large-cap fund that represents 12% and 13% of total U.S. plan assets for 2024 and 2023, respectively.

(d)These investments are based on quoted bid prices for comparable securities in the marketplace and broker/dealer quotes in active markets. Corporate bonds of U.S.-based companies represent 31% of total U.S. plan assets for both 2024 and 2023.

(e)Based on the fair value of the contracts as determined by the insurance companies using inputs that are not observable. The changes in Level 3 amounts were not significant in the years ended December 28, 2024 and December 30, 2023.

(f)Includes Level 1 assets of $456 million and $3 million, and Level 2 assets of $276 million and $346 million for 2024 and 2023, respectively.

(g)Includes $447 million of cash collateral under the securities lending program offset by corresponding securities lending payable of the same amount. The net impact on the fair value of U.S. plan assets is zero.

(h)Includes investments in limited partnerships and private credit funds. These funds are based on the net asset value of the investments owned by these funds as determined by independent third parties using inputs that are not observable. The majority of the funds are redeemable quarterly subject to availability of cash and have notice periods ranging from 30 to 90 days.

(i)Based on the published price of the fund.

97

Table of Contents

Retiree Medical Cost Trend Rates

The assumed health care cost trend rates for both 2025 and 2024 are as follows:

[[GREPCENT_TABLE]]
[["Average increase assumed","5","%"],["Ultimate projected increase","4","%"],["Year of ultimate projected increase","2046"]]
[[/GREPCENT_TABLE]]

Annually, we review external data and our historical experience to estimate assumed health care cost trend rates that impact our retiree medical plan obligation and expense, however the cap on our share of retiree medical costs limits the impact.

Savings Plan

Certain U.S. employees are eligible to participate in a 401(k) savings plan, which is a voluntary defined contribution plan. The plan is designed to help employees accumulate savings for retirement and we make Company matching contributions for certain employees on a portion of employee contributions based on years of service.

Certain U.S. employees, who are either not eligible to participate in a defined benefit pension plan or whose benefit is capped, are also eligible to receive an employer contribution based on either years of service or age and years of service regardless of employee contribution.

In 2024, 2023 and 2022, our total Company contributions were $411 million, $356 million and $283 million, respectively.

Note 8 — Debt Obligations

The following table summarizes our debt obligations:

[[GREPCENT_TABLE]]
[["","2024(a)","","2023(a)"],["Short-term debt obligations (b)"],["Current maturities of long-term debt","$","4,004","","","$","3,924"],["Commercial paper (4.5% and 5.5%)","2,818","","","2,286"],["Other borrowings (8.6% and 7.8%)","260","","","300"],["","$","7,082","","","$","6,510"],["Long-term debt obligations (b)"],["Notes due 2024 (3.0%)","$","\u2014","","","$","3,919"],["Notes due 2025 (3.2% and 3.2%)","3,999","","","3,994"],["Notes due 2026 (3.7% and 3.7%)","3,941","","","3,961"],["Notes due 2027 (3.1% and 2.4%)","3,370","","","2,544"],["Notes due 2028 (2.1% and 2.1%)","3,240","","","3,323"],["Notes due 2029 (4.6% and 4.0%)","3,239","","","1,925"],["Notes due 2030-2060 (3.2% and 2.9%)","23,400","","","21,800"],["Other, due 2024-2033 (5.7% and 3.6%)","39","","","53"],["","41,228","","","41,519"],["Less: current maturities of long-term debt obligations","4,004","","","3,924"],["Total","$","37,224","","","$","37,595"]]
[[/GREPCENT_TABLE]]

(a)Amounts are shown net of unamortized net discounts of $267 million and $225 million for 2024 and 2023, respectively.

(b)The interest rates presented reflect weighted-average effective interest rates at year-end. Certain of our fixed rate indebtedness have been swapped to floating rates through the use of interest rate derivative instruments. See Note 9 for further information regarding our interest rate swap contracts.

98

Table of Contents

As of December 28, 2024 and December 30, 2023, our international debt of $325 million and $279 million, respectively, was related to borrowings from external parties, including various lines of credit. These lines of credit are subject to normal banking terms and conditions and are fully committed at least to the extent of our borrowings.

In 2024, we issued the following senior notes:

[[GREPCENT_TABLE]]
[["Interest Rate","","Maturity Date","","Principal Amount(a)"],["Floating rate","","February 2027","","$","300","","(b)"],["4.650","%","","February 2027","","$","550","","(b)"],["4.550","%","","February 2029","","$","450","","(b)"],["4.700","%","","February 2034","","$","450","","(b)"],["4.500","%","","July 2029","","$","850"],["4.800","%","","July 2034","","$","650"],["5.250","%","","July 2054","","$","750"]]
[[/GREPCENT_TABLE]]

(a)Excludes debt issuance costs, discounts and premiums.

(b)Issued through our wholly-owned consolidated finance subsidiary, PepsiCo Singapore Financing I Pte. Ltd., which has no assets, operations, revenues or cash flows other than those related to the issuance, administration and repayment of the notes and any other notes that may be issued in the future. The notes are fully and unconditionally guaranteed by PepsiCo, Inc. on a senior unsecured basis and may be assumed at any time by PepsiCo, Inc. as the primary and sole obligor.

The net proceeds from the issuances of the above notes were used for general corporate purposes, including the repayment of commercial paper.

In 2024, we entered into a new five-year unsecured revolving credit agreement (Five-Year Credit Agreement), which expires on May 24, 2029. The Five-Year Credit Agreement enables us and our borrowing subsidiaries to borrow up to $5.0 billion in U.S. dollars and/or euros, including a $0.75 billion swing line subfacility for euro-denominated borrowings permitted to be borrowed on a same-day basis, subject to customary terms and conditions. We may request that commitments under this agreement be increased up to $5.75 billion (or the equivalent amount in euros). Additionally, we may, up to two times during the term of the 2024 Five-Year Credit Agreement, request renewal of the agreement for an additional one-year period. The Five-Year Credit Agreement replaced our $4.2 billion five-year credit agreement, dated as of May 26, 2023.

Also in 2024, we entered into a new 364-day unsecured revolving credit agreement (364-Day Credit Agreement), which expires on May 23, 2025. The 364-Day Credit Agreement enables us and our borrowing subsidiaries to borrow up to $5.0 billion in U.S. dollars and/or euros, subject to customary terms and conditions. We may request that commitments under this agreement be increased up to $5.75 billion (or the equivalent amount in euros). We may request renewal of this facility for an additional 364-day period or convert any amounts outstanding into a term loan for a period of up to one year, which term loan would mature no later than the anniversary of the then effective termination date. The 364-Day Credit Agreement replaced our $4.2 billion 364-day credit agreement, dated as of May 26, 2023.

Funds borrowed under the Five-Year Credit Agreement and the 364-Day Credit Agreement may be used for general corporate purposes. Subject to certain conditions, we may borrow, prepay and reborrow amounts under these agreements. As of December 28, 2024, there were no outstanding borrowings under the Five-Year Credit Agreement or the 364-Day Credit Agreement.

In 2023, we discharged via legal defeasance $94 million outstanding principal amount of certain notes originally issued by our subsidiary, The Quaker Oats Company, following the deposit of $102 million of U.S. government securities with the Bank of New York Mellon, as trustee, in the fourth quarter of 2022.

In 2022, we paid $750 million to redeem all $750 million outstanding principal amount of our 2.25% senior notes due May 2022, we paid $800 million to redeem all $800 million outstanding principal amount

99

Table of Contents

of our 3.10% senior notes due July 2022 and we paid $154 million to redeem all $133 million outstanding principal amount of our subsidiary, Pepsi-Cola Metropolitan Bottling Company, Inc.’s 7.00% senior notes due March 2029 and 5.50% notes due May 2035.

Note 9 — Financial Instruments

Derivatives and Hedging

We are exposed to market risks arising from adverse changes in:

•commodity prices, affecting the cost of our raw materials and energy;

•foreign exchange rates and currency restrictions; and

•interest rates.

In the normal course of business, we manage commodity price, foreign exchange and interest rate risks through a variety of strategies, including productivity initiatives, global purchasing programs and hedging. Ongoing productivity initiatives involve the identification and effective implementation of meaningful cost-saving opportunities or efficiencies, including the use of derivatives. We do not use derivative instruments for trading or speculative purposes. Our global purchasing programs include fixed-price contracts and purchase orders and pricing agreements.

Our hedging strategies include the use of derivatives and non-derivative debt instruments. Certain derivatives are designated as either cash flow, fair value or net investment hedges and qualify for hedge accounting treatment, while others do not qualify and are marked to market through earnings. The accounting for qualifying hedges allows changes in a hedging instrument’s fair value to offset corresponding changes in the hedged item in the same reporting period that the hedged item impacts earnings. Gains or losses on derivatives designated as cash flow and net investment hedges are recorded in accumulated other comprehensive loss within common shareholders’ equity and reclassified to our income statement when the hedged transaction affects earnings for cash flow hedges and when the hedged foreign operation is either sold or substantially liquidated for net investment hedges. If it becomes probable that the hedged transaction will not occur, we immediately recognize the related hedging gains or losses in earnings; there were no such gains or losses reclassified during the year ended December 28, 2024.

Cash flows from derivatives used to manage commodity price, foreign exchange or interest rate risks are classified as operating activities in the cash flow statement. We classify both the earnings and cash flow impact from these derivatives consistent with the underlying hedged item. Cash flows associated with the settlement of derivative instruments designated as net investment hedges of foreign operations are classified within investing activities.

Credit Risk

We perform assessments of our counterparty credit risk regularly, including reviewing netting agreements, if any, and a review of credit ratings, credit default swap rates and potential nonperformance of the counterparty. Based on our most recent assessment of our counterparty credit risk, we consider this risk to be low. In addition, we enter into derivative contracts with a variety of financial institutions that we believe are creditworthy in order to reduce our concentration of credit risk.

Certain of our agreements with our counterparties require us to post full collateral on derivative instruments in a net liability position if our credit rating is at A2 (Moody’s Investors Service, Inc.) or A (S&P Global Ratings) and we have been placed on credit watch for possible downgrade or if our credit rating falls below either of these levels. The fair value of all derivative instruments with credit-risk-related contingent features that were in a net liability position as of December 28, 2024 was $208 million. We have posted no collateral under these contracts and no credit-risk-related contingent features were triggered as of December 28, 2024.

100

Table of Contents

Commodity Prices

We are subject to commodity price risk because our ability to recover increased costs through higher pricing may be limited in the competitive environment in which we operate. This risk is managed through the use of fixed-price contracts and purchase orders, pricing agreements and derivative instruments, which primarily include swaps and futures. In addition, risk to our supply of certain raw materials is mitigated through purchases from multiple geographies and suppliers. We use derivatives, with terms of no more than two years, to hedge price fluctuations related to a portion of our anticipated commodity purchases, primarily for agricultural products, metals, and energy. Derivatives used to hedge commodity price risk that do not qualify for hedge accounting treatment are marked to market each period with the resulting gains and losses recorded in corporate unallocated expenses as either cost of sales or selling, general and administrative expenses, depending on the underlying commodity. These gains and losses are subsequently reflected in division results when the divisions recognize the cost of the underlying commodity in operating profit.

Interest Rates

We centrally manage our debt and investment portfolios considering investment opportunities and risks, tax consequences and overall financing strategies. We use various interest rate derivative instruments including, but not limited to, interest rate swaps, cross-currency interest rate swaps, Treasury locks and swap locks to manage our overall interest expense. These instruments effectively change the interest rate of specific debt issuances. Certain of our fixed rate indebtedness have been swapped to floating rates. The notional amount, interest payment and maturity date of our interest rate swap contracts match the principal, interest payment and maturity date of the related debt, and they have terms of no more than six years. Our Treasury locks and swap locks are entered into to protect against unfavorable interest rate changes relating to forecasted debt transactions.

As of December 28, 2024, approximately 13% of total debt was subject to variable rates, after the impact of the related interest rate swap contracts, compared to approximately 9% as of December 30, 2023.

Foreign Exchange

We are exposed to foreign exchange risks in the international markets in which our products are made, manufactured, distributed or sold. Additionally, we are exposed to foreign exchange risk from foreign currency purchases and foreign currency assets and liabilities created in the normal course of business. We manage this risk through sourcing purchases from local suppliers, negotiating contracts in local currencies with foreign suppliers and through the use of derivatives including, but not limited to, forward contracts and cross-currency interest rate swap contracts. Exchange rate gains or losses related to foreign currency transactions are recognized as transaction gains or losses on our income statement as incurred. The forward contracts and cross-currency interest rate swap contracts have terms of no more than two years and twelve years, respectively. The notional amount, interest payment and maturity date of our cross-currency interest rate swap contracts match the principal, interest payment and maturity date of the related foreign currency debt. For foreign currency derivatives that do not qualify for hedge accounting treatment, gains and losses were offset by changes in the underlying hedged items, resulting in no material net impact on earnings.

Net Investment Hedges

We are exposed to foreign exchange risk from net investments in our foreign operations. We manage this risk for certain of our foreign operations by utilizing derivative and non-derivative instruments, including cross-currency interest rate swaps and foreign currency denominated debt designated as net investment hedges.

101

Table of Contents

In 2024, we entered into cross-currency interest rate swaps with a total notional amount of $500 million for Chinese renminbi and maturity dates ranging from November 2025 to November 2029. The cross-currency interest rate swaps are designated as net investment hedges to hedge the net assets of certain foreign operations with Chinese renminbi functional currency.

We use the spot method to assess hedge effectiveness for our net investment hedges. Excluded components in the form of interest accruals on cross-currency interest rate swaps are recorded in net interest expense and other.

The notional amounts of our financial instruments used to hedge the above risks as of December 28, 2024 and December 30, 2023 are as follows:

[[GREPCENT_TABLE]]
[["","Notional Amounts(a)"],["","2024","","2023"],["Commodity contracts","$","1.4","","","$","1.7"],["Interest rate swap contracts","$","2.0","","","$","\u2014"],["Foreign exchange contracts","$","3.1","","","$","3.8"],["Cross-currency contracts","$","1.2","","","$","1.3"],["Non-derivative debt instruments","$","2.9","","","$","3.0"]]
[[/GREPCENT_TABLE]]

(a)In billions.

Debt Securities

Held-to-Maturity

Investments in debt securities that we have the positive intent and ability to hold until maturity are classified as held-to-maturity. Highly liquid debt securities with original maturities of three months or less are recorded as cash equivalents. Our held-to-maturity debt securities consist of commercial paper. As of December 28, 2024, we have no investments in held-to-maturity debt securities. As of December 30, 2023, we had $309 million investments in commercial paper recorded in cash and cash equivalents. Held-to-maturity debt securities are recorded at amortized cost, which approximates fair value, and realized gains or losses are reported in earnings. As of December 30, 2023, gross unrecognized gains and losses and the allowance for expected credit losses were not material.

Available-for-Sale

Investments in available-for-sale debt securities are reported at fair value. Changes in the fair value of available-for-sale debt securities are generally recognized in accumulated other comprehensive loss within common shareholders’ equity. Changes in the fair value of available-for-sale debt securities impact earnings only when such securities are sold, or an allowance for expected credit losses or impairment is recognized. We regularly evaluate our investment portfolio for expected credit losses and impairment. In making this judgment, we evaluate, among other things, the extent to which the fair value of a debt security is less than its amortized cost; the financial condition of the issuer, including the credit quality, and any changes thereto; and our intent to sell, or whether we will more likely than not be required to sell, the debt security before recovery of its amortized cost basis. Our assessment of whether a debt security has a credit loss or is impaired could change in the future due to new developments or changes in assumptions related to any particular debt security.

In 2022, we entered into an agreement with Celsius Holdings, Inc. (Celsius) to distribute Celsius energy drinks in the United States and invested $550 million in Series A convertible preferred shares issued by Celsius, which included certain conversion and redemption features. The preferred shares automatically convert into Celsius common shares after six years if certain market-based conditions are met, or can be redeemed after seven years. Shares underlying the transaction were priced at $75 per share, and the

102

Table of Contents

preferred shares are entitled to a 5% annual dividend, payable either in cash or in-kind. Given our redemption right, we classified our investment in the convertible preferred stock as an available-for-sale debt security. As of December 31, 2022, the fair value of this investment was classified as Level 2, based primarily on the transaction price. There were no unrealized gains and losses on our investment in the year ended December 31, 2022. In the year ended December 30, 2023, we transferred $558 million from Level 2 to Level 3 as unobservable inputs to the fair value became more significant and subsequently recorded an unrealized gain of $612 million in other comprehensive income and a decrease in the investment of $14 million due to cash dividends received. In the year ended December 28, 2024, we recorded an unrealized loss of $350 million in other comprehensive income and a decrease in the investment of $21 million due to cash dividends received.

In addition, during the year ended December 28, 2024, we transferred $184 million of other available-for-sale debt securities from Level 2 to Level 3, as unobservable inputs to the fair value became more significant, and subsequently recorded an unrealized gain of $72 million in other comprehensive income.

There were no impairment charges related to our investments in available-for-sale debt securities in the years ended December 28, 2024, December 30, 2023 and December 31, 2022. There were net unrealized gains of $334 million and $612 million as of December 28, 2024 and December 30, 2023, respectively, associated with our available-for-sale debt securities.

TBG Investment

In the first quarter of 2022, we sold our Tropicana, Naked and other select juice brands to PAI Partners, while retaining a 39% noncontrolling interest in TBG, operating across North America and Europe. We have significant influence over our investment in TBG and account for our investment under the equity method, recognizing our proportionate share of TBG’s earnings on our income statement (recorded in selling, general and administrative expenses). See Note 13 for further information.

In 2023, we recorded our proportionate share of TBG’s earnings, which included an impairment of TBG’s indefinite-lived intangible assets, and recorded an other-than-temporary impairment of our investment, both of which resulted in pre-tax impairment charges of $321 million ($243 million after-tax or $0.18 per share), recorded in selling, general and administrative expenses in our PBNA division. We estimated the fair value of our ownership in TBG using discounted cash flows and an option pricing model related to our liquidation preference in TBG, which we categorized as Level 3 in the fair value hierarchy.

In 2024, after identifying several indicators of impairment such as worsening operating losses and liquidity position, we quantitatively assessed our investment in TBG for impairment and, consequently, recorded an other-than-temporary impairment of our remaining investment, resulting in pre-tax impairment charges of $498 million ($416 million after-tax or $0.30 per share), with $409 million in our PBNA division and $89 million in our Europe division, recorded in selling, general and administrative expenses. We estimated the fair value of our ownership in TBG using discounted cash flows. We also recorded an allowance for expected credit losses in selling, general and administrative expenses in 2024, primarily related to outstanding receivables associated with the Juice Transaction; see Note 1 for further information.

103

Table of Contents

Recurring Fair Value Measurements

The fair values of our financial assets and liabilities as of December 28, 2024 and December 30, 2023 are categorized as follows:

[[GREPCENT_TABLE]]
[["","","","2024","","2023"],["","Fair Value Hierarchy Levels(a)","","Assets(a)","","Liabilities(a)","","Assets(a)","","Liabilities(a)"],["Available-for-sale debt securities (b)","3, 2","","$","1,041","","","$","\u2014","","","$","1,334","","","$","\u2014"],["Index funds (c)","1","","$","336","","","$","\u2014","","","$","292","","","$","\u2014"],["Prepaid forward contracts (d)","2","","$","15","","","$","\u2014","","","$","13","","","$","\u2014"],["Deferred compensation (e)","2","","$","\u2014","","","$","503","","","$","\u2014","","","$","477"],["Derivatives designated as fair value hedging instruments:"],["Interest rate swap contracts (f)","2","","$","\u2014","","","$","46","","","$","\u2014","","","$","\u2014"],["Derivatives designated as cash flow hedging instruments:"],["Foreign exchange contracts (g)","2","","$","55","","","$","3","","","$","3","","","$","31"],["Cross-currency contracts (g)","2","","\u2014","","","165","","","5","","","135"],["Commodity contracts (h)","2","","27","","","6","","","10","","","24"],["","","","$","82","","","$","174","","","$","18","","","$","190"],["Derivatives designated as net investment hedging instruments:"],["Cross-currency contracts (g)","2","","$","1","","","$","4","","","$","\u2014","","","$","\u2014"],["Derivatives not designated as hedging instruments:"],["Foreign exchange contracts (g)","2","","$","28","","","$","12","","","$","33","","","$","38"],["Commodity contracts (h)","2","","3","","","10","","","5","","","13"],["","","","$","31","","","$","22","","","$","38","","","$","51"],["Total derivatives at fair value (i)","","","$","114","","","$","246","","","$","56","","","$","241"],["Total","","","$","1,506","","","$","749","","","$","1,695","","","$","718"]]
[[/GREPCENT_TABLE]]

(a)Fair value hierarchy levels are defined in Note 7. Unless otherwise noted, financial assets are classified on our balance sheet within prepaid expenses and other current assets and other assets. Financial liabilities are classified on our balance sheet within accounts payable and other current liabilities and other liabilities.

(b)Classified as other assets. Includes Level 3 assets of $1,041 million as of December 28, 2024, and Level 2 assets of $178 million and Level 3 assets of $1,156 million as of December 30, 2023. The fair value of our Level 3 investment in Celsius is estimated using probability-weighted discounted future cash flows based on a Monte Carlo simulation using significant unobservable inputs such as an 80% probability that a certain market-based condition will be met and an average estimated discount rate of 7.3% and 8.1% as of December 28, 2024 and December 30, 2023, respectively, based on Celsius’ estimated synthetic credit rating. The fair value of the other Level 3 investment is estimated using a lattice model primarily based on the underlying stock price, volatility and certain significant unobservable inputs, such as a discount rate of 8.3% as of December 28, 2024, based upon an estimated synthetic credit rating. An increase in the probability that certain market-based conditions will be met or a decrease in the discount rate would result in a higher fair value measurement, while a decrease in the probability that certain market-based conditions will be met or an increase in the discount rate would result in a lower fair value measurement. The fair value of our Level 2 investment as of December 30, 2023 approximates the transaction price and any accrued returns, as well as the amortized cost.

(c)Based on the price of index funds. These investments are classified as short-term investments and are used to manage a portion of market risk arising from our deferred compensation liability.

(d)Based primarily on the price of our common stock.

(e)Based on the fair value of investments corresponding to employees’ investment elections.

(f)Based on Secured Overnight Financing Rate forward rates. As of December 28, 2024, the carrying amount of hedged fixed-rate debt was $1.9 billion, which was classified on the balance sheet within long-term debt obligations.

104

Table of Contents

(g)Based on recently reported market transactions of spot and forward rates.

(h)Primarily based on recently reported market transactions of swap arrangements.

(i)Derivative assets and liabilities are presented on a gross basis on our balance sheet. Amounts subject to enforceable master netting arrangements or similar agreements which are not offset on our balance sheet as of December 28, 2024 and December 30, 2023 were not material. Collateral received or posted against our asset or liability positions was not material. Exchange-traded commodity futures are cash-settled on a daily basis and, therefore, not included in the table.

The carrying amounts of our cash and cash equivalents and short-term investments recorded at amortized cost approximate fair value (classified as Level 2 in the fair value hierarchy) due to their short-term maturity. The fair value of our debt obligations as of December 28, 2024 and December 30, 2023 was $40 billion and $41 billion, respectively, based upon prices of identical or similar instruments in the marketplace, which are considered Level 2 inputs.

Losses/(gains) on our fair value hedges are categorized as follows:

[[GREPCENT_TABLE]]
[["","","","Losses/(Gains) Recognized in Income Statement(a)"],["","","","","2024","","2023"],["Interest rate swap contracts","","","","","$","46","","","$","\u2014"]]
[[/GREPCENT_TABLE]]

(a)Interest rate derivative losses/(gains) are included in net interest expense and other. These losses/(gains) are substantially offset by decreases/increases in the value of the underlying debt, which are also included in net interest expense and other.

Losses/(gains) on our cash flow hedges are categorized as follows:

[[GREPCENT_TABLE]]
[["","","","Losses/(Gains) Recognized in Accumulated Other Comprehensive Loss","","Losses/(Gains)Reclassified fromAccumulated OtherComprehensive Lossinto IncomeStatement(a)"],["","","","","2024","","2023","","2024","","2023"],["Foreign exchange contracts","","","","","$","(101)","","","$","93","","","$","(6)","","","$","61"],["Cross-currency contracts","","","","","46","","","(34)","","","48","","","(31)"],["Commodity contracts","","","","","57","","","149","","","123","","","125"],["Total","","","","","$","2","","","$","208","","","$","165","","","$","155"]]
[[/GREPCENT_TABLE]]

(a)Foreign exchange derivative losses/(gains) are included in net revenue and cost of sales. Cross-currency interest rate swap derivative losses/(gains) are included in selling, general and administrative expenses. Commodity derivative losses/(gains) are included in either cost of sales or selling, general and administrative expenses, depending on the underlying commodity. See Note 11 for further information.

Losses/(gains) on our net investment hedges are categorized as follows:

[[GREPCENT_TABLE]]
[["","","","Losses/(Gains) Recognized in Accumulated Other Comprehensive Loss","","Losses/(Gains) Recognized in Income Statement(a)"],["","","","","","2024","","2023","","2024","","2023"],["Non-derivative debt instruments","","","","","$","(133)","","","$","122","","","$","\u2014","","","$","\u2014"],["Cross-currency contracts","","","","","3","","","\u2014","","","(5)","","","\u2014"],["Total","","","","","$","(130)","","","$","122","","","$","(5)","","","$","\u2014"]]
[[/GREPCENT_TABLE]]

(a)Amount excluded from the assessment of effectiveness recognized in earnings associated with cross-currency interest rate swaps.

105

Table of Contents

Based on current market conditions, we expect to reclassify net gains of $45 million related to our cash flow hedges from accumulated other comprehensive loss within common shareholders’ equity into net income during the next 12 months.

Losses/(gains) recognized in the income statement related to our non-designated hedges are categorized as follows:

[[GREPCENT_TABLE]]
[["","2024","","2023"],["","Cost of sales","","Selling, general and administrative expenses","","Total","","Cost of sales","","Selling, general and administrative expenses","","Total"],["Foreign exchange contracts","$","1","","","$","2","","","$","3","","","$","(1)","","","$","41","","","$","40"],["Commodity contracts","2","","","8","","","10","","","39","","","33","","","72"],["Total","$","3","","","$","10","","","$","13","","","$","38","","","$","74","","","$","112"]]
[[/GREPCENT_TABLE]]

Note 10 — Net Income Attributable to PepsiCo per Common Share

The computations of basic and diluted net income attributable to PepsiCo per common share are as follows:

[[GREPCENT_TABLE]]
[["","2024","","2023","","2022"],["","Income","","Shares(a)","","Income","","Shares(a)","","Income","","Shares(a)"],["Basic net income attributable to PepsiCo per common share","$","6.97","","","","","$","6.59","","","","","$","6.45"],["Net income available for PepsiCo common shareholders","$","9,578","","","1,373","","","$","9,074","","","1,376","","","$","8,910","","","1,380"],["Dilutive securities:"],["Stock options, RSUs, PSUs and other (b)","\u2014","","","5","","","\u2014","","","7","","","\u2014","","","7"],["Diluted","$","9,578","","","1,378","","","$","9,074","","","1,383","","","$","8,910","","","1,387"],["Diluted net income attributable to PepsiCo per common share","$","6.95","","","","","$","6.56","","","","","$","6.42"]]
[[/GREPCENT_TABLE]]

(a)Weighted-average common shares outstanding (in millions).

(b)The dilutive effect of these securities is calculated using the treasury stock method.

The weighted-average amount of antidilutive securities excluded from the calculation of diluted earnings per common share was 4 million, 3 million and immaterial for the years ended December 28, 2024, December 30, 2023 and December 31, 2022, respectively. 

106

Table of Contents

Note 11 — Accumulated Other Comprehensive Loss Attributable to PepsiCo

The changes in the balances of each component of accumulated other comprehensive loss attributable to PepsiCo are as follows:

[[GREPCENT_TABLE]]
[["","Currency Translation Adjustment","","Cash Flow Hedges","","Pension and Retiree Medical","","Available-for-Sale Debt Securities and Other(a)","","Accumulated Other Comprehensive Loss Attributable to PepsiCo"],["Balance as of December 25, 2021 (b)","$","(12,309)","","","$","159","","","$","(2,750)","","","$","2","","","$","(14,898)"],["Other comprehensive (loss)/income before reclassifications (c)","(603)","","","(78)","","","48","","","8","","","(625)"],["Amounts reclassified from accumulated other comprehensive loss","\u2014","","","(129)","","","440","","","\u2014","","","311"],["Net other comprehensive (loss)/income","(603)","","","(207)","","","488","","","8","","","(314)"],["Tax amounts","(36)","","","49","","","(99)","","","(4)","","","(90)"],["Balance as of December 31, 2022 (b)","(12,948)","","","1","","","(2,361)","","","6","","","(15,302)"],["Other comprehensive (loss)/income before reclassifications (d)","(442)","","","(188)","","","(493)","","","608","","","(515)"],["Amounts reclassified from accumulated other comprehensive loss","108","","","146","","","37","","","\u2014","","","291"],["Net other comprehensive (loss)/income","(334)","","","(42)","","","(456)","","","608","","","(224)"],["Tax amounts","27","","","10","","","98","","","(143)","","","(8)"],["Balance as of December 30, 2023 (b)","(13,255)","","","(31)","","","(2,719)","","","471","","","(15,534)"],["Other comprehensive loss before reclassifications (e)","(1,965)","","","(6)","","","(280)","","","(306)","","","(2,557)"],["Amounts reclassified from accumulated other comprehensive loss","\u2014","","","158","","","285","","","\u2014","","","443"],["Net other comprehensive (loss)/income","(1,965)","","","152","","","5","","","(306)","","","(2,114)"],["Tax amounts","3","","","(39)","","","\u2014","","","72","","","36"],["Balance as of December 28, 2024 (b)","$","(15,217)","","","$","82","","","$","(2,714)","","","$","237","","","$","(17,612)"]]
[[/GREPCENT_TABLE]]

(a)The movements primarily represent fair value changes in available-for-sale debt securities, including our investment in Celsius convertible preferred stock. See Note 9 for further information.

(b)Pension and retiree medical amounts are net of taxes of $1,283 million as of December 25, 2021, $1,184 million as of December 31, 2022 and $1,282 million as of both December 30, 2023 and December 28, 2024.

(c)Currency translation adjustment primarily reflects depreciation of the Egyptian pound and British pound sterling.

(d)Currency translation adjustment primarily reflects depreciation of the Russian ruble and South African rand, partially offset by appreciation of the Mexican peso.

(e)Currency translation adjustment primarily reflects depreciation of the Mexican peso and Russian ruble.

107

Table of Contents

The following table summarizes the reclassifications from accumulated other comprehensive loss to the income statement:

[[GREPCENT_TABLE]]
[["","Amount Reclassified from Accumulated Other Comprehensive Loss","","Affected Line Item in the Income Statement"],["","2024","","2023","","2022"],["Currency translation:"],["Divestitures","$","\u2014","","","$","108","","","$","\u2014","","","Selling, general and administrative expenses"],["Cash flow hedges:"],["Foreign exchange contracts","$","(1)","","","$","(3)","","","$","(11)","","","Net revenue"],["Foreign exchange contracts","(5)","","","64","","","(10)","","","Cost of sales"],["Cross-currency contracts","48","","","(31)","","","159","","","Selling, general and administrative expenses"],["Interest rate swap contracts","(7)","","","(9)","","","\u2014","","","Selling, general and administrative expenses"],["Commodity contracts","122","","","126","","","(252)","","","Cost of sales"],["Commodity contracts","1","","","(1)","","","(15)","","","Selling, general and administrative expenses"],["Net losses/(gains) before tax","158","","","146","","","(129)"],["Tax amounts","(37)","","","(39)","","","23"],["Net losses/(gains) after tax","$","121","","","$","107","","","$","(106)"],["Pension and retiree medical items:"],["Amortization of net prior service credit","$","(31)","","","$","(33)","","","$","(37)","","","Other pension and retiree medical benefits (expense)/income"],["Amortization of net losses","73","","","56","","","164","","","Other pension and retiree medical benefits (expense)/income"],["Settlement/curtailment losses","243","","","14","","","313","","","Other pension and retiree medical benefits (expense)/income"],["Net losses before tax","285","","","37","","","440"],["Tax amounts","(62)","","","(7)","","","(80)"],["Net losses after tax","$","223","","","$","30","","","$","360"],["Total net losses reclassified for the year, net of tax","$","344","","","$","245","","","$","254"]]
[[/GREPCENT_TABLE]]

Note 12 — Leases

Lessee

We determine whether an arrangement is a lease at inception. We have operating leases for plants, warehouses, distribution centers, storage facilities, offices and other facilities, as well as machinery and equipment, including fleet. Our leases generally have remaining lease terms of up to 20 years, some of which include options to extend the lease term for up to five years and some of which include options to terminate the lease within one year. We consider these options in determining the lease term used to establish our right-of-use assets and lease liabilities. Our lease agreements do not contain any material residual value guarantees or material restrictive covenants.

As most of our leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments.

We have lease agreements that contain both lease and non-lease components. For real estate leases, we account for lease components together with non-lease components (e.g., common-area maintenance).

108

Table of Contents

Components of lease cost are as follows:

[[GREPCENT_TABLE]]
[["","2024","","2023","","2022"],["Operating lease cost (a)","$","788","","","$","666","","","$","585"],["Variable lease cost (b)","$","165","","","$","146","","","$","115"],["Short-term lease cost (c)","$","566","","","$","582","","","$","510"]]
[[/GREPCENT_TABLE]]

(a)Includes right-of-use asset amortization of $655 million, $570 million, and $517 million in 2024, 2023, and 2022, respectively.

(b)Primarily related to adjustments for inflation, common-area maintenance and property tax.

(c)Not recorded on our balance sheet.

In 2024, 2023 and 2022, we recognized gains of $118 million, $52 million and $175 million, respectively, on sale-leaseback transactions with terms generally under five years.

Supplemental cash flow information and non-cash activity related to our operating leases are as follows:

[[GREPCENT_TABLE]]
[["","2024","","2023","","2022"],["Operating cash flow information:"],["Cash paid for amounts included in the measurement of lease liabilities","$","775","","","$","655","","","$","573"],["Non-cash activity:"],["Right-of-use assets obtained in exchange for lease obligations","$","1,218","","","$","1,088","","","$","871"]]
[[/GREPCENT_TABLE]]

Supplemental balance sheet information related to our operating leases is as follows:

[[GREPCENT_TABLE]]
[["","","Balance Sheet Classification","","2024","","2023"],["Right-of-use assets","","Other assets","","$","3,383","","","$","2,905"],["Current lease liabilities","","Accounts payable and other current liabilities","","$","642","","","$","556"],["Non-current lease liabilities","","Other liabilities","","$","2,803","","","$","2,400"]]
[[/GREPCENT_TABLE]]

Weighted-average remaining lease term and discount rate for our operating leases are as follows:

[[GREPCENT_TABLE]]
[["","2024","","2023","","2022"],["Weighted-average remaining lease term","7 years","","7 years","","7 years"],["Weighted-average discount rate","4","%","","4","%","","3","%"]]
[[/GREPCENT_TABLE]]

Maturities of lease liabilities by year for our operating leases are as follows:

[[GREPCENT_TABLE]]
[["2025","$","770"],["2026","680"],["2027","579"],["2028","478"],["2029","377"],["2030 and beyond","1,129"],["Total lease payments","4,013"],["Less: Imputed interest","568"],["Present value of lease liabilities","$","3,445"]]
[[/GREPCENT_TABLE]]

Finance leases were not material as of December 28, 2024, December 30, 2023 and December 31, 2022.

Lessor

We have various arrangements for certain foodservice and vending equipment under which we are the lessor. These leases meet the criteria for operating lease classification. Lease income associated with these leases is not material.

109

Table of Contents

Note 13 — Acquisitions and Divestitures

Acquisition of remaining ownership in Sabra

On December 3, 2024, we acquired the Strauss Group’s 50% ownership in Sabra for total consideration of $241 million in cash, resulting in Sabra becoming a wholly-owned subsidiary. Upon consolidation, we recognized a pre-tax gain of $122 million ($92 million after-tax or $0.07 per share) in our FLNA division, recorded in selling, general and administrative expenses, related to the remeasurement of our previously held 50% equity ownership in Sabra at fair value using a combination of the transaction price, net of a control premium, and discounted cash flows.

We accounted for the acquisition as a business combination in the fourth quarter of 2024. We recognized and measured the identifiable assets acquired and liabilities assumed at their estimated fair values on the date of acquisition, in our FLNA division. The preliminary estimates of the fair value of the identifiable assets acquired and liabilities assumed in this transaction as of the acquisition date primarily include goodwill and other intangible assets of $0.3 billion and property, plant and equipment of $0.1 billion. The preliminary estimates of the fair value of identifiable assets acquired and liabilities assumed are subject to revision, which may result in adjustments to the preliminary values discussed above as valuations are finalized. We expect to finalize these amounts as soon as possible, but no later than the fourth quarter of 2025.

Acquisition of Siete

On January 17, 2025, we acquired all of the outstanding equity interest in Siete, a Mexican-American foods business, in a transaction valued at approximately $1.2 billion. The total consideration transferred was approximately $1.2 billion in cash. The purchase price will be adjusted for net working capital and net debt amounts as of the acquisition date.

We will account for the transaction as a business combination in the first quarter of 2025. We will recognize and measure the identifiable assets acquired and liabilities assumed at their estimated fair values on the date of acquisition. The identifiable assets acquired and liabilities assumed in Siete as of the acquisition date, which primarily include goodwill and other intangible assets, will be based on preliminary estimates that are subject to revisions and may result in adjustments to the preliminary values as valuations are finalized. We expect to finalize these amounts as soon as possible, but no later than the first quarter of 2026.

Juice Transaction

In the first quarter of 2022, we sold our Tropicana, Naked and other select juice brands to PAI Partners for approximately $3.5 billion in cash, subject to purchase price adjustments, and a 39% noncontrolling interest in TBG, operating across North America and Europe. The North America portion of the transaction was completed on January 24, 2022 and the Europe portion of the transaction was completed on February 1, 2022. In the United States, PepsiCo acts as the exclusive distributor for TBG’s portfolio of brands for small-format and foodservice customers with chilled DSD. We have significant influence over our investment in TBG and account for our investment under the equity method, recognizing our proportionate share of TBG’s earnings on our income statement (recorded in selling, general and administrative expenses).

As a result of this transaction, in the year ended December 31, 2022, we recorded a gain in our PBNA and Europe divisions (see detailed income statement activity below), including $520 million related to the remeasurement of our 39% ownership in TBG at fair value using a combination of the transaction price, discounted cash flows and an option pricing model related to our liquidation preference in TBG. In the fourth quarter of 2022, we reached an agreement on final purchase price adjustments for net working

110

Table of Contents

capital and net debt amounts as of the transaction close date compared to targeted amounts set forth in the purchase agreement.

A summary of income statement activity related to the Juice Transaction for the year ended December 31, 2022 is as follows:

[[GREPCENT_TABLE]]
[["","PBNA","","Europe","","Corporate","","Total PepsiCo","","Provision for income taxes(a)","","Net income attributable to PepsiCo","","Impact on net income attributable to PepsiCo per common share"],["Gain associated with the Juice Transaction","$","(3,029)","","","$","(292)","","","$","\u2014","","","$","(3,321)","","","$","433","","","$","(2,888)","","","$","2.08"],["Acquisition and divestiture-related charges","51","","","14","","","6","","","71","","","(13)","","","58","","","(0.04)"],["Operating profit","$","(2,978)","","","$","(278)","","","$","6","","","(3,250)","","","420","","","(2,830)","","","2.04"],["Other pension and retiree medical benefits income (b)","","","","","","","(10)","","","3","","","(7)","","","0.01"],["Total Juice Transaction","","","","","","","$","(3,260)","","","$","423","","","$","(2,837)","","","$","2.04","","(c)"]]
[[/GREPCENT_TABLE]]

(a)Includes $186 million of deferred tax expense related to the recognition of our investment in TBG.

(b)Includes $16 million curtailment gain, partially offset by $6 million special termination benefits.

(c)Does not sum due to rounding.

In connection with the sale, we entered into a transition services agreement with PAI Partners, under which we provide certain services to TBG to help facilitate an orderly transition of the business following the sale. In return for these services, TBG is required to pay certain agreed upon fees to reimburse us for our costs without markup.

The Juice Transaction did not meet the criteria to be classified as discontinued operations.

In the years ended December 28, 2024 and December 30, 2023, we recognized impairment and other charges related to our TBG investment. See Notes 1 and 9 for further information.

Acquisition and Divestiture-Related Charges

Acquisition and divestiture-related charges primarily include transaction expenses, such as consulting, advisory and other professional fees, and merger and integration charges. Merger and integration charges include employee-related costs, contract termination costs, closing costs and other integration costs.

A summary of our acquisition and divestiture-related charges is as follows:

[[GREPCENT_TABLE]]
[["","2024","","2023","","2022"],["FLNA","$","9","","","$","\u2014","","","$","\u2014"],["PBNA","8","","","16","","","51"],["Europe (a)","\u2014","","","(2)","","","14"],["AMESA","5","","","2","","","3"],["APAC","\u2014","","","\u2014","","","\u2014"],["Corporate","\u2014","","","25","","","6"],["Total (b)","22","","","41","","","74"],["Other pension and retiree medical benefits expense","\u2014","","","\u2014","","","6"],["Total acquisition and divestiture-related charges","$","22","","","$","41","","","$","80"],["After-tax amount","$","18","","","$","23","","","$","66"],["Impact on net income attributable to PepsiCo per common share","$","(0.01)","","","$","(0.02)","","","$","(0.05)"]]
[[/GREPCENT_TABLE]]

(a)Income amount represents adjustments for changes in estimates of previously recorded amounts.

(b)Recorded in selling, general and administrative expenses.

111

Table of Contents

Note 14 — Supply Chain Financing Arrangements

As part of our evolving market practices, we work with our suppliers to optimize our terms and conditions, which include the extension of payment terms. Our current payment terms with a majority of our suppliers generally range from 60 to 90 days, which we deem to be commercially reasonable. We will continue to monitor economic conditions and market practice working with our suppliers to adjust as necessary. We also maintain voluntary supply chain finance agreements with several participating global financial institutions. Under these agreements, our suppliers, at their sole discretion, may elect to sell their accounts receivable with PepsiCo to these participating global financial institutions. Supplier participation in these financing arrangements is voluntary. Our suppliers negotiate their financing agreements directly with the respective global financial institutions and we are not a party to these agreements. These financing arrangements allow participating suppliers to leverage PepsiCo’s creditworthiness in establishing credit spreads and associated costs, which generally provides our suppliers with more favorable terms than they would be able to secure on their own. Neither PepsiCo nor any of its subsidiaries provide any guarantees to any third party in connection with these financing arrangements. We have no economic interest in our suppliers’ decision to participate in these agreements. Our obligations to our suppliers, including amounts due and scheduled payment terms, are not impacted. All outstanding amounts related to suppliers participating in such financing arrangements are recorded within accounts payable and other current liabilities in our consolidated balance sheet.

A summary of our outstanding obligations confirmed as valid under the supplier finance program for the year ended December 28, 2024 is as follows:

[[GREPCENT_TABLE]]
[["","2024"],["Confirmed obligations outstanding at beginning of year","$","1,655"],["Invoices confirmed","6,552"],["Confirmed invoices paid","(6,636)"],["Translation and other","(93)"],["Confirmed obligations outstanding at end of year","$","1,478"]]
[[/GREPCENT_TABLE]]

112

Table of Contents

Note 15 — Supplemental Financial Information

Balance Sheet

[[GREPCENT_TABLE]]
[["","","","2024","","2023","","2022"],["Accounts and notes receivable"],["Trade receivables","","","$","8,487","","","$","8,675"],["Other receivables","","","2,202","","","2,315"],["Total","","","10,689","","","10,990"],["Allowance, beginning of year","","","175","","","150","","","$","147"],["Net amounts charged to expense (a)","","","228","","","55","","","21"],["Deductions","","","(36)","","","(26)","","","(12)"],["Translation and other","","","(11)","","","(4)","","","(6)"],["Allowance, end of year","","","356","","","175","","","$","150"],["Accounts and notes receivable, net","","","$","10,333","","","$","10,815"],["Property, plant and equipment, net","Average Useful Life (Years)"],["Land","","","$","1,136","","","$","1,159"],["Buildings and improvements","15 - 44","","11,938","","","11,579"],["Machinery and equipment, including fleet and software","5 - 15","","36,990","","","36,006"],["Construction in progress","","","5,941","","","5,695"],["","","","56,005","","","54,439"],["Accumulated depreciation","","","(27,997)","","","(27,400)"],["Property, plant and equipment, net","","","$","28,008","","","$","27,039"],["Depreciation expense","","","$","2,945","","","$","2,714","","","$","2,523"],["Other assets"],["Noncurrent notes and accounts receivable","","","$","111","","","$","200"],["Deferred marketplace spending","","","100","","","103"],["Pension plans (b)","","","1,190","","","1,057"],["Right-of-use assets (c)","","","3,383","","","2,905"],["Other investments (d)","","","1,346","","","1,616"],["Other","","","821","","","780"],["Total","","","$","6,951","","","$","6,661"],["Accounts payable and other current liabilities"],["Accounts payable (e)","","","$","10,997","","","$","11,635"],["Accrued marketplace spending","","","3,458","","","3,523"],["Accrued compensation and benefits","","","2,256","","","2,687"],["Dividends payable","","","1,885","","","1,767"],["Current lease liabilities","","","642","","","556"],["Other current liabilities","","","5,216","","","4,969"],["Total","","","$","24,454","","","$","25,137"]]
[[/GREPCENT_TABLE]]

(a)Increase primarily reflects an allowance for expected credit losses related to outstanding receivables from TBG associated with the Juice Transaction; see Note 1 for further information.

(b)See Note 7 for further information.

(c)See Note 12 for further information.

(d)Includes our investment in Celsius convertible preferred stock. See Note 9 for further information.

(e)Primarily reflects a decrease in capital expenditure payables, currency translation adjustments, as well as timing of payments.

113

Table of Contents

Statement of Cash Flows

[[GREPCENT_TABLE]]
[["","2024","","2023","","2022"],["Interest paid (a)","$","1,585","","","$","1,401","","","$","1,043"],["Income taxes paid, net of refunds (b)","$","3,064","","","$","2,532","","","$","2,766"]]
[[/GREPCENT_TABLE]]

(a)2022 excludes the premiums paid in accordance with certain debt transactions. See Note 8 for further information.

(b)Includes tax payments of $579 million in 2024, and $309 million in each of 2023 and 2022, related to the TCJ Act.

Supplemental Non-Cash Activity

[[GREPCENT_TABLE]]
[["","2024","","2023","","2022"],["Debt discharged via legal defeasance","$","\u2014","","","$","94","","","$","\u2014"]]
[[/GREPCENT_TABLE]]

The following table provides a reconciliation of cash and cash equivalents and restricted cash as reported within the balance sheet to the same items as reported in the cash flow statement:

[[GREPCENT_TABLE]]
[["","2024","","2023"],["Cash and cash equivalents","$","8,505","","","$","9,711"],["Restricted cash included in other assets (a)","48","","","50"],["Total cash and cash equivalents and restricted cash","$","8,553","","","$","9,761"]]
[[/GREPCENT_TABLE]]

(a)Primarily relates to collateral posted against certain of our derivative positions.

Note 16 — Legal Contingencies

The Company is party to a variety of litigation, claims, legal or regulatory proceedings, inquiries and investigations. While the results of such litigation, claims, legal or regulatory proceedings, inquiries and investigations cannot be predicted with certainty, management believes that the final outcome of the foregoing will not have a material adverse effect on our financial condition, results of operations or cash flows.

114

Table of Contents